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Abstract: 
The Mtr (Multiple transferable resistance) transport system in Neisseria gonorrhoeae was 
found to confer the resistance of gonococci to penicillin and structural diverse hydrophobic 
agents (HAs), such as daigs, dyes, detergents and host-derived compounds (fatty acids and 
bile salts), as well as some cationic antimicrobial peptides. The mtr operon encodes an 
energy-dependant efflux pump system and this MtrC-MtrD-MtrE system is negatively 
regulated by the transcriptional repressor MtrR. 
The first part of this thesis presents insights into a structural study of the two membrane 
components, the inner membrane protein MtrD and the outer membrane protein MtrE. MtrD 
and MtrE have been overexpressed, purified and ci7Stallized using the sitting-drop 
vapour-diffusion method. Unfoitunately, due to the difficulty of membrane protein 
crystallography, the best resolution of the MtrE crystals was only 8A and of the MtrD ci-ystals 
was 20A, so the stmctures of both MtrE and MtrD haven't been solved yet. However, this 
preliminary X-ray analysis leads to the possibility of solving these stmctures in the near 
future. In the mean time, using pull-down assay, growth curve analyses and ITC( Isothermal 
Titration Calorimetry), we established that the antiporter MtrD, the adaptor MtrC and the 
ouier membrane protein MtrE fomT a contiguous complex. Assembly of the pump is 
constitutive, even in absence of substrate. Without the assistance of MtrC, MtrD was unable 
to export its substrate, Nafcil l in, and the efficiency of this assembly could be enhanced by the 
presence of the outer membrane protein MtrE. MtrD could interact with MtiE independently 
in pull-down assays, showing they can form a complex even in the absence of MtrC. This 
behaviour is consistant with the increased hypersensitivity to Vancomycin of the recombinant 
strain expressing MtrE-MtrD, which indicated that MtrE could be opened by MtrD in the 
presence of the substrate. However, the interaction between them was not detected by ITC, 
suggesting this interaction is weak or energetically unfavourable. The a-helical hairpin 
domain of MtrC was also overexpressed and purified to test for its interaction with MtrE or 
MtrD. Fascinatingly, the cross-linked hairpin formed a hexamer and A F M (Atomic Force 
Microscopy) studies revealed it arranged into a cylindrical structure. In addition, ITC studies 
revealed that the haiipin domain could bind to both MtrE and MtrD, suggesting that MtrC 
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might form a channel, one end of which interacts with MtrD and the other with MtrE. Growth 
curves also showed that the periplasmic hairpin domain could enhance the transport activity 
of MtrCDE, but couldn't activate the transport of MirD. indicating it probably works by 
stabilizeing the open form of MtrE. 
The expression of mtiCDE is believed to be under the control of a TetR-type 
transcriptional regulator repressor, mirR. MtrR forms a dimer but with presence of dsDNA, it 
fomis a tetramer. Fragments of the antimicrobial polypeptide LL-37 were synthesized and 
tested by titrating to MtrR by ITC. The C-tenninal of LL-37(29-37) is the part that binds to 
MtiR and N-terminal (1-11) is not. Interesdngly, interaction of MtrR with Penicillin G 
demonstrated for first time that MtrR might work as a P-lactamase; with its enzyme activity 
reduced after mutaniing Hisl05 to Tyr, which was reported to be found naturally in penicillin 
sensitive A'', iionorrhoeae strains. 
Chapter 1 Introduction-Antibiotic resistance 
1.1 antibiotics and antibiotics resistance 
An antimicrobial is a substance that can either k i l l or inhibit the growth of 
microorganism, such as bacteria, fungi. The discovery of antibiotics started with the 
observation that the growth of one type of bacteria can inhibit the growth of another. In term 
of usage, antibiotic refers to any drugs that cure a bacterial infection. 
Among the antimicrobial, the antibiotics are natural or synthetic compounds that kills or 
inhibits the growth o f bacteria. The most well-known antibiotic is penicillin, which was 
adopted as a medicine in 1940'. Following the success of the penicillin, a lot of antibiotics 
were discovered by screening a bacteria extract against other bacteria. The antimicrobial 
agents are categorized by their principle mechanisms of action, which include interference 
with the synthesis of the cell wall; the inhibition of the synthesis of proteins or nucleic acids; 
the inhibition of metabolic pathway or disruption of bacterial membranes. The use of 
antibiotics has created a possibility for human beings to combate bacterial infections. 
However, nowadays, the treatment of bacterial infection is increasly complicated by the 
development of resistance of bacteria to antimicrobial agents. Antibiotic resistance is an 
ability of microorganism to withstand the existence of the antibiotic, and is a consequence of 
mutation and natural selection. 
1.2 Mechanisms of antibiotics resistance 
Microorganism may aquire resistance to antimicrobial agents through a variety of 
mechanisms. The four main mechanisms are described below. 
Drug inactivation or modification 
Production of beta-Iactamases is one of the commonest mechanisms of bacterial 
resistance to beta-lactam antibiotics. They work on beta-lactam antibiotics by breaking the 
beta-lactam ring open. Among the gram negative bacteria, it appeared initially in a limited 
number of bacterial species (E. cloacae , C. Jreiinclii. S. niarcescens, and P. aeruginosa ) that 
could mutate lo hypcrproduce their chromosomal class C P-lactamase. A few years later, 
resistance appeared in bacterial species not naturally producing AmpC enzymes (A'. 
pneumoniae. Salmonella .spp.. P. mirabilis) due to the production of extended-spectrum 
beta-lactamases (ESBLs)(Philippon ef al., 2002). 
Alteration of target site 
Modifying the target sites of antibiotics is another common mechanism of antibiotic 
resistance. In addition to the production of beta-lactamases, the resistance to beta-lactam 
antibiotics can also result from mutations in Penicillin Binding Proteins (PBP). Penicillin 
Binding Proteins (PBPs) are a group of proteins that can bind Penicillin, they can catalyze the 
polymerization of the glycan strand and the cross-linking between glycan chains. Upon 
binding with Penicillin their peptidoglycan cross-linking capability can be impaired, therefore 
disrupt the construction of cell wall. It has been found that in many beta-lactam antibiotics 
resistant strains, like Streptococcus pneumoniae(¥rere, 1995; Ward et al., 2007; Zaitseva el 
al., 2005) , Neisseria gonorrhoeaeiVonl^nz et al., 1990; Takahala et al., 2006) and in 
Enterococci J'aecalis{K^\Q\-\mam et al.. 1996), the alterations mainly cause a decreased in 
affinity of the PBP for beta-lactam antibiotics. 
The resistance to glycopeptide antibiotics was considered to be related to the various 
changes in the target of Vancomycin, the D-Ala-A-Ala tenninus of the stem peptide of the 
peptideoglycan precursor. In glycopeplide resistant Staphylococcus aureus strains, the cell 
wall was found to have an increased content of glutamate, a decreased level of cross-linking 
of peptidoglycan and a decreased dimeric muropeptide/monomeric muropeptide 
ratio(Boyle-Vavra et al., 2001; I-Janaki et al., 1998). Al l of this contributes to the lower 
binding affinity to cell wall or decreased amount of vancomycin available to reach 
D-Ala-A-Ala peptidoglyan precursor target. 
In the study of D N A gyrase and topoisomerase f V , which are the two enzymes involved 
in bacterial DNA synthesis and also the target of quinolone antimicrobial agents, the mutation 
was found to be related to a reduced binding of drags to the DNA-gyrase complex(Willmott 
and Maxwell, 1993). 
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Alteration of metabolic pathway 
The sulfa drugs are used to treat the infection that is caused by bacteria and diseases that 
are caused by eukaryotes, such as, the cause of the pneumonia in HIV patients. The targets of 
sulfa antibiotics are two enzymes in the folic acid synthesis pathway, dihydropteroate 
synthase (DHPS) and the dihydrofolate reductase (DHFR). They can compete with the natural 
substrate para-aminobenzoic acid (pABA), therefore depletes the cell o f folates, causing 
death(Patel etal.,2003). 
In addition to the sequence alteration in DHPS caused by mutation, the utilisation of 
exogenous folic acid has also been found to be one mechanism o f sulfa drug resistance. In 
DHPS and DHFR knock out Pneumocystis carinii, which lack the related synthesis pathway, 
the selected mutants can grow with the presence of folic acid in the mediuiTi(Bayly et al., 
2001; Bayly and Macreadie, 2002), indicating that the cells can utilise the prefonned folic 
acid like mammalian cells. 
Reduced drug accumulation 
Reducing the dmg accumulation can be achieved by either changing the penneability of 
the cell membrane or by activating drug efflux pumps. 
In Pseudomonas aeruginosa, drug resistance can be caused by a lack of the D2 porin 
protein in the outer membrane protein(Trias and Nikaido, 1990b), which plays a 
physiologically significant role in the uptake of basic amino acids and peptides containing 
these amino acids across the outer membrane(Trias and Nikaido, 1990a). This outer 
membrane protein is also used to take up drugs, therefore lack of it can prevent the drugs to 
get through outer membrane and reach their targets. 
Another way to reduce drug accumulation is via energy-driven antibiotic efflux pumps, 
which are found in both gram positive and negative bacteria. According to the bioenergetic 
requirement, the multidaig transporters can be classified into primary and secondary-active 
transporters. In the primary-active transporters, such as ABC (ATP-binding cassette) 
transporters, the energy that is used to drive the transport of substrates directly comes from 
the hydrolysis of ATP; however, in secondary transporters, the transport is driven by 
chemiosmotic energy produced by electrochemical gradient of proton/sodium ions. 
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1.3 Multidrug transporters 
The active efflux of drugs has been considered as a major mechanism of multidrug 
resistance. It has been found ubiquitously from microorganisms to human caner cell. As 
described before, they can be classified into primary and secondary active pumps by the 
resource o f the energy that is used to drive the substrates efflux. The primary active pumps 
include ABC pumps that utilise the hydrolysis ATP as driving energy; the secondary active 
pumps include proton driven transporters, including the Resistance-nodulation-cell division 
(RND) super family, the Major facilitator super family (MPS) and the Small multidrug 
resistance super family (SMR). There is another super family called the Multidrug and toxic 
compound extrusion (MATE) super family that are driven by a sodium gradient 
(Borges-Walmsley et ai, 2003; Cattoir, 2004; Hasdemir, 2007). 
Figure 1.1 Five well-characterised super families involved in multidrug efflux (McKeegan et 
ai, 2004) 
A highly simplified representation of the five major super families that are included in multidrug 
transport. The RND family is shown as a triparrite complex in gram negative cells, which have an iimer 
and outer membrane. The complex is formed by three components, an outer membrane protein (OMP), 
an inner membrane protein (IMP) and a membrane fusion protein (MFP). 
Extracellular 
periplasm 
j m MATE 
Cytoplasm ATP ADP.Pi 
1.3.1 ATP-binding cassette (ABC) transporters 
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ABC transporters are a group of integral membrane protein that use the energy from 
ATP hydrolysis to transport substrates across biological membranes. The core of this group of 
membrane transporters is composed of two domains according to their position and functions, 
the transmenbrane domains (TMDs) and the nucleotide-binding domains (NBDs). Based on 
the direction of transport activity, ABC transporters can be divided into two subtypes, 
importers and exporters. In ABC importers, the TMDs and NBDs are separate polypeptides 
and transport needs the assistance of a substrate binding protein, but in bacterial exporters, a 
single gene usually encodes both the transmembrane domain and its partner ATP-binding 
domain, so that one T M D is fused to one NBD and the substrates are delivered directly from 
the cytoplasm.(Davidson and Maloney, 2007; Hollenstein el a!., 2007a). 
To date, the stmctures of six ABC transporters are available. Four of them are importers: 
the Vitamin B12 transporter BtuCD from Escherichia coli (Hvoaip er «/., 2007; Locher el ai, 
2002), the putative metal-chelate-type transporter H11470/1 from Heamophiliis influenzae 
(Pinketl el a/., 2007), the molybdate transporter ModB2C2 from Archaeoglohus fulgichis 
(Hollenstein et ai, 2007b) and the maltose uptake system MalFGK.2 from Escherichia coli 
(Oldham et ai, 2007). There are currently two structures for ABC exporters, the multidrug 
transporter Savl866 from Siaphylococcus aureus (Dawson and Locher, 2006) and the lipid 
flippase MsbA from Escherichia coli. Salmonella lyphimurium and vibrio cholerae (Ward el 
al., 2007). We wil l now discuss the structurally relevant features and a common mechanism 
that rationalize the ATP-driven substrate transport. 
Figure 1.2 Six cunently available crystal stnictures of ABC transporters, with the tranporter 
name, organism source and putative function indicated below each graph(Dawson and 
Locher, 2006; Hollenstein et al., 2007b; Hvonip et al., 2007; Oldham el al., 2007; Pinkett el 
a/., 2007; Ward etal.,2001). 
Impovt ABC transporters 
Except H11470/i, the other three transporters are all complex with the correspondence binding 
protein. The TMDs and NBDs are separate subunits. 
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metal-chelate-type transporter 





maltose uptakeing system 
Export ABC transporter 
The TMDs of exporters are fused to the NBDs. 
Sav 1866 staphylococcus aureus 
multidrug transporter 




Typically, the functional forni of the ABC tianporters consists of two hydrophilic 
nucleotide-binding domains that are located at the cytoplasmic side of the membrane and two 
hydrophobic transmembrane domains that are considered to fonn the translocation pathway 
and define the substrate specificity. The nucleotide-binding domain is known to hydrolyze 
ATP, coupling this to transport. Although the ABC superfamily can be divided into several 
subfamilies, their primary sequences of Nucleotide-binding domain are highly conserved. 
The most prominent among the conserved features are the Walker A and Walker B 
motifs, which are also found highly conserved in many enzymes that employ ATP in 
catalysis. The Walker B motif is able to bind both ADP and ATP as required for catalysis; 
whilst the walker A motif is considered to involved in the regulation of ATP synthase 
activity(Walker el «/., 1982). Within the consensus CxxG^GC/KT sequence of the Walker A 
motif it has been found that the cysteine/lysine residue plays a critical role in ATP 
hydrolysis(.Iha el. al., 2003). After substituting the lysine of the maltose transporter, MalK 
from Salmonella typhimiihum. to arginine, although it sti l l retains the capability to bind 
nucleotides, the ATPase activity was greatly reduced{Schneider el al., 1994). [n the mouse 
M D R l protein, mutants that bear the lysine to arginine completely abrogate the ability to 
confer multidmg resistance(Azzaria el al., 1989). The other conserved ATP-binding 
signature, the Walker B motif, is downstream of the Walker A moti f The Walker B motif 
terminates with an Asp residues ( N B D l ) , which has been found to be the catalytic base for 
ATP hydrolysis. It interacts with the Mg"* that chelated the bound ATP. The Glu following 
Asp is also highly conserved, it hydrogen bonds with water and is most the likely candidate 
for 'attacking'water during ATP hydrolysis(Smith el al., 2002). After being changed to 
various of amino acids, although each mutant is able to trap a high amount of nucleotide, the 
nucleotide species trapped is exclusively the ATP form, which indicates the importance of the 
Glu residue of the Walker B motif in ATP hydrolysis(Orelle et al., 2003; Payen et al., 2003). 
Another highly conserved motif, known as the C-loop or family signature motif, is a 
unique feature of each ABC transporter. It has been found in the active conformation of 
NBDs, the signature motif (LSGGQ) from one subunit forms a "nucleotide sandwich" with 
the walker A motif from another subunit(Smith et al., 2002). This was also proved by 
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cross-linking analysis after pairs of cysteines were introduced into the signature motif of 
human multidrug resistance P-glycoprotein (P-gp) and its opposing Walker A motif. This 
indicates that the signature motifs are adjacent to the opposing Walker A site(Loo el al., 
2002). They likely participate in forming the ATP-binding site and are displaced by ATP 
hydrolysis (Buchaklian and Klug, 2006). Numerous of studies have been undertaken to 
substitute the conserved residues in the signature motif to various amino acids. These studies 
have established that the fourth residue glycine plays an important role in the posthydrolytic 
complex formation and is part of the conformational network, which is responsible for the 
accelerated hydrolytic activity upon interaction of transporter with its transported 
substrates(Szentpetery el al., 2004). Some mutagenesis studies have been done to show the 
functions of this moti f It is quite clear that the signature motif is involved in ATP hydrolysis 
during transport. Moreover, some researchers also suggested that this motif is directly 
involved in the transporter function; for example, by acting as a signal transducer between the 
hydrophobic domain and the NBD of the transporter(Browne el al., 1996). 
Transmembrane domains ( T M D ) 
Unlike the NBDs, the transmembrane domains of ABC transporters vai7 in primary 
sequence, length and architecture, and the number of transmembrane helix. 
In the two reported exporter structures, SavI866 from Staphylococcus aureus and MsbA 
from E.coli. it has been found thai they share high similarity. Their TMDs traverse the lipid 
bilayer six times to yield 6 transmembrane helices; for these homodimer transporters, each 
bundle of T M helices consists of TM1-2 from one subunit and TM3-6 from the other subunit. 
Both of them interact with the NBDs through the intracellular loop 1 ( I L L between TM2 and 
TM3) and the intracellular loop 2 (IL2, between TM4 and TM5). They both revealed the 
existence of domain swapping, with one intracellular loop reaching across and contacting the 
opposite NBD. Because the open inward-facing and close inward-facing conformations of 
MsbA have also been reported, it is possible for us now to have a deep look into the 
confoiTnational change that occurs during the substrate translocation, which will be discussed 
in the following section(Dawson and Locher, 2006; Ward et al., 2007). 
From the reported structures of importer ABC transporters, the number of 
transmembrane helices vary from six to ten (ModB2C2A and MalG have 6 T M helices; MalF 
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has 8 and 10 in the cases of BtuCD and HI 1470/1471). The overall architecture of the intact 
metal-chelate-type ABC transporter H11470/1 resembles thai of the Vitamin B12 transporter 
BtuCD. They both have 10 transmembrane helices and a pseudo-two-fold rotation axis relates 
two groups of transmembrane helices and their connecting loops in one subunit (the first 
group comprises TM2 through TM5, whilst the second group comprises TM7 through TMIO, 
but TM1 and TM6 are not related by this symmetry). The interface between the two 
membrane-embedded subunits is fornied by TM5 from one subunit and TMIO from the other 
one, with residues from TM3 and TM8 lining the pemieation pathway. Although these two 
stmctures have similarities, there are still some detailed differences in the tertiary and 
quaternary arrangements between them that may be functionally relevant. An important one is 
that HI 1470/1 and BtuCD adopt inward- and outward-facing conformations respectively. In 
the reported structure of a putative molybdate transporter ModB2C2. each ModB subunit 
crosses the membrane 6 times for a total of 12 transmembrane helices in the transporter, 
which doesn't resembles the structures of other reported ABC transporters. The two ModB 
subunits fonn a large inward-facing cavity, which is presumed to be the translocation 
pathway. The cavity forms a closed "gate'" underneath the interface with the substrate binding 
protein ModA. This gate is composed of four converging protein stretches, two from each 
ModB subunit. Among the four importer ABC transporters, the maltose transporter MalFGK2 
is a unique one. Unlike the other three transporters, the TMDs of M a l F G K 2 are not assembled 
from homodimer, but from a heterodimer; the two T M subunits, MalF and MalG are not 
arranged side-by-side and MalF has eight transmembrane helices whilst MalG only has six. 
As mentioned before, the TMDs of the exporter ABC transporters in the 
nucleotide-binding state interact with the opposite NBDs via intracellular loops. \n the 
importer ABC transporters, their interface is common between TMDs and NBDs. From the 
four reported stnictures, the interface residues of the NBDs are all located in the Q-loop. The 
conformational switching of the Q-Ioop, that has been found may mediate communication 
between the TMDs and NBDs of ABC transporters, and may be involved in the movement of 
the highly conserved glutamine in and out of the catalytic site due to the conformational 
change(Jones and George, 2002). The cytoplasmic loops in TMDs represent a general 
interface with the Q-loop, between the ABC cassette and membrane-spanning domains. It is 
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between T N P and T M S m B t i i C I I I I 4 7 1 and M a l F . but between T M 4 and T M 5 in the cases 
o f M o d B and MalCI. This cytoplasmic loop consists o f two short hehces and has been found 
to undergo conibnnat ional clianges in order to comnuinicale structural changes in the two 
N H I l s upon A T P b ind ing to the two T M D s in M a l F G K : transpoiler(Daus et ai. 2007). 
Mechanism of .ABC transporters 
•As mentioned before, the A B C transporters can be d iv ided into two groups on the basis 
o f their transport d i rect ion and the reaction mechanism. A B C importers need to recruit a 
periplasmic binding-prote in to deliver the substrates to the system, whi le .ABC exporters don't 
need. 
Figure 1.3 A model for maltose transporter(Davidson and Maloney, 2007). 
(a) I hc rc-iting state, the MBP closes atfer the binding ol" a maltose and transfers it to the 
transporter. 
(b) Tlic iransilioii state, after tlic binding of MBP and ATP, the two siibiiifil of the .\1V binding 
cassette close, the ,\TP-acli\ ity is activated: the conformational elianue o f the T.M helices to 
form a translocation pathway that faces the periplasm; MBP releases the maltose into the 
transporter. 
(c) The posthydrol_\'sis state, folUws ing .VTP h\drolysis, in which the mallnse and .ADP are released 
to the C N l o p l a s m : the MBP tlissociates from the transporter; the translocation p;ith\\a_\ changes 
to face the cytoplasm. 
! ^ f MBP 
* 
Maltosp I 1 \ 1 1 
CyJoptasm 
A f P Ai)P + P, 
23 
Among the ABC importers, the best-studied model is ihe maltose transporter, 
MBP-MalFGKi. The following model (Davidson and Maloney, 2007) is based upon several 
important informations that have been found. First, only the ATP and ATP/Mg""^ binding state 
of the NBDs form a dimer, while the nucleotide -free and ADP state are monomeric proteins 
(Zaitseva el al, 2006); second, the interaction of the MBP with MalFGK., stimulates its 
ATPase activity by stabilizing the transition state confomiation of the transporter, there by 
lowering the activation energy for hydrolysis(Chen er al., 2001); third, the MBP binds to 
maltose with high-affinity, acts "open cleft" (without bound sugar) and closed (with bound 
sugar) conformations through a flexible hinge(Spurlino el al., 1991); last, the crystal staicture 
of H11470/1 and ModB^CjA have revealed the resting stale conformation and the transition 
state is based on the stniclure of MBP-MalFGK.2(Hollenstein el al., 2007b; Oldham ei al., 
2007;Pinkett e/fl/.,2007). 
After the report of the three staictures of MsbA, in the open, closed and the nucleotide 
bond staies(Ward el al., 2007). it is now possible to set up a model of the mechanism of the 
exponer ABC transporters. Unlike the importer transporters, exporters do not recruit cognate 
proteins (such as maltose binding protein in maltose transporter IVlalFGK2) to deliver the 
substrate to themselves. In order to achieve the extrusion of the substrates, exporters need to 
commit significant conformational changes. 
Figure 1.4 summary of confonnational change in MsbA(Ward et al., 2007) 
(A) The conformational changes of MsbA from inward to outwards-facing. The T M helices of one 
monomer are highlighted in cyan. Both the open and closed Apo protein form a 
CNloplasmic-facing V chamber between TIV14/5 and TM3/6, which is represent by a red asterisk. 
After the binding of nucleotide, The TM4/TM5 moves and TM3/TM6 splits away from 
TM1/TM2. At the same time, the c>'toplasmic end of the TMDs closes and the periplasmic end 
widens, thereby forming an outward-facing V chamber. 
(B) The cartoon view to elucidate the model above. 
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Open Apo Closed Apo Nucleotide Bound 
The model o f MsbA conformational changes are supported by structural and 
biochemical studies. It has been found that in the resting state o f MsbA, the top of the helical 
bundles is closed (Buchaklian et al., 2004) and form a V shaped conformation that faces the 
cytoplasm(Dong et al., 2005). Dong J. et al has provided the evidence for a large 
conformational change upon the binding of nucleotide by electron paramagnetic spin 
resonance (EPR), which is consistent with the change from the open apo conformation to the 
nucleotide bound conformation(Dong et al., 2005). Moreover, this structural transition also 
consistant with the distance measurements by pulse dipolar spectroscopy and fluorescence 
homotransfer, which indicates that the substrate binds to the open chamber at the cytoplasmic 
side o f MsbA and they undergo a significant conformational change to fo rm a dimer after the 
binding of ATP(Borbat et al., 2007). Large conformational changes (50 A) of domains in a 
transporter during its transport cycle have also been observed for P-type ATPases such as the 
Ca^^-ATPase(Toyoshima and hiesi, 2004).The structure o f the ABC exporter Savl866 
demonstrates the structure of the nucleotide bound conformation, in which there is 
dimerization of the NBDs with bound nucleotide, whilst the periplasmic facing chamber is 
also in agreement with the nucleotide binding conformation o f MsbA(Dawson and Locher, 
2006). However, some biochemical studies are not consistent with this model, they mainly 
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question the existence of the cytoplasmic facing chamber and the big confomiational change 
upon the binding of ATP(Buchaklian and Klug, 2006: Eckford and Sharom, 2008). Further 
studies on other ABC exporters wi l l be required to evaluate the relevance of these studies for 
other members in the ABC transporter family. 
1.3.2 Proton driven transporters 
This group of transporters belongs to the secondary active transporters. Unlike primary 
active transporters, such as ABC transporters that we described before, there is no direct 
coupling of ATP; instead, the potential proton difference created by pumping ions out of the 
cell is used. These pumps are often termed H^ antiporters and can be categorized into a 
number of families based on their primary structure: SMR (small multidnig resistance) 
family, MF (major facilitator) family and RND (resistance nodulation) family. 
1.3.2.1 Small M i i l t i d a i g Resistance ( S M R ) Family 
The transporters belong to the SMR family are much smaller than those belong to other 
families. Members of the SMR family generally contain 100-120 amino acid residues, which 
are organised into four transmembrane helices. Amongst them, the best characterized one is 
EmrE from Escherichia.coli. which confer resistance to EtBr (ethidium bromide) and Methyl 
Viologen with the coupling of the proton electrochemical gradient(Yeaishalmi el al., 1995). 
Another transporter, EbrAB from Bacillus sublilis, is found to belong to the SMR family as 
well. However, EbrAB likely forms a heterodimer in contrast to the Emi-E homodimer 
(Masaoka eiai, 2000). 
The basic functional unit of EmrE has been shown to be an oligomer, most likely a 
homodimer, which appears to be supported by Cryo-electron microscopy, high-resolution 
size-exclusive chromatography, substrate binding analyses and X-ray crystallography(Butler 
el al., 2004; Chen el al., 2007; Tate et al., 2001; Ubanetxena-Belandia et al., 2003). 
Figure 1.5 the structure of the EmrE homodimer with bound TPP(Chen et al., 2007) 
A: The antiparallel homodimer of EmrE, the two monomers are coloied yellow and blue, the bound 
TPP is pink. 
26 
B: Docking the EmrE-TPP X-ray structure into the EM density map, the two monomers are 
distinguished by asterisks. The red arrow represents the bound substrate in the EM map, which is in 
agreement with the position of TPP in X-ray structure. 
From the E M data (2D-crystal) and X-ray data, the structure of EmrE is an asymmetric 
antiparallel homodimer, consisting of a bundle o f eight transmembrane helices with one 
substrate bound near the centre. The substrate binding chamber is formed from six helices, 
three from each monomer. The two TM4 helices are not involved in forming the binding site 
but only participate in the dimeri2ation interaction with TM1-TM3. At the same time, the 
antiparallel configuration shows that the EmrE protein is inserted into the E.coli membrane in 
two orientations, in common with the report by Gunnar von Heijne group that EmrE has a 
dual topology(Rapp et al., 2007). 
Although the antiparallel topology is supported by lots of data, other studies have been 
done and the results indicate that EmrE might have a parallel topology in functional dimer. It 
has been reported by Schuldiner's group that the carboxy-terminus of EmrE faces the 
cytoplasm while the first loop between T M l and TM2 faces the periplasm, which indicates 
that EmrE has a Nin/Cin topology(Ninio et al., 2004). Subsequently, they found, that EmrE 
with a parallel topology is frilly functional using a chemical cross-linking analysis afrer 
introducing cysteines into positions not permissible by an antiparallel topology (Soskine et 
al., 2006). Most recently, the same group tested the transport activity o f a tandem EmrE that 
was built with two identical monomers genetically fused head to tail with a hydrophilic linker. 
They found the obligating EmrE parallel dimer still confered resistance to ethidium. 
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Interestingly, after mutates the essential glutamate of this tandem EmrE, it could only 
transport monovalent substrates and displayed a modified stoichiometi^, which also supports 
the conclusion that the transporter is functional(Steiner-Mordoch et al., 2008). However, by a 
series of in vivo complementation studies with the EiruE protein subtly mutated to obtain a 
unique orientationvon, Heijne and colleagues showed that only an antiparaiiel arrangement 
of the EinrE subunits is functional(Rapp et a!., 2007). This conclusion is also supported by 
recent data of zhang et al(Zhang et al., 2007). It has been suggested that parallel topology is 
based on mainly cross-linking results with protein in the detergent-solubilized state, a 
nonnatural enviromnent, whilst antiparallel topology is more reliable because the usage of the 
native lipid membrane.Nevertheless, the antiparallel topology hypothesis is still faced a tricky 
question about the insertion and assembly of these proteins in the membrane(Schuldiner, 
2007). 
Due to the small size of SMR transporters, another question has been raised, how does 
such a small protein do such a big jobs? For example, the substrates of EmrE are all large 
hydrophobic cations, like tetraphenylphosphonium (TPP'), ethidium, propidium and 
dequalinium. It is unlikely that one monoiner of EmrE with four transmembrane helices could 
perform the translocation of the substrates, considering both the size of the transporter and the 
character of the molecule, which has been shown not to contain any hydrophobic core(Chen 
et al., 2007). As described before, it has been reported in many studies that EmrE fonns 
oligomers as a functional unit, most likely a dinner. Froin the Cryo-electron-microscope, 
electron crystallography and X-ray data, the substrates bind to the centre of the diiner within 
the same pocket {Chen et al., 2007; Korkhov and Tate, 2008; Ubartetxena-Belandia el al., 
2003). The electron crystallography studies also revealed that, while retaining the overall fold 
of the protein, the binding o f daigs is accompanied by a small artangements of the 
transinembrane domains(Korkhov and Tate, 2008; Tate et al., 2003). 
It has been found that the proton and substrates share the same binding site in EmrE and 
one monomer releases a proton upon substrate binding (Soskine et al., 2004). In the same 
year, studies of proton-substrate antiport for EmrE reconstituted into proteoliposomes by 
same group, found the protein to be electrogenic for monovalent and electroneutral for 
divalent substrates(RoteiTi and Schuldiner, 2004). This lead to the conclusion, that during one 
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transport cycle, two protons are exchanged with one substrate molecule, therefore the basic 
functional unit of EmrE is a dimer with both monomers participating in a single binding site 
shared by protons and substrates. 
EmrE has eight charged residues, five basic (Lys-22, Arg-29, Arg-8, Arg-106 and 
His-110) and three acidic (Glu 14, Glu-25 and Asp-84), seven of these residues are located in 
the hydrophilic loops and can be replaced by with either cysteine or other amino acids bearing 
the same charge, without significant decreas in either resistance or uptake activity. Glu-14 is 
the only charged residue in T M l of the transmembrane domain and is highly conserved in the 
SMR fainily(Ninio et ai, 2001), which suggests the functional importance of this residue. 
From the recently published structure of EmrE, with bound TPP, both Glu-14 residues point 
toward the binding chamber and appear well placed to form ionic contacts with the positively 
charged TPP molecule (figure 1.6). 
Figure 1.6 "Top" view of EmrE-TPP structure(Sennhauser et al, 2007) 
The two monomers are represented in yellow and blue, the TPP molecule is colored pink. 
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Many biochemical studies are also indicative of the importance of the Glu-14 residue: 
after finding an unusually high for Glu-14 of 8.5, the stoichiometry of the proton release 
and PH dependence were measured in the wi ld type protein as well as in a ful ly active mutant 
only with a single carboxyl at position 14 with a lower pA:, the results showed that the high 
pAT o f the carboxyl at position 14 is essential for coupling the fluxe of the proton and 
substrates(Soskine et al., 2004). After finding this, the study by the same research group using 
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dicyclohexylcarbodiimide (DCCD), which is known to react with carboxyl, it showed that 
binding of substrates limits the accessibility of DCCD to its site of action, Glu-14, also 
suggesting that this residue is part of the substrate binding site(Yerushalmi et al., 2001). An 
analyses of substrates transport also demonstrated reduced activity and different PH profile 
after replacing the Glu-14 with various amino acids (Yerushalmi and Sehuldiner, 2000). In 
order to determine the number of Glu-14 residues reacting in the fiinctional unit, electrospray 
ionization mass spectrometry was exploited with the earboxyl-specific modification reagent 
DiPC. The resiilts showed that Glu-14 is modified by DiPC and the modification can be 
reduced by 80% upon the binding of TPP, indicating that both Glu-14 residues in the 
functional unit are close enough to the binding sites that TPP prevents their 
modification(Weinglass etal., 2005). 
1.3.2.2 Major Facilitator (MF) Family 
The MF family transporters are much larger than those belong to the SMR family. They 
are normally composed of 400 amino acids and putatively arranged into 12 transmembrane 
helices, with a cytoplasmic loop between helice 6 and 7. As the two halves of the transporter 
have similar sequence, this indicates that this structure was most likely arisen by gene 
duplication(Pao et al, 1998). Like the transporters in the SMR family, MF transporters are 
proton driven secondary active transporter, which means the transport of the substrates is 
accompanied by H"^  influx. 
To date, the structure of three MF transporters has been reported: the Lactose permease 
LacY from Escherichia co//(Abramson et al., 2003), the Glycerol-3-Phosphate transporter 
GlpT from Escherichia co/z(Huang et al., 2003), and the amphipathic compound transporter 
EmrD from Escherichia coli (Yin et al., 2006a). Among them, LacY adopted a mutant 
C154G, which binds substrate with high affinity but catalyzes little or no transport, whilst 
structures for GlpT and EmrD are proteins without bound substrates. Both the LacY and GlpT 
represent inward-facing conformations and EmrD is not in a V shape and consquently 
probably represents an structure of intermediate state, (figure 1.7) 
Figure 1.7 Overall structures of LacY, GlpT and EmrD(Abramson et al., 2003; Huang et al., 
2003; Yin etal., 2006a) 
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A: (1) Ribbon presentation of LacY viewed parallel to the membrane. Substrate TDG is represented 
by black sphere. 
(2) Ribbon presentation of LacY viewed from cytoplasmic side. Substrate TDG is represented by 
black sphere. 
B: (1) Ribbon presentation of GlpT viewed parallel to the membrane. 
(2) Ribbon presentation of GlpT viewed from cytoplasmic side. 
C: (1) Ribbon presentation of EmrD viewed parallel to the membrane. 
(2) Ribbon presentation of EmrD viewed from periplasmic side. 
A ( l ) A (2) 
B ( l ) 
Periplasm 
H12 
C ( l ) 
C(2) H5 H8 H10 
Cytoplasm 
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From the staictures above, these three transporters are all composed of 12 
transmembrane helices with a large cytoplasmic loop between H6 and H7. The structures of 
LacY and GlpT form a " V " shape inward-facing conformation, which support the alternating 
access inodel of transporters, whereby the substrate-bind site is accessible from one side of 
the membrane at one time. 
The anangements of the transmembrane helices of these tlii^ee transporters share 
similarity as well. The 12 transmembrane helices organize into two pseudo syinmetric 
a-helical bundles, with helices H3, H6, H9and FI12 facing away from the interior(Guan et al., 
2007), while the remaining transmembrane helices fonn the internal cavity, which has also 
been found in other MF transporter(Kasahara and Kasahara, 2003). The most notable 
difference is that while both LacY and GlpT have an hydrophilic interior in the internal 
cavity, the internal cavity of EirirD coinprises mostly hydrophobic residues, consistent with 
its function of transporting lipophilic compounds(Yin et al., 2006a). 
The best studied mechanistic inodel for an MF family transporter is that for Fl'/Lactose 
symporter LacY. Several residues have been found to be irreplaceable for HVLactose 
substrate translocation after mutating almost every position in the protein: they are Glul26 
(helix 4) and Argl44 (helix 5), which are crucial for substiate binding and substrates 
specificity (Sahin-Toth et al., 1999; Venkatesan and Kaback, 1998); Glu269 (helix 8) which 
is involved in both substrate and H"^  translocation(Weinglass et al., 2005); Arg 302 (helix 
9),His 322 (helix 10) and Glu325 (helix 10) which play an important role in H ' translocation 
(Sahin-Toth and ICaback, 2001; Schlor et al., 1997; Zhang et al., 2007). 
A model for the transport mechanism has been postulated based on the reported structure 
and biochemical analyses. Briefly, influx consists of seven steps:(l) starting from the 
outward-facing conformation; (2) protonation of LacY; (3) binding of lactose; (4) a 
conformational change that results in the reorientation of the substrate binding site to the 
inward-facing conformation; (5) release of substrate; (6) release of H^ and (7) return to the 
outward facing confonTiation(Kaback, 2005). The outward-facing conformation of LacY is 
considered unstable and is immediately protonated. Before the binding o f ligands, Argl44 is 
displaced from Glu 269 and forms a salt bridge with Glul26; Glu269 is located away from 
the hydrophilic cavity and H-bonded to T i p I 5 1 , fonning a platform for the initial recognition 
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of galaclopyranosyl ring of lactose. Thus, the essential residues for substrate binding are not 
in the correct configuration to bind substrate immediately. After Glu269 binds H", the sugar 
initially recognizes T r p l S l and this interaction leads to binding to Glul26 and Argl44. Then 
Glu269 moves out of the relatively hydrophobic environment and fonns a new salt bridge and 
an H-bond with the sugar to complete ligand binding. Upon the binding of substrate, Glu269 
transfers the H ' to H322, causing the conformational change to the inward-facing 
confonnation (Weinglass et al., 2005). H322 may pass the H ' to Glu325 after\vards{Schlor ef 
cil, 1997). Substrate is then released to the cytoplasmic cavity and the salt bridge between 
Glu269 and Argl44 breaks and a new salt bridge is rebuilt between ArgJ44 and Glul26(Yin 
et a!., 2006b). Arg302, which is located in the C-terminal domain, and is charged-paired with 
Glu325, are considered to facilitate the deprotonation of Glu325 (Sahin-Toth and Kaback, 
2001; Weinglass et cil., 2005). Finally, the is released to the same cavity as the substrate 
and the transporter returns to the out-ward facing conformation(Mirza el al., 2006; 
Sahin-Toth et al., 2000; Venkatesan and Kaback, 1998). 
1.3.2.3 Resistance Nodulat ion Div i s ion ( R N D ) transpoiters 
RND transporters are larger ones than the other transporters previously described, being 
composed typically of approx. 1000 amino acids. They typically form 12 transmembrane 
helices and two large periplasmic loops, which contain more than 300 amino acid, between 
helice 1 and 2 and helice 7 and 8(Goldberg et al., 1999; Gotoh et al., 1999; Guan et al., 1999; 
Hagman et al., 1997). Similar to MF transporters, the sequence of the N-terminal half of these 
transporters resembles the C-temiinal half, which again indicates these transporters have 
arisen by gene duplication. The two large periplasmic loops have been reported to forni a 
periplasmic headpiece. Many studies have been done to define the importance of these 
periplasmic loops. After swapping the periplasmic loops between AcrB and AcrD, the 
substrate specificity of the transporter was found to have been interchanged(Elkins and 
Nikaido, 2002); some mutants in the central cavity and periplasmic domain have been 
reported to affect the substrate sensitivity and effiux activity (Heam et al., 2006; Mao et al., 
2002), therefore drawing the conclusion that these two periplasmic loops play an important 
role in substrate recognition in RND transporters. 
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The structure of AcrB {Escherichia coli) and its substrates translocation 
Amongst all the RND transporters, the AcrB from Escherichia coli is the best studied 
one, its structure have been reported with and without bound substrates at 3.5A resolution. 
Figure 1.8 the crystal structure o f AcrB (Murakami et ai, 2002) 
A: Ribbon representation of AcrB side view, the protomers are colored to red, green and blue. 
B: top view of AcrB 
C: the arrangement of the transmembrane helices near the periplasmic side. The label numbers 
indicate the transmembrane helix numbers 
( 3oAo 
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The overall AcrB structure is shovm to be a trimer with "jel lyfish" appearance. I t 
comprises a periplasmic headpiece and a transmembrane region approximately 70A and 50A 
thick, with maximum diameters of lOOA and 80A respectively. The headpiece is divided into 
two stacked parts: the upper part is 30 A thick and the lower part is 40 A thick, together they 
have a trapezoidal appearance when viewed from the side; this domain is about 70A wide at 
the bottom and 40A wide at the top. 
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The iransmeinbrane domain of each protomcr contains twelve transmembrane a-heUces. 
A pseudo-two-tblcl symmeli^ axis exists in each transmembrane domain, that is, the six 
N-terminal helices are symmetrically an-anged with the six C-tennianl helices (Figure 1.8). 
Viewed from the top, the upper part is open like a funnel. The internal diameter of the 
funnel opening is about 30A. It is composed of two four-stranded mixed P-sheets. The 
headpiece is held together by a 35A long hairpin structure that protnides from the upper 
headpiece domain of each protomer and inserts into the next protomer. The six vertical 
hairpins at the top of AcrB trimer, are found to contact with the six a-helix-tum- a-helix 
structure at the bottom o f TolC(Koronakis et ai, 2000) to form a tight seal by manual 
docking, therefore, the upper part of the headpiece is also called 'To lC docking domain". 
Three pore domains form a pore at the centre of the lower headpiece. Each protomer 
contributes one pore domain. The pore exists in the lower part of the headpiece and connects 
with the bottom of the fumiel. The pore domain is composed o f four subdomains: P N l , PN2, 
PCI and PC2. PNl and PN2 comprise the polypeptide segment between T M l and TM2. and 
PCI and PC2 comprise the segment between TM7 and TM8. A l l these subdomains contain a 
characteristic structural motif, that is, two P-strand-a-helix-P-strand motifs that are directly 
repeated and sandwiched with each other. Four subdomains in the pore domain are packed 
back to back in the centre, placing the a-helices on the outside. The pore fonning helix is the 
second helix (Na2) of PNl . A cleft exists between PCI and PC2 at the periphery of each 
protomer. Vestibules are open at the side of the headpiece between PN2 and PC2, which lead 
to a cavity located at the bottom o f the pore. 
As a member of the secondary active transporter family, AcrB is energized by 
proton-motive force. It recognizes many stmcturally unrelated toxic compounds and actively 
engages in extruding them f rom cells. Many research studies have been done on transport 
mechanism; among them, the crystal stnictures of AcrB with four different bound ligands no 
doubt extend our understanding of the substrate binding sites in this transporter(Ward el ai, 
2007). 
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Figure 1.10 AcrB wi th bound substrates (Borges-Walmsley et al, 2003; Ward et al., 2007) 
The three protomers of AcrB are distinguished as red, blue and green respectively. Three distinct 
domains are formed by the trimer: the funnel, the pore and the central cavity, which are generalized by 
the black lines. The approximate binding positions of the drug dequalinium (Dq), ciprofloxacin (Cip), 
EtBr (Et) and R6G are indicated. 
Funnel 
Inner membrane 
The central cavity that is formed by the three transmembrane domains o f each AcrB 
protomer has been shown to play an important role in substrates binding. The crystal structure 
illustrates that all the four different ligands bind to various positions within the central cavity 
wi th the approximate positions shown in Figure 1.10. It has been reported that the interior 
surface o f the upper part o f the central cavity is surrounded by many hydrophobic residues, 
includes several phenylalanines. Most o f them are highly conserved among the homologs o f 
AcrB(Das et al.,2007), which also indicates that they may be involved in the fianction o f these 
transporters. The four drugs, dequalinium (Dq), ciprofloxacin (Cip), EtBr (Et) and R6G, bind 
to sites that are not quite the same. A l l the residues close to the bound ligand are hydrophobic 
amino acids, suggesting the importance o f hydrophobic and possible van der Waals 
interactions in drug binding. Moreover, the four drugs seem likely to bind close to the 
periplasmic surface o f the inner membrane, which indicates the central cavity may be filled 
wi th the bilayer. Another notable feature is that after the binding o f drugs, AcrB undergoes a 
conformational change compared to the drug-lree structure. Each subunit is triggered to 
perform a 1° rigid-body rotation.The axis o f rotation, passing through the side o f each subunit. 
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is approximately parallel to the plane o f the lipid-bilayer. Due to this rotation, the diameter o f 
the periplasmic domain is enlarged by ~2.5A(Ward et al., 2007). 
From the structure o f AcrB wi th boimd ligand, a mechanism for substrate ef f lux has been 
postulated: the drug entries the central cavity from either the vestibules or outer leaflet o f the 
l ip id bilayer(Aires and Nikaido, 2005), then it passes through the open pore domain to the 
funnel domain, and is eventually extrude into the external medium through the outer 
membrane protein TolC. This hypothesis is tentatively termed the "elevator mechanism". 
However, in 2006, a new model for the mechanism o f substrates extrusion by AcrB was 
proposed as the "functional rotation mechanism", in which the eff lux o f the drugs is 
accomplished by a conformational change in each protomer(Dastidar et al, 2007; Murakami 
et al., 2006; Seeger et al., 2006; Takatsuka and Nikaido, 2007). 
Figure 1.11 Schematic representation o f AcrB functional rotation mechanism(Seeger et al., 
2006) 
A: Side view schematic representation of two of the three protomers of AcrB trimer. The accessory 
proteins of AcrB, AcrA and TolC are indicated by arrows. The three conformational states, loose (L), 
tight (T) and open (O) are colored blue, yellow and orange. 
B: The lateral grooves in the L and T protomers indicate the dmg binding sites. The different 




Two recently published papers reported the structure o f AcrB at 2.8 and 3.0 angstrom 
resolution in a space group that allows asymmetry o f the monomers. Both o f the papers 
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reported a conformational difference in the pore domain between each protomer(Murakami et 
al., 2006; Seeger et al., 2006), which has led to the functional rotating pump mechanism. 
Among the tliree protomers, one of them is found to have a substrate binding pocket, 
which is rich in aromatic amino-acid that connect to the vestibule, which is considered to be 
the drugs uptake pathway. In this state, exit from the binding site is blocked by the central 
helix. In the next state, the access to the vestibule is closed and the central helix that blocks 
the exit of drugs from the binding pocket is opened due to the movement of PN2 and PCI . 
The bound drug is then pushed out into the top funnel. After extruding the substrate, the 
binding pocket then shrinkes and the vestibule opens to the periplasm so that potential 
substrates can access to the vestibule, and another transport cycle starts. 
After proposing the transport mechanism for AcrB, Seeger and colleagues undertook a 
biochemical study on AcrB, in which the interfaces of potential moving subdomains of AcrB 
were cross-linked. Its susceptibility of AcrB to noxious compounds increased and this effect 
could be reversed by adding the reducing reagent DTT, supporting the mechanism of 
functional rotation(Seeger et al., 2008). 
The transport of drugs by AcrB is driven by the proton motive force(Zgurskaya and 
Nikaido, 1999a). It has been found that energization of the transport machinery occurs in the 
transmembrane domain and is transmitted to the pore domain. Three charged residues in the 
transmembrane region are found to be functionally essential: Asp407, Asp480 and Lys940, 
which are located in the middle of TM4 and TMIO, where they fomi an Asp-Lys-Asp 
ion-pair/hydrogen-bonding network in the T M segments. They are possible candidates for the 
proton-translocating pathway(Guan and Nakae, 2001; Murakami et al., 2002). Recently, 
another residue, Thr978 in T M l 1, which in close to Asp407 has also been found to possibly 
be involved in the proton translocation pathway(Takatsuka and Nikaido, 2006). It has been 
shown that conversion of any of these residues to alanine produces a widespread 
conformational alteration, suggesting that the trigger for change is the disniption of the same 
salt bridge/H-bonding network(Borbat et al., 2007). The conformational difference in this 
proton-translocation site in the T M domain is coupled to the closing and opening of the 
channel entrance and the exit to the funnel domain in each protomer. This indicates a 
coordinated control in coupling drug export and proton-translocation(Sennhauser et al., 
2007). 
Tripartite multidrug efflux pump 
In gram negative bacteria, some transporters utilize a tripartite protein complex rather 
than a single transporter protein. These transporter systems consist of an inner membrane 
protein (IMP, such as an RND or MF transporter), a porin like outer membrane protein 
(OMP) and a membrane fusion protein (MFP), which is anchored to inner membrane by 
either a lipid moiety or a transmembrane a-helice. These three parts form a channel-like 
substrate translocation pathway that spans across both the inner membrane and outer 
membranes(Figure I .l)(Borges-Walmsley el al., 2003). Two well-studied pump systems are 
AcrAB/TolC from Escherichia, coli and MexAB/OprM from Pseudomonas aeruginosa. 
Among the three components, AcrB and MexB are IMPs belonging to the RND family; AcrA 
and MexA are MFP; TolC and OprM are OMP. In addition to transporters belonging to RND 
family, some MF transporters and ABC transporters also fonn tripartite efflux system, such as 
VceAB/VceC from vibrio Cholerae and MacAB/ToIC from Escherichia Coli. 
The structure and mechanism of the outer membrane protein 
The outer membrane proteins of tripartite multidrug efflux pump play an important role 
in the translocation of diverse molecules, which include protein toxins and antibacterial drugs, 
from the cell. With the assistance of the meiubrane fusion protein, outer membrane proteins 
can perform these roles by the process of substrate-induced transient interaction with the inner 
membrane transporters. Some mutants of outer membrane proteins in bacteria can lead to 
heightened sensitivity to their substrates (Gil et al., 2006; L i and Poole, 2001). 
Figure 1.12 the crystal structures of TolC(K.oronakis et al., 2000) 
A: A ribbon representation of TolC side view, the three protomers are colored red, yellow and 
blue respectively. The 3-barrel is at the top (distal) end, and the a-helical domain is at the bottom 
(proximal) end. 
B: A ribbon representation of coiled-coil closing the proximal end. Different protomers are 
colored as A. 
C: A ribbon representation of open-state TolC from the proximal end. Different protomers are 
colored as A. 
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The overall structure of TolC is assembled as a trimer, with the appearance of a cannon 
that has a long axis measuring 140A. For nearly 100 A the body o f TolC forms a uniform 
cylinder of about 35 A internal diameter. The distal end o f the structure is open and provides 
a wide solvent access, while the proximal end is tapered to a virtual close. The whole 
molecule can be divided into three parts: a P-barrel domain, a a-helical domain and a mixed 
a/p-equatorial-domain. In this trimer, the P strands associate in an antiparallel orientation to 
form a right-twisted 12-stranded |3-barrel, to which each protomer contributes 4 strands. The 
P-barrel domain is located in the outer membrane with the top end widely open from this 
structure, but it may enable it to close the conformational movement of the loops between 
each p strand. The a -helical domain is formed by a 12-stranded antiparallel left-twisted 
a-helical barrel. Unlike the p-barrel domain, the helices that form the a -helical barrel are 
composed of long (H3 and H7) and short (H2 and H6, H4 and H8) helix. A n inner pair of 
helices (H7 and H8) forms a conventional antiparallel coiled-coil, whilst an outer pair (H3 
and H4) comprises a straight helix (H3) arotmd its partemer (H4). The coiled-coils also 
contact each other. Coiled coils are stablized by an intermeshing of side chains that is call 
"knobs-into-holes" packing, which indicates the conformation of a small aliphatic side chain 
40 
of one helix fits into a small concavity formed by a ring o f four small side chain on the second 
helix. The equatorial domain of TolC is formed by the loop between H4 and H7, which is 
composed of one short a-helix H5 and one short |3-strand S3, and the C-terminal residues after 
H8 which was partly truncated to facilitate crystallisation of the protein(Koronakis et al., 
2000). 
Apparently, to enable the transport, the tapered proximal end of the TolC must open and 
the present mechanism for the attainment of open state TolC is described by a "twist-to-open" 
model. In this model, the conformational change from the resting closed state of TolC to the 
modelled open state TolC is related to the circular network of intra- and intermonomer 
hydrogen bond and salt bridge(Koronakis et al., 2000). This circular network is composed of 
six coiled coils, two from each protomer. The hydrogen bonds between inner and outer coiled 
coils in same monomer, l inks ( f ig l . l3 ) I and links I Iby connect Asp 153 with Tyr362 and 
Glnl36 with Glu359. Links Illconnect Arg367 of each inner coiled coil to the outer coiled 
coil of adjacent monomer, by a salt bridge to Asp 153 and a hydrogen bond to 
Thrl52(Andersen et al., 2002). 
Figure 1.13 the structure of the TolC periplasmic entrance(Andersen et al., 2002) 
A: the resting closed state of TolC viewed from the periplasmic side. Four helices in one monomer 
are highlighted as yellow (H7), red (H8), green (H3) and blue (H4). The hydrogen bond and salt bridge 
between intra- and intermonomer are numbered and indicated by dotted lines. 
B: the presentation of periplasmic circular network, showing the residues involved in intra- and 





This mechanism is supported by some structural and biochemical data, after disrupting 
the above hydrogen bond and salt bridge by replacing the relative residues, the conductance 
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of TolC increases, which is also prominent after substituting the residues Y362 and R367, 
indicating that these residues are involved in detenuining the entrance diameter(Andersen et 
al., 2002). Similar work demonstrated an increased sensitivity to the large antibiotic, 
vancomycin, which also indicates the importance of these residues in opening the periplasmic 
entrance of TolC(Augustus et al., 2004). A cheiuical cross-linker was used to constrain the 
movement of the coiled-coils by forming disulphide bonds, TolC-dependant export was then 
found to be abolished(Eswaran et al., 2003). Very recently, the published structiu-e of a TolC 
double mutant of Y362 and R367 was shown a partially open state, again prove the 
importance of the coiled-coil interaction in the conformational change between the closed and 
open states(Bavro et al., 2008). 
In 2004 and 2005, the structures two other P-barrel outer membrane proteins, which are 
also components of tripartite multidrug efflux pumps, were reported, OprM from 
pseuclomonas aeruginosa and VceC from Vibrio cholera. OprM is the outer membrane 
accessory protein of the RND transporter MexB and VceC belongs to the MF tripartite 
transporter VceAB/VceC(Akama et al., 2004a; Federici et al., 2005). 
The overall structures of both OprM and VceC resembled TolC, but VceC is structurally 
closer to OprM than TolC. Although the sequence identity between structurally aligned 
segments is very low (OprM is 2 1 % identity with TolC and VceC is 8.3% identity with 
TolC), most of these residues are hydrophobic and play a stmctural role. The major 
differences between OprM and VceC with TolC are the size of the pore that is formed by the 
loops between the (3-strands and the electrostatic surface potential inside the chaimel. The top 
end of the p-barrel is widely open in TolC, while three short loops of OprM protnide toward 
the inside of the pore forming a constriction. In the case of VceC, the pore is formed by the 
loops between strands SI and S2 of each protomer. These loops are five residues longer than 
in TolC and OprM and are oriented so as to rest upon the porin-like domain, providing only a 
small passage with a diameter of ~6A. After comparing the electrostatic surface potential of 
these proteins, it has been found that all the channel interiors are generally electronegative. 
However, in VceC, two rings of clustered negative charge are found, which are partly 
conserved in OprM but barely in TolC. It has been proposed that the difference in charged 
residues may facilitate substrate movement across the channel. Beside these striking 
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differences, the secondary structures of the equatorial domains have also been found to vary 
in these three outer membrane proteins. Because this part is proposed to interact with the 
corresponding membrane flision proteins, the differences in these domains may indicate the 
different requirement of binding their partner membrane ftision protein(Akama et al., 2004a; 
Federicie/a/.,2005). 
The structure of the membrane fusion protein 
The membrane flision protein is another important component o f tripartite antibiotic 
efflux piunps. They are anchored to the inner membrane by either an N-terminal lipid 
modification or a transmembrane helix. However, i t has been shown that membrane fusion 
proteins are frilly fimctional as expressed in the periplasmic without attaching to inner 
membrane(Yoneyama et al., 2000). Some biochemical experimental results indicate that the 
interaction between the membrane fusion protein and their cognate partner plays an important 
role in the drug efflux process(Mokhonov et al., 2004; Stegmeier et al., 2006). 
Two structures of the membrane fusion proteins that are accessory proteins of RND 
transporters have been reported: MexA of the MexAB/OprM system from pseudomonas 
aeruginosa and AcrA of the AcrAB/TolC system from Escherichia coli. 
Figure 1.14 the strucmre of MexA from pseudomonas aeruginosa(Higgins et al., 2004) 
A: The ribbon representations of MexA, different domains are indicated. 
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The MexA monomer incorporates three domains: a P-bartel domain, a Lipoyl domain 
and an a-helical hairpin. The p-barrel domain is composed of six anti-parallel P-strands with a 
single a-helix located al one entrance to the barrel. The lipoyi domain comprises of two 
interlocking lipoyi motifs of four p-strands. The a-helical haii-pin is 47A long, it fonus an 
intervening sequence between the two lipoyi motifs. Some highly conserved residues through 
the family are found in certain positions of heptad repeat; position a and d contains many 
large hydrophobic side chains, which form the core of the haiipin; alanine is found 
predominantly in the f position whereas the c position contains mainly hydrophilic residues. 
These conserved residues foim strips along the exposed sides of the hairpin with a large 
hydrophilic residues that lie in either end, which are probably involved in hydrogen bond 
formation and in interactions with its cognate inner and outer membrane proteins(Akama et 
al., 2004b; Higgins et al., 2004). 
After the publication of the MexA stnicture, another structure for a membrane fusion 
protein, the stable core of AciA was repoiled. The overall stmcture of AcrA strongly 
resembles MexA, except the a-helical hairpin which is 11 A longer. Notably, AcrA was found 
in four conformations in the cry.stal. The biggest difference is a 15° reorientation of the 
a-helical hairpin. These conformations provide evidence for "hinge-like" conformational 
flexibility between the a-helical hairpin and the lipoyi domain and that this structural change 
is reversible(Ip et al., 2003). Although this flexibili ty wasn't been shown in the crystal 
structure of MexA, similar confoimational changes were found in MexA by using molecular 
dynamics(MD) siinulations(Vaccaro et al., 2006). Interestingly, the magnitude of this 
conformational flexibility is remarkably congruent with the conformational changes 
implicated in opening of TolC channel(Mikolosko el al., 2006), which indicates the 
importance of the hairpin domain(Stegmeier el al., 2006) and its conformation flexibility is 
some how related to the interaction with inner and outer membrane proteins. 
The interaction between each component in the RND tripartite efflux pump 
As we mentioned previously, in gram negative bacteria, the tripartite efflux pumps 
which composed of three types of protein have been found to play an important role in 
exporting a wide variety of drugs and toxic compounds. Although several crystal structures of 
OMP, IMP and MFP have been reported, the question remains as to how these three proteins 
assemble to form a functional pump and how channel opening occurs. 
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Among all the RND tripartite antibiotic efflux pumps, the two best studied models are 
the AcrAB/TolC and MexAB/OprM systems. These two pumps are homologous and share 
similarity in structure. Although there is still no definitive experimental data for the 
stoichiometric composition of an engaged tripartite system, some research has been 
undertaken to study how these components collaborate with each other. 
Cross-linking and isothermal titration calorimetry studies have shown that AcrAB/TolC 
can fonn a stable complex that can be stabilized by the presence of substrates(Tikhonova and 
Zgurskaya, 2004; Touze et al., 2004). Among these three components, the membrane fusion 
protein is considered to span the periplasmic space, where it acts as a very important part in 
maintaining the ternary stRicture of the pumps(Zgurskaya and Nikaido, 1999b). Apart from 
the evidence that the MFP can interact with both the IMP and OMP directly, failure to 
co-purify the IMP and OMP in the absence of the MFP(Mokhonov el al., 2004), also 
indicates the importance of the MFP in the whole system. 
The MFP and its cognate OMP have been reported to interact independently of the 
presence of any externally added substrate or the lMP(Husain el al., 2004). This interaction is 
consistent with genetic studies in which extragenic supressors of a mutant TolC strain were 
found in the AcrA gene(Gerken and Misra, 2004). As mentioned before, the MFP, in the 
cases of AcrA and MexA, is composed of three domains, which are an a-helical domain, a 
P-barrel domain and a lipoyi domain. From these domains, it is the a-helical domain that is 
thought to functionally interact with its cognate OMP(Stegmeier et al., 2006). After changing 
the a-helical domain of AcrA for this part of MexA, the function of the AcrAB/OprM 
complex was restored. To find out the exact residues interacting in both the OMP and MFP, 
cross-link was canied out on both wild type AcrA with site-specific TolC cysteine variants 
and wild type TolC with AcrA cysteine variants. These studies identified the intramolecular 
groove proximal to the TolC entrance as the interaction surface, highlighting the exposed 
residues along the TolC a-helices H3 and H7 from tip and up to just below the equatorial 
domain, and reciprocally, the N-terminal a-helix of the MFP coiled-coil(Lobedanz et ai, 
2007). Although in this study, the one mutant that locates at the equatorial domain of TolC 
didn't interact with AcrA, two hydrophobic residues located at the equatorial domain have 
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been reported to be involved in the transport activity of ToiC(Yamanaka et a/., 2004). The 
possibility is that the equatorial domain of TolC also is involved in the interaction with AcrA. 
Despite the fact that a lot of work has been done to show the interaction between the 
MFP and IMP, none of them elucidated the precise interaction between the MFP and IMP yet. 
It has been shown that the MFP and IMP can interact specifically and independently of either 
the substrate or OMP(Kawabe et al., 2000; Zguiskaya and Nikaido, 1999a, , 2000). 
Mutagenesis and cross-link studies indicate that the N-tenninal periplasinic domain of the 
IMP is presumably involved in determining the specificity of interaction with the cognate 
MFP, with residues 60-612 apparently of particular importance(Tikhonova el al., 2002). 
These residues are located on the outward-facing surface of a large gi-oove in each monomer 
that was previously predicted to be involved in binding to its partner MFP(Murakami et al., 
2002). Interestingly, in antibiotic resistant pseuchmonas aeinginosa, Jocelyn et al found that 
several mutants in MexB occured in this region, corresponds to the MexA binding part of 
MexB(Middlemiss and Poole, 2004). As to the interacting part of AcrA, its C-terminus is 
reported to be involved in the interaction with its cognate IMP, AcrB(Elkins and Nikaido, 
2003; Touze et al., 2004). Also consistent with the studies of HlyD, which indicate that the 
C-terminal regions of the MFPs is responsible for the binding(Schlor el al.. 1997). 
Furthennore, it has also been found that the residues involved in this binding are poorly 
conserved in the MFP family and these unique residues may be important for and define the 
MFPs interaction with their IMP partner(Nehme el al., 2004).However, in other reports, the 
P-barrel of the MFP is considered to interact with the IMP (Gerken and Misra, 2004; 
Krishnamoorthy ei al., 2008). 
Whether or not there is direct interaction between IMP and OMP hasn't drawn to a 
conclusion yet. More people believe IMP and OMP can not form a stable complex without 
the assistance of MFP(Mokhonov et al., 2004; Tiklionova and Zgurskaya, 2004; Touze el al., 
2004), while some others think the IMP can interact with OMP directly. Norihisa et al has 
shown the interaction between TolC and AcrB via site-directed disulfide cross-linking. They 
found the residues that involved in most contact between AcrB and TolC are located at the tip 
of the vertical haii-pin of AcrB and the tip of coiled-coil of TolC, moreover, there are still 
some residues apart from the lip of TolC involved in second-most contact. These finding have 
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led to a two-step contact mechanism which accompanies a conformational change on both 
AcrB and TolC. Because the cross-linking is independent of AcrA, they propose that AcrB 
first interacts with TolC and then the complex is stablized by AcrA(Tamura et al., 2005). 
Several models of how the tripartite complex is assembled have been proposed. 
Figure 1.15 Models of the proposed assembling of the tripartite complex(Akama et al., 
2004b; Femandez-Recio etai, 2004). 
A l : Side view of the 1:1:1 model, the IMP, OMP and MFP are colored green, blue and red 
respectively. 
A2: View is along the vertical axis 
B l : Side view of the 1:2:1 model, the IMP and OMP are colored purple and blue, two MFP bind to 
one protomer are coloered dark blue and red. 
B2: View is along the vertical axis 
Beside these two models, there are still other alternative models have also been 
proposed. One of them is based on the compositional ratio of 1:3:1 and another suggest a 
tridecamer. Because there is no definitive experimental data for the stoichiometric 
composition of an engaged pump yet, it is hard to decide which model reflects the pump 
composition in native condition. More work is still needed to elucidate this. 
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The Mtr (multiply transferable resistance) system of i\eissena gonorrhoeae 
Strain of Neisseria gonorrhoeae started to emerge with clinically significant levels of 
resistance to penicillin just after the introduction of penicillin to treat gonoirhoea. These 
gonococcal clinical isolates display hypersusceptibility to penicillin and stnictural diverse 
hydrophobic agents (HAs), such as drugs, dyes, detergents and host-derived compounds (fatty 
acids and bile salts), as well as some cationic antimicrobial peptides(Shafer el al., 1998; 
Tzeng ei al., 2005). The Mtr system was found to confer resistance to these antibacteria 
compounds. Genetic and physiological studies demonstrated that the Mtr system functions as 
an energy-depend efflux pump by a mechanism requiring the proton motive force(Hagman ei 
al., 1995; Lucas ei al., 1995). The Mtr system is composed of the mtrCDE genes and the mtrR 
gene encodes a transcriptional repressor that appears to regulate expression of the upstream 
and divergent mtrCDE operon(Hagman and Shafer, 1995). The mtrCDE genes encode 
membrane proteins analogous to the MexAB/OprM of Pseudomonas aeruginosa and 
AcrAB/TolC of Escherichia coli that mediate export of structural diverse antimicrobial 
agents. Hagman el al has reported that the mirD gene encodes a membrane protein with mass 
of nearly 1 l4kDa and displays a significant similarity to RND family proteins(Hagman el al., 
1997). The mirE gene encodes an outer membrane protein with mass of 48.31CDa, which is 
associated with the Mtr phenotype, and is identified as a homologue of export-associated 
outer-membrane proteins, such as OprM and TolC. Insertional inactivation of the nUrE gene 
can result in hypersusceptibility of mutant strains to a range of HAs(Delahay et ai., 1997). 
The expression of MtrCDE are considered to be modulate by two transcriptional regulators, 
MtrA and MtrR, which can activate and repress the expression respectively (Rouquette et al., 
1999). A lot of works has been done on MtrR to establish that the insertional or deletional 
mutants of MtrR can lead strains that are hypeisusceptibile or have decreased susceptibility to 
the substrates of the Mtr system, due to the overexpression or defective expression of 
MtrCDE(Johnson et al., 2003; Veal etal., 1998; Veal et al., 2002; Zarantonelli etal., 2001). 
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1.4 Regulation of bacterial multidrug efflux pumps 
Because bacteria in the environment are exposed to lots of noxious compounds, such as 
antibiotics and deleterious molecules that originate from their own metabolism, their MDR 
genes need to be expressed at a low level before significant efflux of clinically relevant 
antimicrobial compounds occurs. This lead to a proposal that MDR pumps are pre-existing 
and protect bacteria against the low level of toxic compounds they encounter in the 
environment. Therefore, to survive in the unstable surrounding they require rapid, adaptive 
responses to toxic molecules, which are normally mediated by regulatory proteins(Cases et 
al., 2003), such as the TetR, repressor of the tetracycline-specific pump TetA(B) from 
Escherichia coli and QacR of the multidmg transporter QacA from Staphylococcus 
aureiis{Gvkovic el al., 1998) . Analysis of the pumps and their regulatory controls indicates 
that the efflux of medically relevant antimicrobial compounds is the primary function of these 
systems(Grkovic et al., 2002; Ramos et al, 2005). 
Regulators involved in transcriptional control can be classified into families on the basis 
of sequence similarity and stmctural and functional criteria. Among them, the TetR family is 
an important one that play a role in MDR regulation. Members of the TetR family are two 
domains proteins with a DNA-binding domain and a regulatory domain that recognises the 
signals via the binding ligand. They show high sequence similarity in the DNA-binding 
domain, which contains a helix-tum-helix (HTH) motif, and no significant similarity in the 
regulatory domains coiresponding to their various signalling molecules(Dover et al., 2004; 
Frenois et al., 2004; Jeng et al., 2008; Okada et al., 2008; Orth et al., 2000; Schumacher et 
al., 2001). 
TetR and QacR are two members of the TetR family that have been well characterized 
genetically and biochemically. A series of publications about TetR and QacR revealed the 
structures of these two proteins both with their operators and substrates, and proposed a 
mechanism for transcriptional control of MDR by the TetR family of regulatory proteins. It 
has been shown that although these two protein share similarity in structure, they have distinct 
differences in many aspects. 
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1.4.1 The structures of TetR and QacR with bound to their corresponding operators 
The crystal structure of TetR revealed a protein consisting of 10 a-helices, which forms a 
homodimer in the native state, al to alO form the first monomer and a l ' to a 10' form the 
other monomer. The dimerization of TetR is accomplished by the interaction between helices 
a8 and alO with helices a8' and alO', which forms a four-helix bundle(Hinrichs et al., 1994). 
This four -helix bimdle is also reported to involve in the central part of the regulatory domain, 
which w i l l be elucidated in the following section. 
Figure 1.16 structure of TetR-operator complex(Orth et al., 2000) 
A: A ribbon representation of the overall structure of the TetR-DNA complex, a-helices of one 
monomer are labelled. The helices that form the DNA binding domain are colored blue; the helices that 
form the rigid scaffold are colored yellow, the rest of the helices undergo conformational change after 
the binding of inducer are colored green. 
B: schematic representation of interaction between one monomer of TetR and its half-15bp operator 
Hydrogen bonds are represented as arrows and van der Waals interaction as dotted lines. 
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The DNA binding domains are formed by a three-helix bundle (al-a3), within which a2 
and a3 constitute the helix-tum-helix (HTH) motif, which are typical structures involved in 
protein-DNA interactions. These H T H motifs are found in most o f the reported TetR 
repressors, such as AcrR from Escherichia coli, EthR from Mycobacterium tuberculosis 
(Dover et al., 2004; Frenois et al., 2004), SCO0332 from Streptomyces coelicolor (Okada et 
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ciL, 2008) and IcaR from staphylococcus epiderntidis{ieng et at.. 2008). However, i l is also 
been foLind that there is a TetR repressor. CmeR of Campylobacter jejuni, that has a random 
coil in the DNA-binding domain instead of a a3 helix(Guan et al., 2007). In TetR, each HTH 
motif binds to the major groove of the palindromic operator and the minor groove is not 
recognized. Al l base pairs of 15-mer operator fragment, except the central three pairs, are 
engaged in TetR binding. At the recognition sites, the major grooves are widened to 
14-14.5A, while the major gi'oove at the opposite site of the central base pair is narrowed to 
9.5A. With the coiresponding change in the minor grooves, the helical repeat of DNA is 
increased to 38A due to the partial unwinding of the DNA duplex. In the bent half-operator, 
all residues of helix 3 are involved in recognition, except Leu41, which is part of the 
hydrophobic core stabilizing the three-helix bundle. Other residues that are involved in DNA 
contacts are located in the first helix of HTH, the turn of the HTH and both of the interhelical 
loops connect the HTH to the adjacent helices(Aj-amak:i et ai, 1995). Because there are no 
water molecules incorporated into the protein-DNA interface, Pro39 is employed to 
contribute to this close f i t . Moreover, Pro39 switches TetR binding from one DNA strand to 
the other by fonning van der Waals interaction with each of the nucleotides at positions +4 
and -5. (Orth e/a/., 2000) 
Figure 1.17 structure of QacR-operator complex(Schumacher et ai, 2002) 
A: Overall sti'ucture of the QacR-DNA complex. The subunit of one dimer is shown in blue (distal) 
and cyan (proximal), whilst other is purple (distal) and green (proximal). The helices in one monomer 
are numbered. DNA is shown with phosphate, oxygen, carbon and nitrogen colored yellow, orange, 
gray and blue respectively. 
B: Schematic showing QacR-DNA half site contacts. Hydrogen bonds are indicated by arrows, van 
der Waal contacts are shown as diamonds. 
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The structure o f the complex revealed that a pair of QacR dimers bind to one D N A 
(Grkovic et al, 2001). Each QacR monomer consists o f nine helices, the first three helices 
al-a3 form DNA-binding domain that contains a H T H motif, while the a4-a9 form the 
regulatory/dimerization domain. Unlike its homologue TetR, the four-helix dimerization 
motif is formed by a8 and a9 of each monomer, but in case of TetR, it is a8 and a 10. One 
dimer binds to each side of the DNA, with two H T H motifs in contact with the major grooves 
of the DNA. The minor grooves are not recognized as in TetR. Although the distal monomers 
make the majority o f the base-specific interactions, the proximal monomer makes several 
base and phosphate contacts; both interactions show a distinguishing feature o f D N A 
recognition by QacR(Schumacher et al., 2002). 
The binding between duplex D N A and QacR dimer is reported to be cooperative 
(Grkovic et al., 1998; Grkovic et al., 2001). However, it has been shown that such binding is 
not mediated by protein-protein interactions because QacR does not self-assemble into a 
tetramer without the presence of the DNA(Grkovic et al., 2001). Structural analyses have 
shown that features of the DNA and protein conformation are keys to bind cooperatively. The 
center-to-center distance between the recognition helices of each QacR dimer was found to be 
extended, as a result of DNA unwinding and expansion of the major grooves. It leads to a 
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postulate that binding of the first dimer, produces an induced f i t to the protein and DNA to 
make an optimal major groove for the second dimer to bind. 
As homologues of the same family, QacR and TetR and other members share some 
similarities in binding their con-esponding operators; such as their DNA-binding domains all 
consist of al-a3, with a HTH that contacts with the major grooves, while the minor grooves 
are not recognized; their recognition helix interacts deeply with the DNA so that no water 
molecules exist in the interface between the protein and DNA. However, they still have 
distinct differences in the mode of DNA recognition. TetR employs only one dimer to bind 
the duplex DNA operator, while QacR uses two cooperative binding dimers to increase the 
binding affinity and specificity. This cooperative binding are found in most of other members, 
such as AcrR, EthR, IcaR, TtgR, TtgV, VceR and CmeR(Chen et al., 2007; Federici et al., 
2005; Guan ei al., 2007; Jeng et al., 2008; Krell et al., 2007), while ElhR is proposed to bind 
one operator with four dimers{Dover et al., 2004). When TetR binds to the operator, it widens 
the major grooves at the recognition sites to create a optimized position for binding, whilst 
naiTOws the minor grooves and other major grooves. In the case of QacR, the entire 
IRl-binding site is widened, causing a longer center-to-center distance. The contacts between 
DNA and the TetR HTH motif from each monomer are nearly identical, while the HTH motif 
of QacR from each monomer in one homodimer makes a different set of contacts, each with a 
non-palindromic site(Orth el al., 2000; Schumacher et al., 2002). 
1.4.2 The structures of TetR and QacR binding their coiTesponding substrates 
The Tetracycline (Tc) binding pocket is composed of the COOH-termini of a4 and a6 
and the helices a5, al, a8, a8' and a9' (prime refers to the second monomer o f the 
homodimer). The entrance of the dmg binding tunnel has been proposed to be the opening 
next to the C-terminus; the docking of [Mg Tc] ' suggested a lateral motion of a9'comparable 
to a "sliding door"(Orth et al., 1998). 
Figure 1.18 Chemical structure of tetracycline and schematic description of the 
interaction between tetracycline and TetR. 
Hydrogen bonds are represented by dashed lines; hydrophobic interactions are shown by hatched 
lines. W l , VV2 and W3 are water molecules in the octahedral coordination shell of Mg'* and Me 
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represent methyl. Charges are marked {+) and (-). The residues involved are labelled with the 
corresponding helix. (Hinrichs el al., 1994) 
.0 
M e t - " ' ' i i t i i i i i " " " " ; 
The drug binding in TetR binding cavity is mediated by M g " ' , which is octahedrally 
coordinated by the group 011/012 of Tc, HislOO (a6) and three water molecules W l , W2 
and W3. VVl and W2 also interact with Glul47'(a8') via hydrogen bonds. The highly 
conserved Phe86 (a5) fonn a aromatic hydrogen bond with the hydroxyl group 0-121. 
Gin 116 (a7) and His64 (a4) fonn hydrogen bonds to the Tc amide oxygen in position 2 and to 
0-3. The interaction with His64 is quite important because after its substitution to Lysine, the 
affinity to Tc is reduced and the substrate specificity can be changed(Scholz et ai, 2003). The 
0-3 and N-4 of Tc are bridged to Asn82 (a5) by hydrogen bonds(Hinrichs et al., 1994). It has 
been reported that modifications of the functional groups of Tc involved in forming hydrogen 
bonds and Mg^' coordination, like ring A and hydrophilic positions O'", O" , O'", O''^', can 
abolish the bacteriostatic interaction with the ribosoine, thereby losing antibiotic activity 
(Hlavka & Boothe, 1985).Variations of those groups that are only in hydrophobic contact 
(presents in hatched lines) wi th the protein are permissible (Sum et al, 1994). This explains 
why the 9-(N,N-dimethyIglycylamido)-6-demethyl-6-deoxy-tetracycline, which has 
modifications at position 6 and 7, leads to a reduced but still significant induction of TetR 
(Orth et al., 1999). However, it has been proposed that the Tc variants bind slightly different 
positions in the TetR Tc binding pocket(Henssler et al., 2004; Scholz et al., 2003). 
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Figure 1.19 The structure of the temary QacR-proflavin(pf)-ethidium(Et)(Schumacher et al., 
2004). 
A: The ribbon diagram of the QacR-pf-Et temary complex, the nine helices are numbered and the Pf 
and Et molecules are presented as yellow and red sticks respectively. 
B: The key residues involved in the binding of pf and Et, acidic residues are colored red. 
B oS 
1100 
Unlike TetR, QacR is a multidrug binding protein and its drug binding mechanism is 
rather different to that for TetR. Several binary and temary structures of QacR with drugs 
have shown the common and distinct features of QacR when it binds to drugs with different 
structures. 
A l l the reports so far agree with the presence of separate but linked drug-binding sites in 
QacR, which means QacR contains a large multidrug binding pocket composed of lots of 
overlapping mini binding pockets. The large drug-binding pocket is composed of residues 
from all the helices of the inducer-binding domain except a9, as well as the residues from a8'. 
The entrance to the aromatic drug-binding site is formed by divergence of a6, al, a8 and a8'. 
Different drugs bind to different binding pockets by making hydrophobic interactions, 
hydrogen bonds and van der waal interactions with the corresponding residues, h i 2001, the 
report of the structures of six QacR complexes with different drugs, including Rhodamine 6G 
(R6G), Ethidium (Et), Dequalinium (Dq), crystal violet (CV), Malachite Green (MG) and 
Berberine (Be), revealed that there are different dmg-binding pockets for each inducer. 
Among them, the binding pockets of R6G, Et and CV are distinct but partially overlapped, 
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while MG and Be bind within the pockets of CV and R6G respectively. Because Dq is a 
bivalent cationic lipophilic compounds, it binds the same pocket as that defmed for R6G 
and Et (Schumacher et al., 2001). The stnictures of QacR with the other three drugs, proflavin 
(Pf) and the two bivalent diamidines, pentamidine and hexamidine, indicates the presence of 
individual drug-binding pockets. Pf has been shown to bind in the R6G pocket, while 
hexamidine spans the multidmg-binding pockets like Dq, pentamidine twists about its central 
linker and is therefore bent into the core of the protein, creating a noval daig-binding 
pocket(Mun-ay et al., 2004; Schumacher et al., 2004). Another distinguishing feature of 
multidrug binding proteins that recognize cationic drugs is the need for the presence of 
negatively charged glutamate or aspartate residues. In QacR, five glutamate residues have so 
far been found that can neutralizes the positive charge of dmgs; they are Glu57, Glu58 and 
Glu63 from a4, Glu90 from a5 and Glul20 from a7(Mun-ay el al., 2004; Schumacher el al., 
2001; Schumacher et al., 2004). In 2004, Schumacher et al repoiled a ternary structure of 
QacR with two dnigs bound, pf and Et, which shows how the drug-binding pocket adjusts to 
permit binding of more than one dnig. In the QacR-PF-Et ternary stmcture, Pf remains in the 
R6G pocket, with the protein-drug contacts nearly identical to those observed in QacR-Pf 
binaiy stmcture, while the Et molecule has shifted considerably, with the side chain of 
Tyrl23 moved to a position that is identical to that which it assumes in the QacR-binary 
structure, in which there is a l A increase in the distance from the side chain carboxylate of 
the drug-neutralizing residue Glul20 to the positive charged Et. However, the key contacts 
between Et and QacR are still maintained. This confonnational change after the binding of the 
first daig may facilitate binding of the second drug(Schumacher e/ al., 2004). 
The C-tennial multidrug-binding pocket has also been found in other reported stmctural 
and functional studies of TetR family members. Although they may have a variable size and 
entrance, the overall staicture and features resemble one-another. For example, the inner wall 
of the ligand-binding pocket is composed mainly of hydrophobic residues, with the exception 
of TetR, other members can accoinmodate different dnigs in the binding cavity, with different 
drugs bound to distinct binding site(Borbat et al., 2007; Chen et al., 2007; Guan el al., 2007). 
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1.4.3 Induction mechanism o f TetR and QacR 
The TetR repressor mediates an important mechanism of bacterial resistance against the 
antibiotic tetracycline. It controls the expression of TetA, a membrane associated protein 
that export the antibiotic out of the cell, by tightly binding, its operator D N A in the absence 
of Tc; upon binding o f Tc with an associated Mg^"^ ion, it dissociates f rom the D N A and 
allows the expression of TetA. Several models have been proposed for the induction 
mechanism(Lanig et al., 2006; Orth et al., 1998). Among all the mechanisms, the one that 
deduces from the TetR, TetR:Tc and TetR:DNA crystal structures is supported by most 
structural and biochemical studies. 
Figure 1.20 the conformational change of TetR upon binding of [Mg Tc]^(Grkovic et al., 
2002) 
The TetR: DNA is colored blue and TetR:Tc is yellow. The DNA phosphate-ribose backbone is shown 
in red, bases in grey, Tc in orange and Mg'* in red, the water molecules that constitute the water zipper 
in the induced conformation as blue spheres, which locks the DNA binding domain in a conformation 
unable to bind to the operator. 
pendulum 
The subsequent events that are triggered by the entry o f [Mg Tc]"into the binding site 
are listed below, (a) Functional groups of Tc-ring A form tight hydrogen bonds to His64 (a4), 
Asn82 (a5) and Glnl 16 (a7). (b) Mg^^binding to HislOO (a6) triggers the formation o f a type 
I I P-tum, HislOO to Thrl03, at the expense of the C-terminal turn of, produces a partial 
unwinding of a6. The importance o f Mg^^ also been established because when Tc binds in the 
absence of Mg^ ' , TetR remains in the non-induced state and can bind to D N A 
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(Kedracka-Krok et al., 2005). (c) Next to this p-tum, the loop, incorporating residues Argl04 
to Pro 105, is reoriented to form a part o f the hydrophobic pocket surrounding the Tc ring D. 
(d) by rotating 90°, the Glul47' (a8') can hydrogen bond to Glyl02 o f new P-tum and also to 
the remaining two Mg^ ' coordinated water molecules, W l and W2. (e) Formation of a salt 
bridge between Asp 178' (a9') and Arg l04 draws a9' closer and completes the "sliding door" 
movement o f a9' residues, closing the entrance to the binding pocket. It has also been shown 
that the loop separating a8 and a9, which only has weak electron density in the TetR-[Mg 
Tc]* complex structure, is important for induction by interfering with the initial closure o f 
the Tc-binding pocket(Berens et al., 1995; Berens et al., 1997; Hecht et al., 1993). ( f ) a4 is in 
contact with the unwinding part of a6 and the resulting void is f i l led by a4 moving in the 
same direction, like a pendulum, (g) the movement of a4 is associated with a displacement of 
the DNA-binding domain a l to a3 into a position where the homodimer TetR no longer fits 
into the adjacent major grooves o f the operator DNA, thereby inducing the expression of 
TetA(B)(Aleksandrov et al., 2008; Orth et al., 1998). 
Figure 1.21 conformational changes between DNA-bound QacR and drug (R6G)-bound QacR 
A: superimposition of the DNA-bound conformation (yellow) and the drug-bound conformation (blue) 
of the QacR drug binding domain.R6G is colored red. 
B: Details of the conformational changes upon the binding of R6G. The expulsion of Tyr92 and Tyr93 








As a repressor that belongs to the same family as TetR, QacR shares similarities in its 
induction mechanism. In analogy with TetR, the binding of daigs triggers a conformational 
change that starts from helix a5 and a6, which leads to a penduluin motion of a4, finally 
producing a translation and rotation of the DNA-binding domain (al-a3), causing QacR to 
dissociate from the DNA. However, QacR still displays distinct features in the events after 
binding to drugs. First of all, QacR binds to its ligands with a stoichiometry of 2:1, compared 
with 1:1 in TetR; in dmg-bound subunit, the binding of drugs triggers a coil-to-helix 
transition of the C-terminus of a5, which is facilitated by expulsion of Tyr92 and Tyr93; the 
dnig-free subunit of the dimer also undergoes a translation and rotation, although not as 
obvious as for the dmg-bound subunit, which makes a large increase in the center-to-center 
distance as described before(Schumacher et al., 2001). 
The conformational changes due to the binding of ligands to TetR and QacR reflect the 
common induction mechanism of TetR family reprssors. These staictural analyses resemble 
the functional analysis on some levels: for example, it has been shown in biochemical 
studies that upon the binding of ligand, the interaction between the repressor and their 
corresponding operator can be dissociated (Federici el al., 2005; Krell et al., 2007; Teran ei 
al.,2006). 
1.4.4 Regulation by the MtrR repressor of Mtr efflux system of Neisseria gonorrhoea 
As described before in section 1.3.2.3, the MtrCDE efflux pump of Neisseria 
gonorrhoea is associated with increased resistance to inhibitory hydrophobic agents (HAs) 
(Hagman el al., 1995; Tanaka el al., 2006; Veal et al., 1998). It has been characterized as an 
active efflux pump that is driven by the proton gradient(Rouquette-Loughlin et al., 2004; 
Tanaka el al., 2006). Noticeably, this system has also been reported to confer resistance to 
antimicrobial polypeptides, such as a procine Protegrin-l(PG-l) and a linear synthetic 
protegrin variant( PC-8), as well as a human cathelicidin peptide( LL-37)(Shafer el al., 
1998). Genetic studies have shown that the expression of the Mtr system is negatively 
controlled by the transcriptional repressor MtrR, which belongs to the TetR family; deletion 
or inactive mutation o f MtrR can lead to overexpression of the Mtr system and 
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hyperSLisceptibility to HAs(Hagman and Shafer, 1995; Pan and Spratt, 1994; Veal et al., 
1998; Veal el ciL, 2002; Zarantonelli ei al., 2001). l l has been repoiled that the Mtr system is 
positively controlled by a transcriptional activator, MtrA, which belong to the AcrC/Xyls 
family(Roiiquette et al., 1999). A recent report indicated that MtrA can mutate spontaneously 
to compensate for the mutant MtrR during infection(Wamer et al., 2007), however, the 
detailed mechanism of this protein is still unknown. 
Figure 1.22 organization of the mirCDE region of A^.go/7o/'/-/7oefl(Delahay et al., 1997) 
mtrR mtrC mtrD A mtrE 
630bp 1236bp 3204bp 1401bp 
The miiR gene is divergently transcribed with respect to the mtrCDE operon and it has 
been shown be capable of specifically binding the DNA sequence between the mtrR and mtrC 
genes. This binding site is located at 27-nucleotides 
(5'-TTTTTATCCGTGCAATCGTGTATGTAT-3"> on the mtrC coding sequence that 
includes the promoter for mtrCDE transcription and the complementaiy 22-nucleotides 
(5 '-ATCCGTGCAATCGTGTATGTAT-3') contains the -35 region of the mtrR promoter, 
with an inverted repeat that is underiined(Hagman et al., 1997). Biophysical and biochemical 
studies has shown a stoichiometry of two dimers binding to one DNA site in MtrR(Hoffmami 
et al., 2005), in analogy to QacR that we mentioned before. 
In conclusion, although some work has been done to elucidate the characteristics of 
Mti R, additional studies are still needed to better understand the mechanism of transcriptional 
control in the Mtr system. 
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Chapter 2 Materials and Methods 
2.1 Laboratory Apparatus 
2.1.1 Centrifugation 
The following table is a list o f all the centrifuges that were used in this study; whilst 
further detailes on usage is outlined in the subsequent chapter. 
Table 2.1 Centrifugation apparatus 
Centrifuge Rotor Max speed(ipm) Capacity Temperature 
Progen 
GenFuge 24D 












JLA8.I000 8,000 6 x l L 4°C 
Beckman L8-70M Type 50.2 Ti 50,000 12 x25ml 4°C 
Beckman Coulter 
Optima L-90K 
Type 50.2 Ti 50,000 J 2 x25ml 4°C 
Sigma 3-I6K 4,500 12 x50ml 4°C 
Jouan CR3i 4,100 8 x50ml 4°C 
2.1.2 Cell disruption 
The cell disniption system from Constant system (UK.) was used in this work. Al l 
dismptions were performed at 4°C with a pressure of 15KPSI and passed two or three times 
through the equipment according to the type of sample. Generally, in order to break the cells 
completely to provide as much cell membrane as possible, the membrane protein expressing 
cells were passed through disrupter 3 times and the soluble protein expressing cells were 
passed through two times. 
2.1.3 A K T A purifiers 
A l l the purification steps were conducted on A K T A purifier CU950 from Amersham. 
2.2 The media for bacterial growth 
All the media were sourced from Melford Laboratories Ltd or Signia-Aldrich. 
2.2.1 Preparation of the media 
The quantity of the media or reagents was measured on a digital scale and the required 
volume of the deionsed water, from Purlte Prestige Analyst HP purifier, was used to make up 
the media solution. 
2.2.2 Sterilization 
Sterilization of the media was performed by autoclaving in a Priorclave Tactrol 2 at 
I 2 r c , 4 atmosphere pressure, for 15 minutes, whilst plastic and glass wares were autoclaved 
for 30 minutes at I21°C. 
2.2.3 Media were used in this study 
Luria-Bertani (LB) Medium 
NaCI lOg/litre 
Tryptone lOg/litre 
Yeast extract 5g/litre 
L B Agar 
NaCI lOg/litre 
Tryptone lOg/litre 
Yeast extract 5g/litre 
Agar ISg/litre 






l O t r / l i t r e 
S O C Medium 
NaCl 







The above were autoclaved and the fo l l owing f i l te r sterilised components were 
added: 
lMMgCl2-6H20 lOmI 
l M M g S 0 4 10ml 
2.3 Antibiotic 
The stocks of antibiotics that were used in this study were made at lOOOx the working 
concentration, using deionsed water or ethanol as required. In order to avoid inactivation due 
to the heat in the autoclave, a 0.22|um filter was chosen to sterilize the antibiotic stock that 
was dissolved in water A l l the stocks were stored at -20°C. 
The working concentration of the antibiotics was Carbenicillin 100|ug/ml (water). 
Chloramphenicol 34|ig/ml (ethanol) and Kanamycin 50|.ig/ml (water). 
2.4 Other reagents 
Table 2.2 reagents 






I M 0.2-ImM 
20mg/inl in N , N ' 80|ig/ml 
-dimethylformamide (DMF) 
20%(w/v) 0.04% 
I M ImM 









* The stock was sterilized by passing through 0.22pm syringe filter. 
2.5 The strains and vectors 
The strains and vectors that were used in this study are listed in table 2.3 and table 2.4. 
Table 2.3 Strains 
Strain Description Reference or source 
Nova-blue enclAJ hsdRl 70'Ki2~ niK,2')supE44 thi-l recAl Novagen 
g}:rA96 relAl lac F' [proA+B+ laclqZM4l5 
::Tn/0(TetR)] 
BL2I (DE3) F. ompZ". hsdS6(rB-ni6-). dcm, gal. (DE3) Ion Stratagene 
B L 2 I - A i F- ompT hsdSBO'B- niB-) gal dcm Invitrogen 
araB::T7RNAP-telA. 
C4I The strain C41(DE3) was derived from Miroux and Walker, 
BL21(DE3) [E. coli F- ompT hsdSB (rB- mB-) 1996 
gal dcm (DE3)J. it has at least one 
uncharacterized mutation, which prevents the 
cell death associated with the expression of 
toxic recombinant proteins. 
C43 The strain C43(DE3) was further derived (Miroux and Walker, 
from C4](DE3) transformed with the 1996) 
F-ATPase subunit gene and cured, therefore it 
contains no plasmid 
Kam3 (DE3) AacrAB Morita el al., 1998 
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Table 2.4 Vectors 
Vector Description Antibiotic Reference 
Resistance or source 
PGEM-T The pGEM -T Easy Vector Systems is convenient Ampicill in Promega 
easy systems for the cloning of PGR products. This vector 
has a 3'termincil thymidine to both ends. These 
single 3'-T overhangs at the insertion site greatly 
improve the efficiency of ligation of a PGR product 
into the plasmids by preventing recircularization of 
the vector and providing a compatible overhang for 
PGR products generated by certain thermostable 
polymerases. 
PET21a(+) pET-2l(a) is a transcription vector designed for Ampicillin Novagen 
expression from bacterial translation signals 
carried within a cloned insert. A G-terniinal 
His'Tag® sequence is available. 
pACYCDuet p.4GVGDiiet™-J is designed for the coexpression of Chloramphen Novagen 
I'M 1 two target genes. The vector contains two multiple icol 
cloning sites (MGS). each of which is preceded by a 
T7 promoter/lac operator and ribosome binding site 
(rbs). 
pET24a These vectors differ from pET-2la only by their Kanamycin Novagen 
selectable marker 
(kanamycin vs. ampicillin resistance). 
2.6 Polymerase Chain Reaction (PGR) 
All the PCRs were conducted in a Eppendorf Mastercycler Gradient 5331 thennal cycler. 
Two polymerases used in this study, HotstarTag and Proofstart polymerases, both from 
Qiagen, are described in the following table. 
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Table 2.5 Hotstail and proofstart Thermostable DNA Polymerase 
Characteristic Resulting DNA ends 5'-3' exonuclease 3'-5' exonuclease 
activity activity 
Hotstar Tag 3' A Yes No 
Proofstart Blunt No Yes 
2.6.1 Oligonucleotide primers 
A l l the oligonucleotide primers in this study were synthesized by Invitrogen and Fisher, 
at a scale of 25nmol or 50nmol, desalted. Appropriate amount of deionized water was added 
to resuspend the primers to final concentration of 50pmol/nl. A l l the primers stocks were kept 
at -20°C. 
The following table is a list of the oligonucleotides that were used in this study: 
Table 2.7 primers were used in this thesis 
Name Squence (5 -3 ) 
Bolded sequences indicate restriction endonuclease sites. 
Underlined sequences indicate start and slop codons. 
MtrD Ndel F 
MtrD Xhol R 
MtrD BamHl F 
MtrD Sail R 
MtrD Kpnl R 
MtrC Ndel F 
MtrC Xhol R 
MtrC BamHIF 
MtrC Sail R 












MtrC hairpin Ndel F 
MtrC hairpin Xhol R 
MtrE Ndel F 
MtrE Hindi]] R 
MtrE BaniHI F 
MtrE Kpn] R 
MtrC SD-linlc EcoR] R 
MtrE ATG EcoRI F 
MtrC hairpin Ncol F 
gI] ]Nde] F 
MtrR Ndel F 
MtrR Xho] R 
CATATGATCGACAGTTCCACTTATGAAGC 
CTCGAGAATGCGCGAACGGTTCAGATTG 
C A T A T G A A T A C T A C A T T G A A A A C T A C C T T G A C C T C T G T T G 
AAGCTTTTTGCCGGTTTGGGTATCCCGTTTCAATCCGC 
G G A T C C G A A T A C T A C A T T G A A A A C T A C C T T G 
GGTACCTTTGCCGGTTTGGGTATCCCGTTTCAATCCGC 
GAATTCTAATAATTCCTCTTATTTCGCTTCAGAAGCAGG 
G A A T T C A T G A A T A C T A C A T T G A A A A C T 
CCATGGAGATCGACAGTTCCACTTATGAAGG 
CATATGAAAAAACTGCTGTTCGCGATTCCG 
C A T A T G A G A A A A A C C C A A A A C C G A A G C C T T G 
CACGTGTTTCCGGCGCAGGCAGGGATGG 
2.6.2 DNA ana]ysis tec]iniques 
2.6.2.] Agarose gel electrophoresis 
Molecular grade agarose powder (VWR) and Ix TAE (Tris-acetate-EDTA) buffer were 
mixed to the desired concentration (1-2%), according to the size of DNA fragments that 
needed to be analysized, and the mixture was microwaved to totally dissolve the ingrediants. 
Ethidium Bromide was added to a final concentration o f 0.1|.ig/ml to facilitate visualisation of 
the DNA following electrophoresis. The molten gel was poured into a casting tray, a comb 
was fitted into one end of the gel, and the gel left at room temperature to solidify. The comb 
was removed before running and the gel, which was submerged into 1 x TAE buffer witli in a 
ainning chamber. Each sample was mixed with 6 x DNA loading buffer, which includes 
glycerol to malce the sample deposit in tlie wells and dye to make the migi-ation of the sample 
easy to be tracked. A \kb plus DNA marlcer (Invitrogen) was loaded into at least one well a 
lane. A voltage of 6V/cm was applied to tlie electrophoresis chamber, promoting the 
migi-ation of the DNA in the sample towards the positive electrode (anode) of the 
electrophoresis tank. Adequate migration of the D N A can be assessed visualiy by monitoring 
the migration of the tracking dye from the loading buffer. 
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The DNA samples were visualised by placing the gel on an ultraviolet transillumiiiator 
and photography was taken of the relevant area of the gel using a gel dock (GENE Genius 
Bioimaging System, Syngene). 
6x DNA Loading buffer 
Bromophenol Blue 2.5g/litre 
Glycerol 30% 
2.6.2.2 Quantification of DNA 
The concentration of oligonucleotide DNA was determined by spectrophotomeric 
analysis in preparation for Isothermal Titration Calorimetiy (ITC). 
Oligonucleotides, like double-stranded DNA, are most commonly quantified by 
measuring their absorbance of ultraviolet light at 260 nm. Single-stranded oligonucleotides 
(ssDNA) dissolved in neutral aqueous solution at a concentration of 33 ng/ml wi l l have an 
absorbance at 260 nm (in a 1 cm cuvette) of approximately 1.0 unit. An OD value of 1.0 
conesponds to approximately 50|iig/ml for double-stranded DNA (dsDNA). To determine the 
concentration of an oligonucleotide (e.g. primer) stock solution, make one to a few dilutions 
of the stock solution (e.g., 100 - 500 fold) in distilled water or dilute TE buffer [10 mM 
Tris-HCl, 0.1 mM EDTA (pH 7.0)], measure its (their) absorbance at 260 nm and calculate 
the concentration using the formula below: 
|ag/ml of nucleic acid= OD260 x conversion factor 
1 OD260 Unit = 50|.ig/ml for dsDNA 
1 OD260 Unit = 35|jg/ml ssDNA 
pmol 1 0 ' ' U P 1 
P mol DNA= ]Xg DNAx x ! ^ x — 
330 l / / g A' 
N is the number of nucleotides and 660pg/pmol is the average molecular weight of a 
ssDNA 
P m o l D N A = , g D N A x ^ ^ ! ! ^ ^ x l ^ x - L 
660 p g l / /g N 
N is the number of nucleotides and 660pg/pmol is the average molecular weight of a 
dsDNA 
68 
2.6.2.3 DNA sequencing 
Al l DNA sequencing was all caixied by DBS Genomics, School of Biological and 
Biomedical Sciences, Durham University on an Applied Biosystems 3730 DNA Analyser. 
D N A sequencing is the detemination of the precise sequence of nucleotides in a sample 
of DNA. The most popular method for doing this is called the dideoxy method or Sanger 
method. To perform the sequencing, the single-strand template DNA is supplied with a 
mixture of all four normal (deoxy) nucleotides, in ample quantities, and DNA polymerase I . 
Because all four nonnal nucleotides are present, chain elongation proceeds normally 
until, by chance, DNA polymerase inserts a dideoxy nucleotide (shown as colored letters) 
instead of the nonnal deoxynucleotide (shown as vertical lines). I f the ratio of normal 
nucleotide to the dideoxy versions is high enough, some DNA strands wi l l succeed in adding 
several hundred nucleotides before insertion of the dideoxy version halts the process. 
At the end of the incubation period, the fragments are separated by length from longest 
to shortest. The resolution is so good that a difference of one nucleotide is enough to separate 
that strand from the next shorter and next longer strand. Each of the four dideoxynucleotides 
fluoresce a different color when illuminated by a laser beam and an automatic scanner 
provides a printout of the sequence. 
2.6.3 PCR amplification 
Various size reactions were conducted in thin wall 0.5ml PCR tubes. lOxbuffer, dNTP, 
primer forward, primer reverse, Q solution, water, polymerase, template were added 
according to the table below. 






lOxHotstar Tag 10 
buffer 
dNTP 2 








Primer reverse 1 
Q solution 20 
Hotstar Tag 0.5 
polymerase 






DNA, l-50|ig plasmid 
DNA 
Add water to 100 
Table 2.9 Proofstart polymerase 
Component Amount (|jl)/reaction Stock 
Concentration 
Final concentration 
lOxproof Start buffer 5 lOx Ix 
dNTP 1.5 lOmM 0.3mM 
Primer Fonvard ] 50pmol/l l |LlM 
Primer reverse 1 50pmol/|.il l |LlM 
Q solution 10 5x Ix 
Proofstart polymerase 1 5u/|.il 2.5u/reaction 




Add water to 50 
After mixing all the components according to the above recipes, the tubes were 
centrifuged for short time and put in the thermal cycler. The program was set according to the 
different type of polymerases, melting temperature of the primers and the length of the 
fragments. In general, the annealing temperature should be about 5°C blow the melting 
temperature and 1 minute of extension time for amplification of a Ikb DNA fragment. 
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Table 2.10 PGR program for Hotstar Tag polymerase 
Initial activation step ISmin 95°C 
3-step cycling 
Denatu ration Imin 94°G 
Annealing Imin 50-63°G 
according to the Tm of primers 
Extension Imin/kb 72°G 
Number of cycles 30 
Final extension 1 Omin 72°G 
End of PGR cycling - 4°C 
Table 2.11 PGR program for Proofstart polymerase 
Initial activation step 5min 95°C 
3-step cycling 
Denaturation 1 min 94°G 
Annealing 1 min 50-63°G 
According to the Tm of primers 
Extension 1 min/kb 72°G 
Number of cycles 30 
End of PGR cycling - 4°G 
2.6.4 Purifying the PGR product by Gel Extraction Kit (Qiagen) 
After mixing with 6x|oading buffer, the PGR product was loaded on a 1-2% 
electrophoresis agarose gel. When the samples had ran to the appropriate position, the gel 
was analysised under a UV lamp. 
The DNA bands were excised from the gel with a scalpel and put in 1.5 eppendorf tubes. 
QG buffer from the kit (100|il/100mg) was added, then the tubes were incubated in a 50°C 
water bath until the gel had totally melted. The mixture was applied to spin column and 
centrifuged at 13,000rpm for 1 minute. The flow-through was discarded and the collector was 
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put back to column again. To clean up the unmelted gel, 0.5ml of QG was added to the 
column, followed by centrifugation for 1 minute. After this, 0.75ml of PE washing buffer was 
applied to the column and centrifuged to remove the buffer. In order to get ride of the residual 
ethanol in the membrane, an extra one minute centrifugation was made after discarding the 
flow-through in the collector. Finally, the column was transferred to a clean 1.5ml eppendoif 
tube and 35 | i l o f nucleotidase free water was applied to the membrane of the column to elute 
the DNA. The DNA was collected by centrifugation for ] minute at 13,000rpm. 
2.7 competent ceils 
Two types of competent cells were used in tliis study, according to the requirement of 
the competency. 
Magnesium chloride and Calcium Chloride protocol was used to make fresh competent 
cell of variant host strains for expression. A single co]ony was used to incubate 10ml of LB 
broth. When the OD600 reached 0.5-0.6, the cells were put on ice for 10 minutes, and then 
harvested at 2000rpm for 5 minutes. After draining the rest of the medium, the cells were 
re-suspended with 1ml of ice-cold O.IM magnesium chloride, then transfened to a 1.5ml 
eppendorf tube. The next step was to collect the cells by centrifugation at 4,000rpm for 30 
seconds, which were then resuspended with 1ml O.IM Calcium Chloride. After the 
centrifugation, the cells were suspended in 250^1 O.IM CaCL2 and 150).il was used for a 
single transfomiation. 
Another more complicated method was chosen to make chemically competent cells for 
cloning. This rubidium chloride protocol gives better transformation efficiencies than calcium 
chloride procedures for most strains. A single colony was picked to inoculate 5ml of LB 
broth, which was shaken at 37°C overnight, and 2.5 ml was used to inoculate 250 ml of LB. 
The cells were grown in I L flask until A600 was 0.4 to 0.6 (approx. 5-6 hours). The cells 
were pelletted by centrifugation at 2500rpm for 5 minutes at 4 degrees, and then were gently 
resuspended in 0.4 volumes (of original culture volume) of ice cold T F B l . For a 250 ml 
culture, 100 ml of T F B l was used. The cell suspension was then incubated on ice for 5 
minutes at 4 degrees followed by centrifugation at 2,500rpm for 5 minutes at 4 degrees to 
72 
collect. The cells were gently resuspended in 1/25 volume of ice cold TFB2. For 250 ml 
culture. 10 ml of TFB2 was used. The cells were incubated on ice for 15-60 minutes and then 
aliquoted as 50 |ul /tube. Finally, the tubes were frozen in liquid Nitrogen for storage at -80 
degrees. 
TFBl Buffer - lOOmM rubidium chloride, 50mM manganese chloride, 30mM potassium 
acetate, lOmM calcium chloride, 15% glycerol, pH 5.8. 
TFB2 Buffer- lOmM MOPS, lOmM rubidium chloride, 75mM calcium chloride, 15% 
glycerol, pH 6.8. 
2.8 Cloning the DNA fragment by p G E M T easy vector 
The pGEMT easy vector was chosen for cloning of PCR products in this study because 
it has a 3'tenninal thymidine at both ends. These single 3'-T overhangs at the insertion site 
greatly improve the efficiency of ligation of a PCR product into the plasmid by preventing 
recircularization of the vector and providing a compatible overhang for PCR products 
generated by certain thermostable polymerases. 
Flotstar Tag polymerase can produce 3'-A overhangs at the each end of the PCR product, 
however, Proofstart polymerase can only generate blunt ends to a PCR product, so a 
following 'adding 3'-A overhangs' step was done before hgating in pGEMT vector. 
Table 2.12 Adding 3'-A overhangs 
Component Amount 
(|.il)/reaction 
Stock concentration Final concentration 
5X GoTaq® Reaction Buffer 4 5X 1 X 
PCR product 1-7 
dATP 0.2mM 20mM 0.2mM 
GoTaq polymerase 1 
Add water to 20 
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After mixing all the components above, the reaction was put in a thermal cycler at 72°C 
for 30 minutes. Then it was used for ligation with the pGEMT vector. 
The PCR product and pGEMT easy vector ligation reaction was mixed as the following table. 
Table 2.13 pGEMT easy vector ligation reaction 
component Amount (pi) Stock concentration Final concentration 
2 X ligation buffer 
PCR product 
pGEMT easy vector 







The ligation reaction was mixed well by short centrifiigation and then was put at 4°C to 
ligate overnight. 
The transformation of the ligation was performed by transfening the cloning pGEMT 
vector to Nova-blue competent cell. 
5|il of ligation was gently added into 50|.il competent cells on ice, incubated on ice for 
30 minutes followed by a 30 seconds heat shock at 42°C. The tube was put back to ice for 2 
minutes after heat shock, then 250|.il SOC stock was added to the tube and the tube was 
shaken for 1 hour at 37°C. Finally various amount of the reaction was spreaded on the plates 
that contained 100)ig/ml carbenicillin. After 16 hours incubation at 37°C, the positive 
colonies were checked by PCR. 
Because the insertion of the PGR product intemipts the coding sequence of 
p-galactosidase, recombinant clones can be identified by color screening on indicator plates. 
White colonies are always produced by clones containing PCR products and blue ones can 
result f rom no insertion or PCR fragments that are cloned in-frame with the lacZ gene. 
To achieve the blue-white screen, lOfil o f I M IPTG and 50[i\ 20iTig/ml X-gal were 
spreaded onto the carbenicillin plate. Before transformation reaction was applied, the plate 
was incubated in 37°C for 1 hour, in order to reduce the number of false positive colonies. 
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2.9 Restriction Endonucleases digestion 
After cloning the PGR fragment into the cloning vector pGEMT, for proper expression, 
it needs to be ligated into expression vector. First of all, both of the pGEMT plasmid and the 
expression vector have to be digested with the restriction endonucleases, and digested 
expression vector and the PGR fragment were connected together by T4 ligase. 
The restriction endonucieases digestion was performed according to the following 
reaction 
Table 2.14 Digestion reaction 
components Various volume(|il) 
10 X buffer 2 5 8 
BSA 0.2 0.5 0.8 
Enzyme 1 1 2 3 
Enzyme2 1 2 3 
Recombinant plasmid or 10 20 30 
expressing Vector 
ddHjO 5.8 20.5 35.2 
Total vokime((.il) 20 50 80 
After mixing all the components by high speed centrifugation for a short time, the 
reaction was put in a 37°G incubator or thennal cycler for 3-5 hours, followed by incubation 
at 65°G for 15minutes to inactivate the enzymes. The digestion reactions were analysed by 
1% or 2% agarose gel Electrophoresis. 
2.10 ligate the P C R fragment to expressing vector 
Before ligating the PGR fragment into the correspondent vector, both of them were 
purified using a gel extraction kit. A l l the components were mixed in PGR tube according to 
the following table. 
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Table 2.15 T4 ligase reaction 
Components Amount ( | i l ) 
5 X buffer (invitrogen) 2 
PCR product ( after digested and purified) 4-5* 
Vector (after digested and purified) 2-3* 
45°C 5 minutes, then add 
T4 ligase (Invitrogen) 1 
16°C 1.5 hours, followed by 4°C overnight 
* According to the concentration of the fragments. In general, the PCR fragment should be 3 
times of vector to increase the efficiency of ligation.. 
2.11 Transfer the ligation to competent cells 
In order to get highly efficient Iransfonnation, Nova-blue competent cells that were 
prepared by the inbidium chloride protocol were nomially used at this step. 5|.il of the ligation 
was used for transfermation of 50(,il of competent cell, after incubating on ice for 30 minutes; 
a 45 second heat shock was performed at exact 42°C without shaking. The tube was put on 
ice for 2 minutes and 250|LI1 of SOC medium was added in. after shaked at 37°C incubator for 
1 hour, various amount of the transfonnation reaction was spreaded on the LB-agarose plates 
contain appropriate antibiotic. The plates were put in a 37°C incubator and the result was 
checked after 16 hours. 
The positive colonies were analysed by PCR or restriction endonuclease digestion. 
The plasmid with correct insertion was abstracted from overnight culture of the cells by 
using Miniprep Kit ( Qiagen or Promega). Then it was transferred into the competent cells of 
the host strain used for protein expression. The positive colonies were tested again by PCR. 
The recombinant strain was then ready for protein expression and purification. 
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2.12 Recombinant protein expression methods 
2.12.1 Overexpression of the recombinant protein 
A single colony of the E.coli strain containing the desired recombinant plasmid was 
used to inoculate various amounts of LB broth, with appropriate antibiotic, and shaken at 
37°C overnight. 3-5 ml of overnight culture was used to inoculate 1 litre o f YT Broth 
containing antibiotics. Cultures were grown in flasks at 37°C, with ISOrpm rotary agitation, 
until the optical density at 600nm reached middle log phase, for about 0.5-0.6. Then IPTG at 
various concentrations, ranged from 0. l-0.5mM was added to the culture. According to the 
genotype of expressing host, 0.2% (w/v) of L-arabinose needs to be added in some cases. 
After addition of the inducer, the temperature was adjusted to 25-28°C according to the 
toxicity of the host. At meantime, and the rotary speed was reduced to 160-180rpin. In the 
case of soluble proteins, the cells were harvested 3-4 hours after induction. For membrane 
proteins, at least 5 hours is needed before harvesting, 16 hours of overnight agitation is 
geenerally applicable. 
2.12.2 Preparing the soluble protein Homogenate and cell membrane by centrifugation 
2.12.2.1 Extraction of the soluble protein homogenate 
The cells were harvested by centrifugation at 6,300rpm for 8 minutes. The cell lysis 
buffer was used to resuspend and homogenized the cell pellet. A typical lysis buffer was Tris 
20mM NaCl 300mM Glycerol 10% pH 7.5, the details of which wi l l be mentioned in the 
Chapter 4 an 5. Appropriate amount of DNAse I (Sigma, lOOu/litre culture) and proteinase 
cocktail inhibitor tablet (Roche, 1 tablet/12 litre) were added to the cells, which were put on 
ice for 15 minutes before disruption. 
The cells were homogenized by passing the resuspended cells 3 times through the 
constant cell disruptor, operated at pressure of 15 KPSI, at 4°C. An enriched supernatant 
fraction containing cytosolic proteins from bacterial cell components was obtained by 
ultracentrifugation at 43,000rpm for 1 hour. The supernatant from the centrifugation was kept 
for the subsequent purification. 
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2.12.2.2 Extraction of the cell membrane 
The cells were harvested and disrupted by the same procedure above. The cell 
homogenate was centrifuged at 18,500rpm for 1 hour to spin down the cell debris and the 
supernatant that contains cell membrane and cytosolic protein was ultracentrifuged at 
43,000rpm for 2 hours to deposit the cell membrane. 
The cell membrane from ultracentrifugation was homogenized in membrane 
resuspension buffer (Tris 20mM NaCI I00-300mM Glycerol 20% pH 7.6-7.8 THP 0.5mM) 
by passing through thin syringe needle. Finally, the extracted membrane was stored at -70°C, 
ready for protein purification. 
2.13 Recombinant protein purification methods 
2.13.1 Immobilized metal affinity chromatography 
Immobilized metal affinity chromatography ( IMAC) was used primarily in this work to 
purify polyhistidine tagged recombinant proteins. This is achieved by using the natural 
tendency of histidine to chelate divalent metals. Chelating Sepharose, when charged with N i ' ' 
ions, selectively binds proteins i f complex fomiing amino acid residues, in particular 
histidine, are exposed on the protein surface. (His)6 fusion proteins can be easily bound and 
then eluted with buffers containing imidazole.The basis of the seperation is the different 
affinity with resin between the 6-Histidine proteins and the proteins from host strain. 
The 6xHistidines that cognated to the recombinant proteins were generated by 
expressing vectors. 
A typical purification was done in three steps: binding, washing and elution. 
For soluble protein, the Imidazole concentration of the supernatant from the cell 
homogenate was adjusted to lOmM, loaded into pre-equilibrated nickel chelating columns by 
peristaltic pumps at a speed of O.Sml/minute at 4°C. The loaded columns were coruiected to 
an A K T A purifier for washing and elution. The washing buffer was normally Tris 20mM 
NaCl 300mM Glycerol 10% pH7.5-8.0, with various concentrations of Imidazole, ranging 
from 50mM to ] I 5 m M . In this step, a peak at 280nm could be detected due to the 
contaminant protein from the host. In order to get pure fusion protein, the column would be 
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washed by washing buffei" until the trace returned to the baseline. The elution step was 
undertaken by high concentration of Imidazole in the elution buffer, usually the washing 
buffer with 300mM Imidazole. Because of the high affinity binding of both Nickel and 
Imidazole to the His-tag, the protein bound to resin can be replaced and eluted. 
In the case of membrane proteins, a detergent needs to be used to solubilize the cell 
membrane. The non-ionic detergent Dodecyl-P-D-maltoside (DDM) was adopted for MtrD 
and MtrE in this work. The cell membrane stock was thawed and the total volume was made 
up to 50ml/6 liters of culture in membrane resuspending buffer. Then 2% (w/v) of D D M was 
added and the mixture was gently rotated at 4°G for 1-2 hours until the membrane 
homogenate was totally clear. After ultracentrifugation for I hoiu" at 43,000rpm, and 4°G, the 
supernatant was loaded on to a pre-equilibrated column via a peristaltic pump. Then the 
columns were connected to an A K T A purifier and washed with the washing buffer, Tris 
20mM NaGl 300mM Glycerol 20% D D M 0.2% pH 7.5-7.8 THP 0.5mM, until the trace at 
280nm retumed to the baseline. To elute the protein, an Imidazole concentration of 500mM 
in the washing buffer was used. Protein fractions were collected manually. 
2.13.2 Desalting of the protein sample 
A HiTiap Desalting column packed with the size exclusion medium Sephadex G-25 
superfine was used to perform the buffer exchang procedures in this study. This was 
accomplished by group separation between high and low molecular weight, that buffer 
exchange was accompanied by removal of the low molecular weight contaminants. 
For buffer exchange, the columns were equilibrated with the ideal (elution) buffer on the 
A K T A purifier until the salt concentration reached to a stable level. Then l.5ml/column of 
protein sample was applied to the column using a syringe ( i f the volumn was less than 1.5ml, 
buffer was added to a total volume of 1.5ml), and the flowthough was discarded. Finally, 
2ml/colmn of ideal buffer was injected into the coumn to elute. The protein in elution buffer 
was collected, ready for the next step. 
Nomially, a desalting step was applied before the ion exchange of protein or the dialysis 
before setting crystallization trials. 
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2.13.3 Ion exchange chromatography 
Jon exchange chromatography is based on adsorption and reversible binding of the 
charged sample molecules to oppositely charged groups attached to an insoluble matrix. The 
pH value at which a protein molecule carries no net charge is called the isoelectric point (pi). 
When the buffer pH is higher than the pi of the protein molecule, it wi l l carry a negative 
charge and wil l bind to an anion exchange column; otherwise, the protein wi l l can-y a positive 
charge and wil l bind to a cation exchange column. In addition to the pH of the buffer, the 
ionic strength is also critical for binding and elution of both target and contaminant molecules 
in ion exchange chromatography. Ion exchange chromatography (lEX) separates 
biomolecules according to differences in their net surface charge. 
A typical Ion Exchange Chromatography includes the following steps: equilibration, 
sample application, elution and final wash. Before loading the sample, the column is 
equilibrated with start buffer. Ideally, samples should be in the same conditions as the start 
buffer. After all the sample has been loaded, the column is washed so that all non-binding 
proteins have passed through the column (i.e. the UV signal has returned to baseline), 
conditions are altered in order to elute the bound proteins. Most frequently, proteins are eluted 
by increasing the ionic strength (salt concentration) of the buffer or, occasionally, by 
changing the pH. As ionic strength increases, the salt ions (typically Na+ or CI-) compete 
with the bound components for charges on the surface of the medium and one or more of the 
bound species begin to elute and move down the column. The proteins with the lowest net 
charge at the selected pH wi l l be the first ones eluted from the column as ionic strength 
increases. Similarly, the proteins with the highest charge at a certain pH wi l l be most strongly 
retained and wil l be eluted last. The higher the net charge of the protein, the higher the ionic 
strength that is needed for elution. By controlling changes in ionic strength using different 
forms of gradient, proteins are eluted differentially in a purified, concentrated form. 
A wash step in very high ionic strength buffer removes most tightly bound proteins at the 
end of an elution. 
In this study. Hi trap Desalting columns were adopted for the buffer exchang of samples 
before they were loaded to an ion exchange column. The start buffer was normally Tris (or 
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phosphate) 20mM NaCl 50mM Glycerol 10% with variable pH, detergent was needed when it 
was membrane protein. After applying the sample to the column, 2 column volumes of start 
buffer were used to wash the column. The protein elution was started by using a gradient 
concentration of NaCl in 10-20 column volumes with an up to 0.5 M NaCl in the start buffer. 
At this step, the elution fractions were collected for analysis. Finally, the coumns were 
washed with 5 column volumes of 1 M NaCl to elute any remaining ionically bound material. 
In this study, ion exchange chromatography was also employed to perform the protein 
concentration. To achieve this, the protein sample was desalted and loaded on to an ion 
exchange column, and then it was eluted with a high ionic strength buffer, such as that 
containing 0.4M NaCl. Because of the sudden increase in the ion strength, the protein was 
eluted very fast. This technique is especially suitable for concentrating membrane proteins 
because it doesn't cause detergent accumulation like ultrafiltration spin column do. Ion 
exchange chromatography can also be used to change the detergent of membrane protein for 
crystallography studies. After binding the protein to column, wash the column with at least 2 
column volume of buffer with ideal detergent first, then elute the protein. This is considered 
to be the best way to change the detergent of a membrane protein (Bergfors, 2002). 
2.13.4 Gel Filtration Chromatography 
Gel filtration separates molecules according to differences in their size as they pass 
through a gel filtration medium packed into a column. Unlike ion exchange or affinity 
chromatography, molecules don't bind to the chromatography medium so buffer composition 
does not directly affect the resolution. Consequently, a significant advantage of gel filtration 
is that conditions can be varied to suit the type of sample or the requirements for further 
purification, analysis or storage without altering the separation. 
To perform a separation, the packed bed is equilibrated with buffer which fills the pores 
of the matrix and the space in between the particles. Then the sample is applied to the 
column. When buffer and sample move through the column, molecules diffuse in and out of 
the pores of the matrix. Smaller molecules move further into the matrix and so stay longer on 
the column. 
Hiload 16/60 superdex 75 prep grade and Hiload 16/60 superdex 200 prep grade were 
adopted in this study according to tiie size of molecules that needed to be separated. A typical 
gel filtration mn was to equilibrate the column with more than 3 column volumes of buffer, 
which had been filtered and degassed right before use. According to the manufactural user 
manual, no more than 5 ml of sample was loaded onto the column using a superloop, and 
then the run was started with the same buffer, at a constant f low rate. The fractions of each 
peak were collected and analysized by SDS-PAGE electrophoresis. 
Because of the need to apply a huge volume of washing buffer, gel filtration 
chromatography was only used during the soluble protein purification in this study. The 
detailed buffer conditions of each protein wi l l be discussed in the following chapters. 
Gel filtration chromatography had also been used in this study to detemiine the size of 
the protein molecules. Unlike electrophoretic techniques, gel filtration provides a means of 
determining the molecular weight or size of native proteins under a wide variety of conditions 
of pH, ionic strength and temperature, free from the constraints imposed by the charge state 
of the molecules. Molecular weight determination by gel filtration can be made by comparing 
Ve-Vo 
an elution volume parameter, such as Kav (Kav= ) of the substance of interest, with 
Vl-Vo 
the values obtained for several known calibration standards. Vo, void volume, is the 
interstitial space of the gel particle, which is the elution volume of a very large or excluded 
molecules (Dextran blue in this study) that do not enter the gel pore; Ve is the elution volume 
of the sample and Vt represents the sum of the internal and external volume within the beads. 
A calibration cur\'e is prepared by measuring the elution volumes of several standards, 
calculating their coiTesponding Kav values (or similar parameter), and plotting their Kav 
values versus the logarithm of their molecular weight. After the standard curve is made, apply 
the sample by exact the same condition to determine the elution volume (Ve). Calculate the 
coiresponding Kav for the component of interest and determine its molecular weight f rom the 
calibration curve. 
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2.14 Recombinant protein analysis 
2.14.1 SDS-PAGE 
In this study, SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) 
was used to test the expression and purification of the protein. The commercial resources of 
pre-cast gels from Invitrogen were adopted to perfonn the electrophoresis. Depending on the 
size of the protein of interest and the degree of separation, 12% NuPage Bis-Tris gel or 
4%-12% NuPage Bis-Tris gel were chosen. 
The gels were clamped vertically into a running tank. MOPS running buffer was added 
in until the both anode and cathode were submerged, as well as all the wells of the gel. Before 
loading the samples were mixed with 4x LDS loading buffer (NuPage, Invitrogen), then they 
were loaded into the wells carefully, together with 10|.il o f SeeBlue marker (from Invitrogen) 
to one lane. A voltage of 200v was applied to the tank until the dye from the loading buffer 
had shifted to the bottom of the gel. 
The protein bands were visualised by staining in Coomassie blue for 20 minutes and 
destained with destained buffer via several washes. 
For separation o f some smaller proteins, such as the hairpin domain of MtrC, a home 
made 18% gel was used. The gels were made by using glass slides and the stand from 
BIO-RAD. 
lOx MOPS Running Buffer 
MOPS 104g 
Tris base 61g 
SDS lOg 
EDTA 3g 
dHiO up to 1 litre 
Coomassie Blue stain 
Methanol 40% v/v 
Acetic acid 10% v/v 
Coomassie Brilliant Blue R-250 0 .1% w/v 
dHiO 50% v/v 
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Coomassie blue destain 
Methanol 40% v/v 
Acetic acid 10% v/v 
dHjO 50% v/v 
2.14.2 Blue Native Electrophoresis 
BN-PAGE has been developed for the separation of membrane proteins and multiprotein 
complexes in the molecular mass range from about lOkDa to 10,0001cDa. The basic principles 
of BN-PAGE is that Coomassie blue G250 is added to the membrane protein and this dye 
seems to bind to surface of all membrane protein but not to all water-soluble proteins. 
Binding of a large number of anionic dye molecules is the basis for the Blue Native 
Electrophoresis. 
Table 2.16 buffers and stock solution for BN-PAGE 
solution composition 
Deep Blue Cathode buffer 50mM Tricine, 7.5mM Imidazole, 0.02% 
Coomassie blue G250 
Slightly blue cathode buffer 50mM Tricine, 7.5mM Imidazole, 0.002% 
Coomassie blue G250 
Gel buffer (3x) 75mM Imidazole/HCl, 1.5M 6-aminocaproic 
acid 
Anode buffer 25mM Imidazole 
AB-mix (30%) Commercial product from Sigma 
5% Coomassie blue G250 Suspended in 500mM 6-aminocaproic acid 
Table 2.17 Gradient gel preparation 
Sample gel Gradient separation gel 
4% 6% 15% 
AB-mix 0.5ml 4ml 8.5ml 















Total volume 6ml 20ml 18ml 
The separation gel was casted at 4°C but then was left at room temperature to 
polymerize. The gradient was accomplished by a gradient mixer. The sample gel was casted 
at room temperature. 
BN-PAGE was perfomied at 4°C. The deep blue cathode buffer B was used to fill the 
electrophoresis tank after clamping the gel vertically. The samples were centrifuged at 
lO.OOOg for 15 minutes avoid them to sedimentation; then glycerol, to a final concentration of 
15% was added to them to increase the density and to facilitate the application of the 
samples. After loading the samples, a voltage of lOOV was maintained until the samples had 
moved into the sample gel; then the voltage was increased to 200V. After about one-third of 
the running distance, the cathode buffer was changed to slightly blue cathode buffer. This 
optional buffer exchange improves detection of faint bands. After the samples ran to the 
desired distance, the run was stopped and the gel was dehydrated and analysized. 
2.14.3 Mass Spectrum 
Al l the mass spectmm analyses were performed in the department of Chemistry, 
University of Durham, by Mr Matthew Burton, in a Thermo Finnigan LTQ FT in ES+in 
ES+mode spectrometer. The following experimental parameters were used to record mass 
spectra, O.lmg/ml MtrR was dialysized to lOmM ammonium bicarbonate buffer. 
2.14.4 Protein concentrating 
Several methods of concentrating protein were employed according to the requirement 
of the experiments. The ultrafiltration spin column (Vivascience) was the commonest way to 
concentrate the protein, i f it was a soluble protein or membrane protein that did not require a 
low detergent concentration. 
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Ultrafiltration is a convective process that uses anisotropic semi-permeable membranes 
to separate macromolecular species and solvents primarily on the basis of size. It is 
particularly appropriate for the concentration of macromolecules and can also be used to 
purify molecular species or for solvent exchange. Ultrafiltration is a gentle, none denaturing 
method thai is more efficient and flexible than alternative processes. 
In order to maximize the recovery of the protein, the size of the membrane needs to be 
around two-thirds of the size of the protein. A 30kDa membrane was used for MtrE (MW 
30kDa) and a lOOkDa membrane for MtrD (MW 1 l4kDa). 
Because, in membrane protein solutions, there is always a lot of detergent molecules that 
bind to the protein, which are difficult to remove, the use of ultrafiltration columns can cause 
the accumulation of the detergent in the liquor. Ion exchange was used to concentrate the 
protein when there was a requirement for the detergent concentration to be maintained or 
lowered, and when very high concentrations of the protein was not necessary. The protein 
was desalted and loaded onto a pre-equilibrated ion exchange column, 2 column volumes of 
buffer with the desired concentration of detergent was applied to the column. Finally, the 
protein was eluted at a high salt concentration buffer. This enabled the protein to be 
concentrated at same time without increasing the detergent concentration. 
2.14.5 Bradford protein assay 
The Coomassie Plus - The Better Bradford'^"' Assay Ki t from Pierce was adopted 
throughout this study for detennining the concentration of proteins. The Coomassie Plus Ki t 
is a quick and ready-to-use coomassie-binding, colorimetric method for total protein 
quantitation. This modification of the well-known Bradford method greatly reduces the 
tendency of coomassie reagents to give nonlinear response curves by a formulation that 
substantially improves linearity for a defined range of protein concentration. In addition, the 
Coomassie Plus Reagent results in significantly less protein-to-protein variation than is 
observed with other Bradford-type coomassie foiTnulations. 
To perform the test, combine a small amount of protein sample with the assay reagent, 
mix well, incubate briefiy and measure the absorbance at 595 nm. Protein concentrations are 
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estimated by reference to the absorbances obtained for a series of standard protein dilutions, 
which are assayed alongside the unknown samples. 
2.14.6 Western blot 
The western blot is an analytical technique used to detect specific proteins in a 
given sample. It uses gel electrophoresis to separate native or denatured proteins by 
the length o f the polypeptide. A n d then the proteins are transferred to a membrane, 
where they are detected using probed specific antibody. 
2.14.6.1 Buffer used in this study 
Table 2.18 
A. Transfer buffer 
(fresh made) 
Glycine 2.9g (=39mM) 
Trizma base 5.8g (=48mM) 
SDS 0.37g 
Methanol 200ml 
Add water to 1000ml 
E L I S A washing buffer 
Phosphate stock 30ml 
NaCl 4.38g 
Tween 20 250ul 




Add water to 400ml 
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2.14.6.2 Western blot procedure 
Firstly, a SDS-PAGE gel o f the protein samples was ran, and then the gel was 
soaked in transfer buffer for 15 to 30 minutes. A t same time, a piece o f P V D F 
membrane that was sl ightly bigger than the gel was cut and a marker was made at the 
corner. The membrane was soaked in methanol for 30 seconds fol lowed by proper 
wash by deionized water. Finally the membrane was soaked in transfer buf fer for 15 
minutes, as we l l as the nylon sponges and the fi l ter paper that were used for the 
transfer. 
The apparatus was assembled as the following order from Anode to Cathode: nylon 
sponge, filter paper, gel, PVDF membrane, filter paper, nylon sponge. The bubbles between 
the layers need to be gently removed. 
The transformation was performed by using a potential of 180mA for 1.5 hours. 
Afier the transfomiation finished, the membrane was washed with washing buffer for 15 
minutes, then the washing buffer was carefully Pipetted out and blocking buffer (washing 
buffer with 3% of Bovine Serum Albumin) was added in. The blocking was done by gently 
shaking at room temperature for one hour and overnight at 4°C 
The blocked membrane was washed with washing buffer 3 times at room temperature, 
for 5 minutes each. The first antibody, mouse anti 6His monoclonal antibody (sigma, 1:3000 
diluted with washing buffer) or mouse anti S-tag (a fusion peptide tag derived f r o m 
pancreatic RNase A that is widely used in protein expression applications) monoclonal 
antibody (novagen, 1:5000 diluted with washing buffer) was added to the membrane and 
shaked at room temperature for 1 hour. Followed by three times 10 minute washes with 
washing buffer, the second antibody was added to the membrane. The goat anti mouse IgG 
(Sigma), conjugated with an Alkaline phosphatase, was diluted to 1:5000 before use. After 
allowing the reaction to proceed for one hour with the second antibody, the membrane was 
washed 3 times with washing buffer. 
Finally, the chemiluminesence detection method was used: 1ml of Immune-star substrate 
(Bio-Rad) was added to a clean square Petri dish onto which the membrane was put, then 
another 1 ml was added on the top surface of the membrane, so that the substrate could react 
with the membrane properly. The reaction was left for 5 minutes, and then the membrane was 
placed between 2 pieces of Saran film, and safely attached to the autoradiographic cassette. 
Finally, the blot was exposed to a X-ray film in the dark room for different times until optimal 
signals were produced. 
2.15 Biochemical Assay 
2.15.1 Antimicrobial susceptibility assays 
The Minimum Inhibitory Concentration (MIC) of dmgs was determined using 96 well 
microplates with various dnigs (Penicillin G, Tetracycline, erythromycin, nafcillin) at 
different concentrations. 
The fresh plates containing chlorampenicol (34mg/ml) were made for growth of the 
strains to be tested. A single colony was picked and used to inoculate LB broth supplemented 
chlorampenicol and shaken overnight at 37°C. 
A 0.3 ml overnight culture was used to inoculate 30ml of LB broth with supplemented 
chlorampenicol, which was shaken at 37°C until the optical density at 600nm(OD6()fj) had 
reached to 0.3-0.5, then Isopropyl P- D -l-thiogalactopyranoside (IPTG) was added to final 
concentration of I m M . After induction, shaking was continued for 2 to 3 hours. 
The cell was adjusted to 3x l0 ' ' c fu /ml (when A(,oo=0.1, the colony forming units is 
Ix lO ' /ml) . 
The 96 well MIC microplates were prepared by adding each antibiotic in triplicated to 
three rows. To the first column, 40ul antibiotic solution of the highest concentration was 
added, and then the rest of the wells each were filled with 20ul L B broth containing 
chlorampenicol. A 20ul from the first well was pipetted and mixed with second one, then a 
20ul from second well was taken and mixed with the third well, continue diluting all the wells 
were continued diluting like these to make 1/2 serial dilution. 
lOOul ceils of 3x l0*cfu /ml was added to each well and mixed well with the antibiotic 
solution. The final colony forming unit o f each well was 5xl0^cfu/ml . 
A l l the plates were checked after incubated at 37°C for 20 hours. The smallest 
concentration of antibiotic that could inhibit the growth of the cells is the minimum inlnbitory 
concentration. 
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2.15.2 Growth curve 
The recombinant strains of Kam3(DE3)[pACYC], Kam3(DE3)[pACYC/MtrD], 
Kam3(DE3)[pACYC/MtrC,MtrD], Kam3(DE3)[pACYC/MtrC,MtrD,MtrE], 
Kam3(DE3)[pACYC/MtrD,glII MtrC hairpin]. Kam3(DE3)[pACYC/MtrE,gIIl MtrC 
hail-pin] of table 4.1 were used in this study. 
Fresh plates and overnight cultures were prepared in the same manner as for MIC tests. 
A 0.3ml of each overnight culture was used to inoculate 30ml of 2xYT broth (containing 
34mg/ml of chlorampenicol), and then was shaken at 37°C until optical density at 600nm had 
reached to 0.3-0.5, and then Isopropyl P- D -l-thiogalactopyranoside (IPTG) was add to final 
concentration of I m M . After induction, shaking was continued for 3 hours. 
Each recombinant strain was diluted with 2^YT broth, containing 34f.ig/ml 
chlorampenicol, to an OD,,oo 0.1. Four test tubes were set for each strain, three of them were 
added appropriate amounts of the test dmgs, while the last one was without test drug and 
served as a control of nomial growth. 
A l l the tubes were shaken violently at 37°C. The OD(,oo was detemiined by spectrometer 
every 30 minutes. 
2.16 in vitro protein interaction analysis 
2.16.1 Pull-down assay 
2.16.1.1 How does the pull-down assay work? 
According to the schematic diagram blow, the pull-down assay is performed by two 
kinds of proteins, one is the bait protein, which fuses with a 6-histidine tag that can be trapped 
by Nickel-NTA sepharose, the other one is the prey protein, it fuses with a fusion tag (eg. an 
S-tag, which is a 15aa peptide with the sequence of KETAAAKFERQHMDS) that can be 
detected by a specific monoclonal antibody. 
After mixing these two kinds of protein together for some time, Nickel-NTA sepharose 
is added in the mixture. Because of the strong affinity of resin-bound Ni for the 6 consecutive 
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histidine (his) residues of the tag on recombinant proteins, the bait protein binds to the Nickel 
agarose. I f the prey protein can interact with the bait protein specifically, it w i l l not be washed 
away from the bait protein easily, so there wi l l be a certain amount of bait-pray protein 
complex that exists in the mixture. When the poly-histidine tag of the bait protein is trapped 
by nickel agarose and after washing properly, the recombinant protein is eluted and analyzed. 
If the fusion tag of the prey protein can be detected, that means the prey protein does from a 
stable complex with the bait protein. 
Bait to 
Bait ]--QJ>-^^^Bead^ 
Bait HDD-( ' 







2.16.1.2 Conslinction of the proteins that were used in pull-down assay 





Bait protein Prey protein Constmcts were used to produce pray 
protein 
lVItrD([MP) MtrD-Histidine^ MtrC-Stag B121 (DE3)[pACYCDuet-MtrC(NdeI 
and +Xhol)] 
MtrC(MFP) 
MtrE(OMP) MtrE-HistidinCf, MtrC-Stag B121 (DE3)[pACYCDuet-MtrC(NdeI 
and +Xhol)] 
MtrC(MFP) 
MtrD(lMP) MtrD-Histidines MtrE-Stag B121(DE3)[pACYCDuet-MtrE(NdeI 
and +Kpnl)] 
MtrE(OMP) 
2.16.1.3 Detect the interaction between the proteins by Pull-down assay 
The Pull-down assay was performed according to the following procedure. 
Pure proteins with a C-teminal histidine tag, which eluted from the Nickel chelating 
coluinns in the previous description, were used as bait protein in this study. In order to reduce 
the effect of the high concentration of imidazole in the protein samples, desalting was 
perfonned by Hitrap desalting columns, by which proteins were exchanged into buffer, Tris 
20mM NaCl 300mM Glycerol 10% DOM 0.1% pH 7.5. 
The crude membrane fraction of the prey protein, was extracted according to the 
2.12.2.2. They were divided into separate tubes that contain the membrane from 2-liter cell 
cultures each. 
The membrane of the prey protein was made up to 20ml with buffer above and 
solubilised with 0.2g D D M ( 1 % , w/v) for 1 hour. Then 2ml of purified 6-Histidine fusion bait 
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protein from above was added to the prey protein solution and mixed with gently rotation at 
4°C for 1 hour. 
After adjusting the Imidazole concentration of the bait and prey protein mixture to 
lOmM, it was loaded onto I ml Ni-chelating HP column with a peristaltic pump at 4°C. 
To get ride of the non-specific binding of the prey protein with Nickel agarose beads, a 
negative control was set at the same time. One tube of the prey protein was solubilised by 
exactly the same procedure as above, except 2 ml of buffer was added instead of bait protein. 
Both the test and negative control columns were connected to an A K T A purifier and 
washed with 30ml of washing buffer (Tris 20mM NaCL 300mM Glycerol 10% Imidazole 
1 l 5mM D D M 0.1% pH 7.5), then eluted with the same buffer with 300mM Imidazole. 
The elutions of both the test and the negative control were analysed by SDS-PAGE 
electrophoresis and Western-blotting using antibodies against the different fusion tags. 
2.16.2 Protein-Protein cross-link analysis 
Cross-linking is the process of chemically joining two molecules by a covalent 
bond. Cross-linking reagents contain reactive ends to specific functional groups (primai^ 
amines, sulfhydryls, etc.) on proteins or other molecules. Several chemical groups that may 
be targets for reactions in proteins and peptides are readily available, allowing them to be 
easily conjugated and studied using cross-linking methods. 
In this study, two different crosslinkers were employed in analysing the interaction of all 
the components of Mtr system, D M A (Dimethyl adipimidate«2 HCI) and EGS (Ethylene 
glycolbis (succinimidylsuccinate)). The spacer amis of D M A are 8.6A and EGS are 16.1 A. 
Because both of them are reactive towards amines, there is a requirement that there are no 
primary amines in the buffer. Before the cross-linking analysis, all the protein samples were 
exchanged into phosphate buffer by dialysis or ion exchange chromatography. The D M A and 
EGS stock solution were made freshly before use, with water and DMSO respectively to 
concentration of 50mM and lOOmM. The concentration of the proteins was determined and a 
20 fold molar excess of the cross-linker was added to them. The reactions were left at room 
temperature for 60 minutes. 
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At last, ihe reactions were mixed with loading buffer; DTT. to a final concentration of 
lOmM, was added in the reactions, which were boiled for 5 minutes before applying to a 
4-12% Bis-Tris Nu-PAGE gel (Invitrogen) for electrophoresis. 
2.16.3 Isothermal Titration Calorimetry (ITC) 
ITC measurements were earned out at 25°C using a VP-ITC MicroCalorimeter 
(MicroCal). This instrument is equipped with a 1.437-ml cell and a 300|al syringe. 
Because MtrD and MtrE were in Tris 20mM NaCl 300mM Glycerol 10% pH 7.5 
containing 0.1% D D M , it was necessary to add D D M to N-terminal truncated MtrC and MtrC 
hairpin proteins, and then to dialyse in different dialysis cassettes at same time with MtrD or 
MtrE respectively against the same buffer above. After dialysis, the concentration of each 
protein was determined using Bradford Protein assay kit. 
In the experiments for the interactions of the MtrR with peptides and Penicillin G, MtrR 
was dialysed against the buffer, which was then used to dissolve the peptides. In the case of 
Penicillin G, MtrR was dialysed against the buffer Na2HP0^ 20mM NaCI 300mM Glycerol 
10% pH8.0. The buffer outside the dialysis cassette was used to dissolve the substrates to the 
appropriate concentration, and they were used to titrate into the protein. When testing the 
interaction of MtrR with its operator DNA, the annealing was can'ied out by mixing 
equimolar amounts (lOOjoM) of each oligonucleotide in annealing buffer (Tris-HCl lOmM, 
MgCL 0.5mM pH8.0). The mixture was incubated at 95°C for 5 minutes, followed by slow 
cooling to room temperature. Both DNA and MtrR were subsequently dialyzed in buffer Tris 
20mM NaCI 300mM Glycerol 10% pH8.0. The MtrR was placed in the cell and fitrated with 
the DNA fragment. 
Because MtrD and MtrE normally have a lower concentration than the soluble 
N-terminal truncated MtrC and MtrC hairpin proteins, the MtrD and E were placed in the 
sample cell whilst the soluble proteins were placed in the syringe for the titration. In the case 
of MtrD and MtrE, MtrE was used to titrate into MtrD. 
Typically, all the proteins and substrates samples were degassed prior to ITC 
measurements. An experiment generally involved using a single 2pl and a series of 8|J1 
injections of protein or substrates into the protein solution. A l l data were corrected by using 
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the heat changes arising from injection of proteins into buffer before data analysis with 
ORIGIN software (MicroCal). 
2.17 Structural study 
2.17.1 Circular Dichroism 
Circular Dichroism (CD) is observed when optically active matter absorbs left and right 
hand circular polarized light slightly differently. It can be used to help determine the structure 
of macromolecules (including the secondary structure of proteins and the handedness of 
DNA). 
Because the measurement of CD is complicated by the fact that typical aqueous buffer 
systems often absorb in the range where structural features exhibit differential absorption of 
circularly polarized light, the proteins buffer needs to be changed to appropriate one. The 
protein concentrations required for performing CD spectroscopy was l-6|aM and the protein 
samples were dialyzed against Tris-sulfate NaF 300mM pH7.5 overnight. The same NaF 
buffer was used to dilute the protein samples, because this has low absorbance. CD spectra 
were recorded using a .lasco J-810 spectropolarimeter from 180 to 260nm with a 0.2cm path 
length quartz cuvette. Each scan is the mean of three accumulations. The data were 
analysised by on-line software, DICHROWEB for Line Circular Dichroism Analysis, which 
is based at the School of Crystallogi'aphy, Birkbeck College, University of London. 
2.17.2 Protein crystallography 
Crystallography is an important experimental science for determining the arrangement of 
atoms in solids. Obtaining crystals is currently the bottleneck in determining the structure of 
macromolecules by crystallography, especially in the crystallization of membrane proteins, 
which have distinct biochemical and biophysical properties from soluble proteins. 
Because membrane proteins are embedded within the lipid bilayer and contain both a 
hydrophilic surface exposed to the solvent and a hydrophobic region buried within the lipid 
bilayer. A suitable detergent, such as deodecyl-p-D maltoside (DDM), is needed to obtain 
membrane protein from lipid bilayer. 
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Obtaining sufficient quantities of a membrane protein is a basic requirement to proceed 
with crystallization trials, a condition that allows the protein to be concentrated is also 
needed. As described previously. Immobilized Metal Af f in i ty Chromatography ( IMAC) and 
Ion Exchange chromatogi'aphy were used to purify the two proteins, MtrD and MtrE, which 
were tried in crysatllization trials in this study. Basically, the preparation of the protein 
samples for crystallography was accomplished by overexpression; membrane extraction; 
membeane solubilisation; initial purification by Immobilized Metal Aff in i ty Chromatography 
( IMAC); concentrating by ion exchange chromatography; dialysis overnight; and finally, 
concentrating using ultrafiltration spin columns. At last the protein concentration was checked 
using a Bradford Protein Assay kit and precessed to crystallization trials. 
Two kinds of crystallization methods were adapted in this study, hanging drops and 
sitting drops. The hanging drops were set mainly for sparse matrix screens and additive 
screens for the purpose of saving protein samples. Nonnally, 1ml of precipitant solution was 
transfened to each reservoir, then l | i l of protein sample and 1|J1 of precipitant solution from 
the reservoir was mixed on the siliconized glass cover lid, at last the lid was screwed on the 
resei-voir. The sitting drops were used in the optimizing screens. After transfening 1ml of 
precipitant solution to a reservoir, a plastic microbridge was put in reservoir. 5|il of protein 
sample was then mixed with 5(il of precipitant solution from the resen'oir. A glass cover was 
then applied to seal the reser\'oir. 
To check the diffraction of the ci^stals, the crystals were picked up by loops and frozen 
in liquid nitrogen. The diffraction of the crystals was checked at the European Synchrotron 
Radiation facility (ESRF) by Dr Xueyuan Pei, University of Cambridge. 
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Chapter 3 Crystallography study of the IMP MtrD and 
the OMP M t r E 
3.1 Cloning, expression, purification and crystallization of the outer membrane protein 
MtrE 
3.1.1 Cloning the nitrE in pET2 la expression vector 
A pair of primers, MtrE forv.'ard and MtrE reverse, which ware designed according to 
the multi-cloning site of the pET21a vector and the 5' and 3' ends of the mIrE sequence, were 
used to amplify the intrE fragment. The start codon was supplied by the 5' Ndel restriction 
site and the stop codon was supplied by pET21a vector, in stead of by the reverse primer. 
The following Hotstar polymerase PCR programme was used to amplify the gene 
fragment of mtiE. after 15mintues of initial activation, the annealing temperature was 60°C 
and run for 30 cycles. Because Hotstar polymerase has terminal transferase activity, which 
means it can add a 3' hanging A tag, there is no special step needed except a 10 minutes final 
extension at 72°C. 
Figure 3.1 PCR amplification of mliE 






Lane 1: Amplified niirE gene 
Lane2: Ikb DNA ladder (Invitrogen) 
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The PGR product was purified from the gel using a Gel Extraction K.it, then it was 
ligated into the pGEM-T easy vector by T4 iigase at 4°C overnight. The whole reaction was 
transfeiTed to Nova-blue competent cell afterwards and white colonies were picked and tested 
by PGR. The positive ones were used to inoculate an overnight culture. The plasmid was 
extracted the next morning from the overnight culture and was digested with Ndel and 
Hindi 11 for 5 hours at 37°G. 





p G E M - T easy vector fragment 
intiE gene fragment 
Lane l : 1 Kb D N A ladder (Invitrogen) 
Lane2: p G E M - T easy-MtrE digested by N d e l and H i n d l l l 
After being purified with a Gel Extraction Kit , the 1.5 Kb mtrE gene fragment was 
ligated into pET21a vector, which had been digested with Ndel and Hindlll with T4 ligase. 
The ligase reaction was transformed to Nova-blue competent cell. White colonies were 
picked and were tested by PGR. The positive plasmid was extracted from the overnight 
culture and confirmed by DNA sequencing; at last was transferred to C43(DE3) competent 
cells. One colony was picked express MtrE. 
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3.1.2 Overexpression of Mtr t . 
One colony of C43/pET2la-mtrE (Ndel+Hindlll) was used to inoculate 50ml of LB 
broth with 100|ag/ml Carbenicillin (final concentration), which was cultured overnight. 3ml 
of overnight culture was used to inoculate 1 litre of YT broth with lOO^g/ml carbenicillin. 12 
litres of culture were usually made for purifying the protein. The culture was induced by 
0.5mM IPTG (final concentration) when the OD reached 0.6-0.7. Then the temperature was 
decreased to 25°C and the rotatation speed was changed from 200rpm to ISOrpm. The cells 
were harvested 5 hours after induction. 
3.1.3 Purification of MtrE by IMAC 
The cell membrane was extracted as described before and then homogenized in the 
membrane resuspension buffer (Tris 20mM NaCl 200mM Glycerol 20% THP O.SmM 
pH7.8). Before solublizing the membrane with D D M , one tablet of proteinase inhibitor was 
added for the membrane from every 6 liters cells. After solublization with D D M and being 
ultracentrifuged, the soluble fraction was loaded onto a pre-charged Ni-chelating column 
( I column/fraction from 6 liters of cells). 
The column was connected to an A K T A purifier and washed with washing buffer 1 (Tris 
20mM NaCl 300mM Imidazole 50mM Glycerol 20% D D M 0.2% THP 0.5mM pH 7.8) first, 
followed by washing buffer 2 (Tris 20mM NaCl 300mM Imidazole lOOmM Glycerol 20% 
D D M 0.2% THP 0.5mM pH7.8), then washing buffer 3 (buffer 2 with higher salt 
concentration), finally, the MtrE was eluted with elution buffer (buffer I with SOOniM 
Imidazole). 
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Fiuvirc 3.3 SDS-PAOH gel ofMtrF-. afler purified by Ni-elielaling counin 
1 2 3 4 5 6 7 
- 5 : K D a 





Lane I-6: Mti E fractions from IMAC (20nl/lane) 
Lane7: Seeblue mariner ( ln\ itrogen) 
3.1.4 CPv 'staliization of MtrE 
X-ray crystallography enables us to visualize protein structures at the atomic le\el and 
enhances our understanding of protein function. Specifically we can study how proteins 
interact with other molecules, how they undergo conformational changes. Because the 
diffraction from a single protein molecule is too weak to measure, we use an ordered 
three-dimensional aixay of molecules, in other words a crystal, to magnify the signal. 
3.1.4.1 Protein preparation 
Before setting up crystallization trials, the buffer condition for MtrE was changed and 
then the protein v\as concentrated by cation exchange chromatography. 
Table 3.1 Buffers for concentrating the Mtrh by Ion exchange chromatography 

















PH 7.8 7.S 
Figure 3.4 SDS-PAGE gel of MtrE after being concentrated by Cation exchange 
chromatography 
1 2 3 4 5 6 7 8 9 






M t r E 
Lanel: Seeblue Marker (Invitrgen) 
Lane2-8: MtrE after being concentrated (5|.il/lane) 
The protein fractions coiTesponding to Lane2-9 of the above gel were desalted, and the 
buffer was changed to Tris lOmM NaCl lOOmM Glycerol 10% D D M 0.1% THP 0.5mM 
pH7.8. Then protein sample was dialysized against the same buffer above by dialysis cassette 
(Pierce). Finally, the protein was concentrated to 5mg/'ml using a 30KDa ultrafiltration spin 
column. After determining the protein concentration with Bradford protein assay kit, the 
protein sample was used for crystallization trials. 
The protein was run on a Blue-Native gel to check the homogeneity of MtrE;. from the 
Blue-Native gel figure 3.5, MtrE forms Trimer in the native state. 
Figure 3.5 blue-Native Gel Electrophoresis of M t r D and MtrE 
1 2 3 








' 51 KDa 
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Lanel: SeeBlue Marker (Invitrogen) 
Lane2, 3: MtrD 
Lane4: MtrE 
3.1.4.2 Sparse matrix screen 
For the identification of initial crystallization conditions, a flexible sparse matrix screen 
is used. In the initial screen we examine the roles of pH, precipitant, additives, and 
temperature. 
The MbGlass and MbGlass I I Suites from Nextal, MemStartT^ and MemSys™ from 
Molecular Dimensions were employed in this study to provide an effective initial screening 
set of crystallization conditions for the membrane proteins MtrE. 
The hanging drop method was used for the sparse matrix screen because of the small 
volumes used, ease of set-up that can be quickly checked. I ml of solution containing 
precipitant or another dehydrate agent, from each initial screening kit, was transfer to the 24 
wells plates respectively. 1^ 1 of protein sample was dropped onto the cover l id, then mixed 
with l | . il of the solution from each reservoir, being careful to avoid bubbles and pervasion. 
Then the lid was screwed onto the correspondence well tightly. After all the wells were done, 
the plates were moved to the incubator at a temperature of 18°C. 
Two weeks after all the trials had been set, one condition was found to produce 
microcrystals and one small crystal, which is condition No.26 of the MemStart•''^' kit from 
Molecular Dimensions. The formulation is 0.2 M tri-sodium citrate 0.1 M Tris 30 % v/v PEG 
400 pH 8.5. 
This condition was used as a base for optimization of the crystallization conditions. 
3.1.4.3 Optimization screen 
3.1.4.3.1 Initial optimization 
The condition above that favoured nucleation was used in the initial optimisation. For 
each condition, a new tray was set up in which one parameter was varied and the others kept 
constant in according with the following table. 
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Table 3.2 Fonnulation of initial optimization 
Formula 
varied in 
precipitant I A l A 2 A3 A4 A 5 
concentrations O . l M T n s O . l M T n s O . l M T n s O . I M Tris O . I M Tris 
varied, with 0.2M Na 0 .2M Na 0 .2M Na 0 .2M Na 0 .2M Na 
precipitant 2 Citrate Citrate Citrate Citrate Citrate 
pH 8.5 p H 8.5 p H 8.5 pH 8.5 p H 8.5 
PEG 400 PEG 400 PEG 400 PEG 400 PEG 400 
v/v 15%) v/v 20% v/v 25% v/v 30% v/v 35% 
precipitant 1 B l B2 83 3 4 B5 
concentrations O . I M Tris O . l M T n s O . I M Tns O . I M Tris O . I M Tris 
varied. without pH 8.5 pH 8.5 pH 8.5 p H 8.5 p H 8.5 
precipitant 2 PEG 400 PEG 400 PEG 400 PEG 400 PEG 400 
v/v 15%o v/v 20% v/v 25%o v/v 30% v/v 35%. 
C I C2 C3 C4 C5 
O . I M O . I M Na O . I M Na O . I M Tris O . I M Tris 
MES HEPES HEPEs 0 .2M Na 0.2M Na 
bulTcr and pH 0.2M Na 0 .2M Na 0 .2M Na Citrate Citrate 
varied Citrate Citrate Citrate D H 8.0 p H 8.5 
p H 6.5 pH 7.0 D H 7.5 PEG 400 PEG 400 
PEG 400 PEG 400 PEG 400 v/v 30%. v/v 30%. 
v/v 30% v/v 30% v/v 30% 
protein D l D2 D3 D4 D5 D6 
concentration 2.5mg/ml 3mg/ml 3.5mg/ml 4 m g / m l 4.5 mg/ml 5mg/ml 
varied 
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The trials were checked after 2 weeks, the best crystals were produced in C1, which is 
O.IM MES 0.2M Na Citrate PEG400 v/v 30% pH6.5, with a protein concentration of 
5mg/ml. This condition was used for further optimization. 
Figure 3.6 MtrE crystals after optimized 
Iweek 2week 
week 
These four photos are for the crystals after different time, which were produced by the 
conditions above. Obviously, the crystals are too many and small, aound only SO-SOjim long, 
so ftirther optimizations were still be needed to be done to get high quality crystals for the 
crystallography. 
3.1.4.3.2 Additive and detergent screen 
The additive screen is a complete reagent kit designed to provide a rapid screening 
method for the manipulation of the sample-sample and sample-solvent interactions to 
enhance or alter sample solubility. The additive screen evaluates the effect of such factors as 
multivalent cations, salts, amino acid, dissociating agents, linkers, polyamines, chaotropes, 
co-factors, reducing agents, polymers, chelating agent, carbohydrates, polyols, 
non-detergents, amphiphiles, detergents, osmolyte, organic (non-volatile) and organic 
(volatile) reagents. The additive screening was performed again using the hanging drop 
method for the benefit of effective cost and setting multidrops with a single reservoir. 1ml o f 
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crystallization reagent (O.IM MES 0.2M Na Citrate 30v/v PEG 400 pH 6.5) was pipetted into 
the reservoirs first, then 1 ^1 of MtrE sample was pipetted onto the cover l id. 0.22 \i 1 o f 
additive was carefully pipetted into the sample and mixed, 1 \i\ o f precipitate solution f rom 
the reservoir was added to the drop and mixed well. The cover l id was sealed tightly on the 
reservoir and the plates were moved to 18°C incubator. 
Figure 3.7 MtrE crystals after Additive screen 
A: The crystals were produced in condition No. 14 (0.1 M Praseodymium(III) acetate 
hydrate) of Additive screen (Flampton research) 
B: The crystals were produced in condition No.24 (1.0 M Cesium chloride) of 
Additive screen (Hampton research) 
The crstals f rom drop A and B in the above graph were frozen and sent to the ESRF. 
The diffraction was checked by Dr Xueyuan Pel, University of Cambridge. The best one 
diffracted to 8A. 
Figure 3.8 diffraction pattem of MtrE 
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Detergent screens are designed to be capable of manipulating hydrophobic 
sample-sample interactions which can lead to non-specific aggregation that prevents or 
interferes with sample crystallization. The detergents also perturb water structure which may 
play a role in sample crystallization. 
The detergent screens from Hampton Research include 72 unique detergents for their 
ability to influence the solubility and crystallization o f the sample. According to the user 
guide, the recommend final concentration is l -3xCMC. To obtain a IxCMC final 
concentration, l ^ i l o f protein was pipetted onto the cover l id and then mixed with 0.22|il 
detergent solution( lOxCMC), 1^1 of precipitant solution(0.1M MES 0.2M Na Citrate 30v/v 
PEG 400 pH 6.5) f rom the well was mixed well in the drop. To get 2xCMC detergent 
concentration, 1|J1 of protein was mixed with 0.5|j,l detergent solution and then l | . i l of 
crystallization reagent. Mixing of protein with l | j . l o f detergent solution and l | . i l o f 
precipitant solution was used to a 3xCMC o f final detergent concentration. After the drops 
had been set, the cover lids were screwed onto the wells and the plates were moved to an 
18°C incubator. 
The plates were checked after three days, bigger crystals were found in the drop which 
has N-Decanoyl-Sucrose at a concentration o f 3xCMC. No better crystals were found in the 
detergent screen of 1 xCMC and 2xCMC. 
Figure 3.9 MtrE crystals with N-Decanoyl-Sucrose f rom the detergent screen 
The biggest crystal in this drop was about ISO^m long and 30nm wide. Unfortunately, 
because the drop was destroyed during the deUvery, the diffraction of the crystals weren't 
tested. The same condition was set several times but we never manage to produce the similar 
crystals again. 
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3.1.4.3.3 Cation exchange chromatography for MtrE 
In order to improve the diffraction of the crystals, further purification of MtrE was 
adopted to increase the purity of the protein, which was accomplished by Ion exchange 
chromatography. Because the pi (Isoelectric Point) of MtrE is 9.5; a Hi-trap SP (5ml column 
volume, Amersham) Cation exchange column was used in this study. 
Before undertaking the Cation exchange of MtrE, the column was pre-equilibrate with 5 
column volume of buffer B2 (table 3.3) followed by 5 column volume of buffer A2 (table 
3.3). The eluted MtrE from 3.3.3 was desalted into buffer A2 using a Hi-trap desalting 
column. The desalted MtrE was then loaded onto a Cation exchange column on an A K T A 
purifier. MtrE was eluted from the column using a gradient of 0%-100% buffer B2. 
Table 3.3 Buffers for concentrating the MtrE by Ion exchange chromatography 
Buf f e rA2 B i i f f e r B 2 
Tris lOmM 10m M 
NaCi 50mM 5 0 0 m M 
Glycerol 10% 10% 
D D M 0.1%, 0.1 %, 
THP O.SmM O.SmM 
PH 7.6 7.6 
Because the B2 buffer has a higher concentration of salt, the gradient of B2 can produce 
a constantly increase of ionic strength in the column. The molecules in the column are eluted 
separately according to their net charge. 
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Figure 3.10 Cation exchange chromatography of MtrE 
The above graph is the cation exchange chromatogi-aphy of MtrE. The fractions from the 
first peak were used for crystallization. 
After being eluted from the cation exchange column, the protein was diluted and 
consequently needed to be concentrated again for setting the trials. In order to avoid 
accumulating detergent in the liquor, cation exchange chromatography was used again for 
concentrating the MtrE, as described in 3.3.4.1. 
The MtrE was desalted into the crystallization buffer, Tris lOmM NaCI lOOmM 
Glycerol 10% D D M 0.1% THP 0.5mM pH7.8, for the purpose of decreasing the salt 
concentration, followed by dialysis against the buffer for 3 hours. The protein was then 
concentrated to 5mg/ml (Bradford Protein Assay Kit , Pierce) using a 30ICDa vivaspin 
centrifugal concentrator. 
The same trials as before were set up using both hanging drop and sitting drop methods. 
The drops were checked after 2 weeks. The sitting drops were set by mixing 5|.il of protein, 
4 | i l o f crystallization reagent and 1^ 1 of additive.The plates were checked 2 weeks after being 
set. 
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Figure 3.11 Crystals of MtrE after further purification 
A , C: crystals fi-om hanging drops 
B: crystals f r o m sitting drops 
• 
From the above figures, we can see the improvement in both size and shape of the 
crystals. Maybe it means that after further purification by cation exchange chromatography, 
both the purity and homogeneity were better than before. These crystals were sent to ESRP to 
check the diffraction, unfortunately, none of them diffracted better than 8A. 
3.2 Cloning, expression, purification and crstallization of the Inner membrane protein 
MtrD 
3.2.1 Cloning ofmtrD in pET21a vector 
3.2.1.1 PCR amplification ofmtrD 
A pair of primers, which were designed according to the multi-cloning site of pET21a 
vector and 5' and 3' end o f the mtrD sequence, MtrD forward and MtrD reverse were used to 
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amplify the wirD fragment. The stall codon was supplied by 5' Ndel restriction site and the 
stop codon was supplied by pET21a vector, instead of in the reverse primer. 
Due to the size of the fragment, which was more than 3kb, the proofstart polymerase 
was employed to amplify the mtrD fragment. The amplification was perfomied with an 
annealing temperamre of 55°C and extension time of 3 minutes 20 seconds for 30 cycles. 
Because Proofstart polymerase can only generate blunt ends on PGR products, it was 
necessary to incorporate a step of 'adding 3'-A overhangs' before ligate to pGEMT vector. 






M t r D fragment 
3.2Kb 
Lane 1: Ikb DNA ladder 
Lane 2: amplified mtrD gene 
3.2.1.2 Sub-cloning the mirD gene fiagiuent into the expression vector pET2 la 
After purifying the fragment from the agarose gel using a Gel Extraction Kit (Chapter 
2.6.3?), then followed by adding 3' - A overhangs, the gene fragment was ligated overnight at 
4°C into pGEM-T easy vector. The ligation mixture was transformed to nova-blue competent 
cells and after incubating these at 37°G overnight, the white colonies were picked and tested 
by PGR with the primers MtrD forward and MtrD reverse. The positive colonies were used to 
inoculate an overnight culture and the plasmid was extracted and digested by endonuclease 
Heall; then the whole digestion reaction was purified using a QIAquick Nucleotide Removal 
Kit, followed by digestion with Ndel and Xhol. The pET2la expression vector was digested 
with Ndel and Xhol simultaneously. 
Figure 3.13 the expression vector pET2la and pGEMT easy-MtrD after digesting with Ndel 
and Xliol 














Lane I : Ikb D N A ladder 
Lane 2: pET2Ia expression vector digested by Ndel and Xhol 
Lane 3: pGEM-T easy/mtrD digested by Heall followed by Ndel and xhol 
The digested pET21a vector and the mtrD fragment were purified using a Gel extraction 
kit, then ligated with T4 D N A ligase. The ligation reaction was transformed to Nova-blue 
competent cells. Several colonies were picked from the plates and tested by PCR. The one 
with the right orientation of insertion was used to inoculate the overnight culture and the 
plasmid was extracted. Finally, the pET21a-MtrD(NdeI+XhoI) construct was used for 
transfonnation of C43 competent cells. A positive colony was accepted for expression od 
MtrD. 
3.2.2 Overexpression of Mt rD 
The recombinant constmct, pET21a-MtrD was used to produce the inner membrane 
protein MtrD with a fused C-terminal 6 Histidine tag. The overexpress strain C43 was 
selected to express the MtrD due to the characteristic of high toxicity of membrane protein. 
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G43(DE3) (Miroux and Walker, 1996)was derived from C41(DE3) by selecting for resistance 
to a different toxic protein and can express a different set of toxic proteins to G41(DE3) , the 
strain C41(DE3) was derived from BL21(DE3) and it has at least one uncharacterized 
mutation, which prevents cell death associated with expression of many recombinant toxic 
proteins. 
As described in Chapter 2.12, one colony was picked to inoculate lOOml of LB broth 
with of lOOiig/ml carbencillin. 3ml of overnight culture was used to inoculate 1 liter of YT 
broth with IOO|ig/ml carbenicillin in. Nomially, one batch of protein (5mg) was obtained 
from 24 liters of medium. After being induced with a final concentration of 0.5mM IPTG, the 
temperature was decreased to 25°G and the cells were harvested 5 hours later. 
3.2.3 Purification of MtrD by Immobilized Metal Aff in i ty Chromatogi'aphy 
The cell membrane was extracted and homogenized in the membrane resuspension buffer 
(Tris 20mM NaCl lOOmM Glycerol 20% THP 0.5mM). pH 7.5 Before being solublized with 
D D M , one tablet of proteinase inhibitor was added for the membrane from 6 liters cells. After 
solublization with DDM and being ultracentrifuged, the soluble fraction was loaded onto a 
pre-charged Ni-chelating column (1 column/fraction from 6 liters of cells). The column was 
connected onto A K T A purifier and washed with the washing buffer 1 (Tris 20mM NaCl 
300mM Imidazole 50mM Glycerol 10% THP 0.5mM D D M 0.2% pH7.5), followed by washing 
buffer 2 (Tris 20mM NaCl 300mM Imidazole lOOmM Glycerol 10% THP 0.5mM D D M 0.2% 
pH7.5). The protein was eluted with the same buffer as above but with 300mM Imidazole. The 
eluted fractions were checked by SDS-PAGE electrophoresis. 
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Figure 3.14 SDS-PAGE of MtrD after being purified by Ni-chelating chromatograpiiy 
Lanel 2 3 4 5 6 7 8 
9 8 K D ; i -
5 2 K D a -
3 3 K D a -
2 I K D a -
1 9 K D a -
M t r D 
114KDa 
- 1 2 K D a 
Lane 2; SeeBIue protein marker(lnvitrogen) 
Lane 3-7: The elution fractions from Ni-Chelating column (20|.il/lane) 
3.2.4 Desalting and Concentrating the Mt rD by anion exchange chromatography 
Due to the high concentration of the hTiidazoie and low amount of protein in the eluted 
fraction, a desahing and concentrating step was perfomied after Mt rD had been purified. 
The desalting of the protein was accomplished using a prepacked HItrap desalting 
column as described before. One 5ml column can be used to desalt 1.5ml of protein, so the 
number of columns can be detemiined from the total amount of protein sample. I f the sample 
amount was not a multiple of 1.5ml, it had to be made up to an exact multiple with buffer. 
The Hitrap desalting column was connected onto A K T A , which was then 
pre-equilibrated by the ideal buffer, Tris 20mM NaCl 50mM Glycerol 10% D D M 0.1% THP 
0.5mM pH7.5. The protein sample was loaded onto the column by a syringe. 2ml per column 
of ideal buffer was used to elute the protein. After this desalting step, 95% of buffer could be 
changed to the ideal buffer. 
In order to get the higher concentration of MtrD for setting the crystallization trials, 
anion exchange chromatography was adopted to concentrate the protein without 
accumulating the detergent. 
A pre-packed RESODRCF'^' Q (6nil) column was used I'or this step; it was connected 
to an A K T A puriflei' and then equilibrated with 3()ml (5 column \olume) of Buffer B 
followed by 30ml (5 column \'olume) of Buffer A. The desalted MtrD was loaded onto the 
Resource Q column at a flow rate of 1 ml/minute. Then the protein was eluted with a high salt 
buffer. 
Table 3.4 Buffers for concentrating the MtrD by Ion exchange 
Buffei-A BufferB 
Tris lOniM lOmM 
NaCl 50mM 500mM 
Glycerol 10% 10% 
DDM 0 .1% 0.1% 
THP 0.5mM 0.5mM 
PH 7.5 7.5 
Figure 3.15 SDS-PACili of Mtr l ) after concentrated by Anion exchange chromatography 
1 2 3 4 5 6 7 8 9 10 
I N X k D a -




2 I K D ; i -
1 2 K D n -
Lane 1: Seeblue marker (Invitrogen) 
Lane 2-10: MtrD after concentrated (5|Lil/lane) 
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3.2.5 C'ryslallizalion o l M l r l ) 
3.2.6 Pmlein preparation 
Before setting up the crystallization trials, tiie buffer was ciianged to Tris lOniM NaCl 
lOOmM Glycerol 10",, DDM O.l",, THP ().5mM. Then the protein sample was dialysized 
against the same buffer using a dialysis cassette (Pierce). Finally, the protein was 
concentrated to I5nig'nil using lOOKDa ultrafiltration spin column. 
Figure 3.16 SDS-PAGE of MtrD before applying to crystallization trials 
1 2 3 
MtiD DiniL-r ' 
MtrD 1 1 3 K D a 
5 2 K D a - - « M — 
: i K D a - t«jii 
m K D a - ^ 
i : K D a -
Lane I : Seeblue marker 
Lane2, 3; MtrD after dialysis and being concentrated (lul/lane) 
From the SDS-PAGH gel above. MtrD sample only contains minor impurities, so further 
purification wasn't used in this study. 
In the Blue-Native SDS-PAGE Gel, the homogeneity of MtrD is poor. Although the 
main part of the sample was a monomer, the dimer and trimer were still obviously visible in 
the gel. Related to the difllculty of crystallization of MtrD in later studies, the heterogeneity 
of the sample might be a major issue. 
3.2.7 Sparse matrix screen 
The same kits as used for MtrE were employed to do the initial screen for MtrD. Again, 
the hanging drop technique was used to set the trials as described before. 
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The plates were checked after two weeks. Lots of microcrystals appeared under 
condition No.8 of the MemSys''''^ kit (Molecular Dimensions Ltd); the formulation is O.IM 
MES 30% VA^ PEG 400 PH6.5. 
Figure 3.17 The microcrystals produced in sparse matrix screen 
Microcrystals 
Microcrystals 
3.2.8 Optimization screen 
The optimizing of conditions was based on the formulation of the sparse matrix screen; 
whilst the additive and detergent screens were applied. The additives and detergents were used 
same as MtrE which we described before. The drop in the following graph was the best one 
among them. It was produced under condition No.77 (50% v/v Jeffamine M-600 ® pH 7.0) 
from additive screen (Hampton research). 
Figure 3.18 The MtrD crystals after opimization 
These crystals were frozen in liquid propane and sent to the ESRF for checking the 
diffraction. Unfortunatly, even the best one among them only diffracted to 22k. 
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3.3 Discussion 
The resistance to a variety of structural diverse hydrophobic agents (HAs), including 
antimicrobial agents in Neisseria gonorrhoea isolates is a global problem in the treatment of 
gonococcal infection. It has been reported HAs resistance in Neisseria gonorrhoea is mainly 
due to the overexpression of the Mtr (multiply transferable resistance) system (Delahay ef al., 
1997; Hagman et al., 1995). The nucleotide sequencing analysis of the mtr operon showed 
that it is composed of a regulatory gene, which encodes the transcriptional repressor MtrR, 
and three other genes, which encode the three membrane proteins components of an efflux 
pump, MtrC, MtrD and MtrE (Hagman el al., 1995; Lucas et al., 1995; Pan and Spratt, 1994). 
Homology studies have been done to determine the fimction of each component of the 
MtrCDE system. MtrC is proposed to be a MFP, which ftinctions co-operatively with an RND 
protein to transport large hydrophobic molecules across the two membranes of the 
Gram-negative bacterial cell envelope(Zhang el al., 2007). MtrD is confiimed to be an inner 
membrane protein that belongs to RND family. It shows 43% identity to AcrB of Escherichia 
call and 49% identical to MexB of pseiiclomonas t/£'/wg;/70.«/(Hagman et al., 1997). MtrE was 
determined to a member of the outer membrane protein family that has TolC from E.coli and 
OprM from P.aeriiginosa{Dt\aV[?iy et al., 1997). 
Among the three components, MtrD and MtrE are particularly important in the pump 
function. Until now, the only known stmcture for an RND inner membrane protein is 
AcrB(Murakami et al., 2002), whilst three structures of the outer membrane proteins were 
reported, TolC(Koronakis et al., 2000), OprM (Akama et al., 2004a)and VceC(Federici et al., 
2005). To better understand the characteristics this kind of multidrug transporter, stmctural 
analyses were cauied out in this work to determine the crystal stnicture of the inner 
membrane protein MtrD and outer membrane protein MtrE. 
Due to the distinct biochemical and biophysical properties of membrane proteins, their 
crystallization is particularly complicated, which has led to only a few stnictures having been 
solved. To achieve the crystallization of these proteins, the first requirement is to have a 
sufficient quantity of protein. For membrane protein, it is quite a big problem because of tJie 
toxicity of the overexpressed protein to the host strain. In this study, we employed 
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C43(Miroux and Walker, 1996) as the host strain and pET21a as the e.xpressing vector. The 
C43 strain is derived from the C41 (DE3) strain and can overcome the toxic effects associated 
with overexpression of membrane proteins; pET21a vector from Novagen confers ampicillin 
resistance; choosing the proper restriction sites is also important because the e.xtra amino 
acids tag may cause difficulties in the crystallization. The concentration of the inducer was 
also optimized to achieve the balance between overexpression and survival of the host strain. 
The cells were harvested nonnally after 5 hours, because for this length of growth, the cells 
had overexpressed the maximum amount of protein compared with the amount of cells. After 
purification, both MtrD and MtrE can reach 95% purity and a quantity of 0.3mg/litre culture 
and 0.6mg/litre culture respectively. 
Choosing the detergent is another tricky question in membrane protein crystallization. 
There is a compromise need to be made between the long alkyl chain detergents, which make 
membrane protein more soluble and stable, and the short chain detergents, which compose the 
more hydrophilic residues for ease of crystallization. Dodecyl-P-D-maltoside (DDM) was 
adapted in this study due to its high success in crystallization of related proteins(Federici e! 
<://., 2005; Murakami e /A / . , 2002). Due to the CMC of 0.17mM and MW of 510.6, ] x C M C is 
0.0087% (wA'). 2% (w/v) of D D M was used to solubilize the membrane, while 0.2% of D D M 
was used in purification buffers. At the final step of purification, nonnally the concentrating 
step by ion exchange chromatography, the D D M concentration was changed to 0.1 %. 
Microcrystals were produced for both MtrD and MtrE from the sparse matrix screen; 
optimization screens were then canied out upon the condition that produced miciocrystals. 
MtrE is the one that was investigated most deeply. After one step of optimization screen, 
using an additive screen and a detergent screen, the best condition so far found gave crystal 
that diffracted to 8A. Although it is still too poor to solve the structure, it is a good start for 
this work. Compared with the outer membrane protein MtrE, the inner membrane protein 
MtrD was found more difficult to crystallize, which is probably because of the huge 
hydrophobic suiface(Gotoh et ciL, 1999; Guan et al, 1999; Hagman et al, 1997) and the 
flexibility of the molecule(Murakami el al., 2006; Seeger et al., 2006). Homogeneity of the 
sample may cause problem in crystallization as well. Because of the lacking o f dynamic light 
scattering equipment, Blue-native electrophoresis was employed to check the homogeneity of 
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the MtrD and MtrE samples before applying to crystallization trials. We found that 95% of 
MtrE formed a irimer in the native state, while MtrD was composed of multiple oligomeric 
states, which may have led to the poor diffracting crystals. Another reason for the failure of 
the ciystallization is the unrepeatable of the trials. Although the proteins were purified in 
exactly the same condition every time, there were still a lot of immeasurable differences 
between each batch of protein. The most imponant, alterable factor, is the detergent 
concentration, which would accumulate at the last step of concentrating in the ultrafiltration 
spin column due to the large micelle size (~70KDa) (Strop and Bmnger, 2005; Urbani and 
Wame, 2005; VanAken et al., 1986). Except the concentration, the type of detergent is also 
very important. To get crystallographic quality crystals, detergents other than DDM need to 
be screened. 
Except optimizing the purification methods, a possible means to improve the quality of 
the crystals is to cut o f f the C-terminai 6xHistidine tag from MtrD and MtiE. It was reported 
that the TolC crystals reached diffraction of 2.1 A after being treated with V8 protease which 
removed 43 residues at the C-tennius(Koronakis et ciL, 2000). It was suggested that these 
extra flexible residues can interfere with the packing of the molecules during the 
crystallization. Moreover, optimizing the ciystallization condition again may be necessary. 
The condition we are using now may not be the most suitable one and can only produce 
crystals of poor quality. More conditions need to be tried in order to find the best one. 
Although the structures of MtrD and MtrE haven't been solved in this study, it still gave 
us lots of infonnalion on the crystallization characteristics of these two proteins. Both Mt rD 
and MtrE were oveiexpressed and purified successfully; the initial attempt at crystallization 
gave us the crystals that diffracted to 20A and 7A respectively. These wi l l allow us to perform 
future stmctural and functional analyses. 
Chapter 4 M t r C , MtrD and M t r E form a precise efflux 
pump and the hairpin domain of MtrC plays an important 
role in pump function 
4.1 M I C and growth curve indicate that the M t r C D E work as a tripartite antibiotic 
erflux pump 
4.1.1 The constnict that were used in this study 
In order to study the transport capability of the Mtr system, an expression vector 
pACYCDuet-1, which has two multiple cloning sites, was employed to express all the 
components. Because this vector confers chlorampenicol resistance, it doesn't have the 
problem of testing the transport of the antibiotics that belong to the penicillin family. 





M t r E 
M t i C - D 
M t r C - E 
M t r D - E 
M t r C - D - E 
MtrE-glil MtrC 
hairpin 
M t r D - g l i l MtrC 
hairpin 
p A C Y C - p E T 2 4 a 
K a m 3 ( D E 3 ) [ p A C Y C Duet] 
K a m 3 ( D E 3 ) [ p A C Y C Duet- MlrC( BamHI+Sa l l ) ] 
K a m 3 ( D E 3 ) [ p A C Y C Duet-MtrD(Bam+Sal l ) ] 
K a m 3 ( D E 3 ) [ p A C Y C D u e t - M t r E ( B a m H I + H i n d l l I ) ] 
K a m 3 ( D E 3 ) [ p A C Y C D u e t - M t i C ( B a m H I + S a l I ) - MtrD(NcleH-Xhol)] 
K a m 3 ( D E 3 ) [ p A C Y C Duet -MtrC(BamHl+Sa l I ) -MtrE(NdeI -HKpn l ) ] 
K a m 3 ( D E 3 ) [ p A C Y C D u e t - M t r E ( N d e l + K p n l ) - M t r D ( B a m H i + S a l l ) ] 
K a i n 3 ( D E 3 ) [ p A C Y C D u e t - M t r C - R B S S D l i n k e r - A T G 
M t r E ( B a m H I + H i n d I I I ) - M t r D ( N d e l + K p n l ) ] 
K a m 3 ( D E 3 ) [ p A C Y C D u e t - M t r E ( B a m H I + H i n d I I I ) - g I l I MtrC 
hairpin(Ndel+Xhol)] 
K a m 3 ( D E 3 ) [ p A C Y C Duet -MtrD(BamHI+Sa l l ) -g I l ! MtrC 
hairpin(Ndel+Xhol)] 
K a m 3 ( D E 3 ) [ p A C Y C Duet] [pET24a] 
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!V1trC'DE-pET24a K a m 3 ( D E 3 ) [ p A C Y C Duct -MtrC S D l i n k c r { B i i m H H E c o R l ) - A T G 
M t r E ( E c o R I +Hindi! l ) -MtrD(Ndel i-Kpnl)][ p E r24a J 
M t r C D E - g l l i K a m 3 ( D E 3 ) [ p A C Y C Duet-MtrC S D i i n k c r ( B a m H H E C D R I ) - A T G 
MtrC hairpin M t r E ( E c o R I + H i n d I I I ) - M t r D ( N d e I + K p n l ) ] [ p E T 2 4 a -gill MtrC hairpin 
(Ndc l+Xhol ) ] 
The pACYC Duet- MtrC (BamHl+Sall), pACYC Duet-MtrD (BamHI+Sall) and pACYC 
Duet-MtrE (BamHI+Hindll l) were made by ligating the mtrC.D.E genes into the pACYC 
Duet vector after digestion with the coiresponding restriction endonucleases. 
The construct of pACYCDuet-MtrC (BamHI+Sall)-MtrD (Ndel+Xhol) was made by 
ligating the fraginent of nitrC (BamHI+Sall) into the pACYC duet vector after digesting with 
the same enzymes. Then ivtrD (Ndel+Xhol) was ligaled into the second multiple cloning site 
of pACYC Duet-mtrC (BamHI+Sall), which was digested by Nclel and Xliol. The pACYC 
Duet-MtrC (BamHI+SalD-MtrE (Ndel+Kpnl) and the pACYC Duet-MtrE 
(NdeI+Kpnl)-MtrD (BamMI+Sall) constructs were made in the same manner. 
Figure 4.1 Endonucleases digestion test of two constructs 












Lanel: I K b D N A ladder 
Lane2: Kam3 (DE3) [pACYCDiiel-MtrC (BamHI+SalI)-MtrD 
(Ndel+Xhol)] digested by BamHI and Sail 
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Lane3: Kam3 (DE3) [pACYCDuet-MtrC (BamHKSall)-MtrD 
(Ndel+Xhol)] digested by Ndel and Xhol 
Lane 4: Kam3 (DE3) [pACYCDuet-MtrC (BamHI+Sall)-MtrE 
(Ndel+Kpnl)] digested by BamHIand Sail 
Lane 5: Kam3 (DE3) [pACYCDuet-MtrC (BamHl+Sall), MtrE 
(Ndel+Kpnl)] digested by Ndel and Kpnl 
As to the [pACYCDuet-MtrC SD linker (BamHl+EcoRl)-ATG MtrE 
(EcoRl+HindlII)-MtrD (^Jdel+Kpnl)], the fragment of MtrC-RBS linker (BamHl+EcoRl) 
was made by PGR with the primers "MtrC BamHI F" and "MtrC SD linker EcoRI R" in table 
2.7, in which GAGGAA is the Shine-Dalgamo sequence(Chen et ciL, 1994), which is reported 
to be a Ribosome Binding Site sequence. Then it was ligated with pGEM-T easy vector, 
followed by digestion with BcimHI and EcoRf. After purify the fragment by Gel Extraction, it 
was ligated into the pACYC Duet vector, which had been digested with the same restriction 
endonucleases. The second fragment of mtrE was made by PGR with the primers "ATG 
MtrE EcoRl F" and "MtrE Hindl l l R". One start code ATG was added to the beginning of the 
sequence. After release from the pGEM-T easy vector by digestion, it was connected to the 
pACYC Duet-MtrC-RBS linker, which was digested by EcoR/ and HincUII. Finally, the 
fragment mtrD (Ndel+Kpnl) was ligated into the second multiple cloning site by the same 
procedure. 
The peiplasmic g\\\-nnrC haiipin construct was constructed according to the following 
description. The primers "MtrC hairpin Ncol F" and "MtrC hairpin Xhol R" given in the table 
2.7 were used to amplify the mtrC hairpin. Extra bases were added to put the MtrC hairpin 
sequence in frame. This fragment was ligated into pGEM-T vector and then digested with 
Ncol and Xhol. It was ligated into the pBAD-gl l lc vector that was digested with the 
corresponding enzymes. Another amplification was done using the " g l l l Ndel F" and "MtrC 
hairpin Xhol R" primers and the product was ligated in the same way as above into the 
cloning site of the vector pACYC Duet or pET24a. 
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4.1.2 The minimum inhibitory concentration for different antibiotics for different nUrCDE 
constructs above 
Table 4.2 MIC of some recombinant strains 
Penici l l in 
(|ag/ml) 
G Tetracycline(| ig/rnl) Erythromycin 
(Mg/ml) 
Nafci l l in( |ag/ml) 
p A C Y C 32 4 0.5 8 
mtrC 64 2 8 32 
intrD 32 16 - 64 
mtvE 16 16 - 64 
mtrC-mtrD 32 32 8 128 
mtrC-mU'E 32 2 4 32 
mtiD-mtiE 64 2 64 64 
According to the data above, except for Penicillin G, the strains that express MtrD and 
MtrCD all had significant increase in MIC, especially for Nafcil l in, which means MtrD and 
MtrCD can work as a efflux pump for these antibiotics. 
Both Tetracycline and Nafcillin were used for the following growth curve analysis, but 
Nafcillin produced more pronounced differences in the growth curves. 
4.1.3 Growth curve studies 
4.1.3.1 A Growth curve analysis indicates that MtrCDE work as an antibiotic efflux pump 
The constructs that express MtrD, MtrCD and MtrCDE were used to study the 
cooperation between the proteins in dnig tranport. The strain Kam3 (DE3) [pACYCDuet] was 
used as a negative control in this study. 
The concennation of Nafcillin in the culture was generally 64|j,g/ml, but 128ng/ml was 
also tested, but there was no obvious difference between them. The OD600 was tested for all 
the strains for 4 hours, until the cells grown to stationary phase. Each experimental test was 
made in triplet, by which the error bars were produced. 
Figure 4.2 the gi'owth curve of strains that overexpress various pump components 
Tune (hour) 
K a n i 3 - p A C Y C 
K a r n 3 - p A C Y C - M t r D 
K a n i 3 - p A C Y C - M t r C D 
K a i r G - p A C Y C - M t r C D E 
It is very clear from this graph that the growth of strain that express MtrCDE wasn't 
inhibited by Nafcillin, whilst the strain expressing MtrCD was partly inhibited by the 
antibiotic In comparison. The strain that with empty plasmid and the one expressing MtrD 
barely grew at all. We conclude that MtrC, MtrD and MtrE can form a stable tripartite efflux 
pump, which can extrude antibiotics from the cell. In the absence of the outemiembrane 
protein MtrE, the activity of the pump was reduced, which led to limited growth in the 
presence of the antibiotic. This finding suggests that probably MtrCD could employ TolC to 
conduct defective transport. Besides this, it also showed that the membrane fusion protein 
MtrC plays an important role by assisting the activity of the inner membrane protein MtrD. In 
the absence of MtrC, apparently M t r D couldn't transport antibiotic its own. 
Due to the toxic effect of overproducing membrane proteins in the host cell, which may 
cause different strains to grow at variable speeds even in the absence of the substrate, the 
growth curve data was amended to the following bar chart. OD600 was checked after 4 hours' 
growth. The relative growth rates were generated by dividing the average of the OD600 of 
three testing tubes with added Nafci l l in by the OD600 of same strain without added Nafcillin. 
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Figure 4.3 a bar chart to show comparatively the growth of strains in the presence and 







Control M t r D MtrC'+MtrD M t r C + M t r D + M t r E 
This data was produce by comparing the OD600 of all the recombinant strains with and 
without 64|.ig/ml of Nafcillin. The bars represent the ratio of growth after 4 hours of growth. 
Comparing these 4 sets of data, the strain that express all three components of the 
MtrCDE pump grew best in the presence of Nafcillin. which is a substrate of the Mtr system. 
Presumably that the expression of MtrC. D and E. a whole efflux pump can be assembled to 
transport the antibiotic out of the cell, reducing the accumulation of the antibiotic inside the 
cell, enabling cell survival. Without the assistance of the outer membrane protein MtrE. the 
function of the pump is incomplete, which is why the growth o f the strain that only express 
MtrCD couldn't catch up with the one expressing MtrCDE. The growth of the strain that 
only expresses the inner membrane protein MtrD was highly inhibited by Nafcillin, which 
suggests that the membrane fusion protein plays an important role in drug transport. 
The same conclusion can be drawn from the bar chart comparing growth in the presence 
and absence of Nafcill in. that MtrCDE can form a stable tripartite efflux pump with activity 
of transport, and the membrane fiasion protein might play a a major part in triggering the 
action of the pump. 
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4.1 .3 .2 The periplasmic MtrC hairpin domain didn't activate the transport of MtrD 
To test i f the MtrC hairpin domain could activate the transport function of MtrD, as does 
full length MtrC; a construct, which contains MtrD and the MtrC hairpin with N-terminal g i l l 
signal, was employed to test the growth situation in the presence of Nafcillin. 
Figure 4.4 Growth curve for strains expressing MtrC-D and MtrD-gl l l MtrC hairpin 
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Figure 4.5 the percentage growth of cells grown in the presence and absence of Nafcill in 
Mti-C ' I ' l l l - l i ; i i i p i n ' M t i D 
In comparison with strain overexpressing ful l length MtrC and MtrD, it is obvious that 
the periplasmic MtrC hairpin domain does not activate the transport function of MtrD, which 
leads to inhibitory growth in the presence of Nafcil l in, or because it failed to transfer the drug 
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to MtrD by its own. 
4.1.3.3 The opening mechanism of the outer membrane protein Mtrl-; 
To better understand the opening mechanism of the outer membrane protein MtrE. a 
series of growth curves were measured in the presence of Vancomycin, which is a large 
hydiophilic antibiotic that can't pass through the outemiembrane. It can only enter cells via a 
channel such as that in MtrE when it is open. 
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M t i C + M t i D + M t i K 
V n n c o m y c i n N a l c i l l i n i V a i K o m v c i n 
A2: percentage growth of control in the presence of Nafcillin (64^g/ml), or/and 
Vancomycin( 150|.ig/ml) 
B2: percentage growth of MtrCE in presence of Nafcillin (64|ag/ml), or/and 
Vancomycin( 150^g/ml) 
C2: percentage growth of MtrDE in presence of Nafcillin (64jag/ml), or/and 
Vancomycin( 150^g/ml) 
D2: percentage growth of MtrCDE in presence of Nafcillin (64|iig/ml), or/and 
Vancomycin(150|.ig/ml) 
From the above data series we can see, the strains that doesn't express any component 
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of the Mtr system and those only expressing the MtrC and MtrE couldn't expoft the substrate 
Nafcill in, leading to inhibitory growth. In addition, the growth of these two strains wasn't 
inhibited by Vancomycin. In contrast, the strains that express MtrD and MtrE and the one 
expressing all the three components, grew in the presence of Nafcil l in or Vancomycin. 
However, in the presence of both of antibiotics, the growth was obviously inhibited. 
4.1.3.4 Periplasmic MtrC haiipin domain can enhance the transport action of the MtrCDE 
system 
In order to analyse the effects of the periplasmic MtrC hairpin on the MtrCDE system 
activity, a recombinant strain with two vectors, pET24a that express the g l l l -MtrC hairpin and 
pACYC Duet that express MtrCDE, was used to test the difference in growth with the strain 
that only expresses MtrCDE. 
Figure 4.7 growth curve showing the effect of the periplasmic MtrC hairpin domain on pump 
activity 
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M l r C D E MtrC D K - g l l l Haiipin 
The strain Kam3(DE3) was adopted as a negative control of this analysis, hi the 
presence of the substrate Nafcillin, the recombinant strain that overexpressed MtrCDE grew 
slightly slower than the one that overe.xpressed MtrCDE and periplasmic MtrC hairpin 
domain. The growth percentages also reflected the same result, which were calculated after 24 
hours" of growth, comparing with the coiresponding strains without Nafcillin. 
4.2 Pull-Down assay indicate that the M t r C D E form a stable complex 
To study the interaction of all the components of the Mtr system vino, pull down 
assays were carried out as described before. Two different fusion tags were adopted for the 
final analysis, using monoclonal antibodies to the 6xHistidine tag and S-tag. These two tags 
were constructed at the C-terminal of these proteins as required. 
pACYC Duet - 1 \ector was employed again for the reason that it provides an in frame 
S-tag sequence. 
Table 4.3 the recombinant strains that were used in Pull-Down assay 
Name Description 
pACYC BL21{DE3)[pACYCDuet] 
MtrD-His C43 [pET21a-MtrD(NdeI+XhoI)] 
MtrE-His C43 [pET21a-MtrE(NdeI+HindIII)] 
MtrC-S BL2 l(DE3)[pACYC-MtrC(Nde]+Xho])] 
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MtrE-S BL2l{DE3)[pACYC-MtrC(Ndel+KpnI)] 
The pull down assays was perfonned according to the principle of using a larger 
molecule to capture smaller ones, which can reduce the interference of the false negative that 
is produced by gravity and flow. 
As described before, the bait protein was purified by IMAC, followed by desalted to the 
buffer without hiiidazole. The crude membrane extract o f prey protein with fusion S tag was 
used without purification. After solubilised this with D D M , the two proteins were mixed 
together and co-purified. One negative control was set by mixing His-tag bait protein with the 
membrane of BL21 (DE3) [pACYCDuet], which only express dissociative S tag; another 
negative control was set by mixing Ni-NTA agarose only with cell membrane containing 
prey protein and then washed and eluted. Finally, the western blot was used to detect the 
presence of both bait and prey protein. 
Figure 4.8 the results of Pull Down a.ssay 
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131 
Mti-E (OIVIP) interact with M t r C ( M F P 
+ - . + + MtrE-His-tag 
+ + + + MtrC-S-tag 
Anti-polyHist idine monoclonal 
antibody 
40 K Da-
Anti-Stag monoclonal antibody 





l U K D a - Anti-polyHis t id ine monoclonal 
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5 1 K D a Anti-Stag monoclonal 
antibody 
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From the above blots we can see, that the MtrC^ M t r D and M t r E can interact 
wi th each other in vitro. The interaction between Mt rC wi th M t r D and M t r E appear 
stronger than M t r E and M t r D . It may because the interaction between the inner 
membrane protein and the outer membrane protein is not persistent, so they can only 
f o m i a strong interaction wi th the assistance o f the membrane fusion protein or when 
the transpoiler is somehow activated. 
4.3 study of the interaction between the M t r C D E proteins by Isothermal Titration 
Calorimetry 
4.3.1 Sample preparation for ITC 
Before starting this study, some additional constructs for the membrane fusion protein 
MtrC were made and the variable domains of MtrC were overexpressed and purified for the 
purpose of analysing their interaction with the Inner membrane protein MtrD and the outer 
membrane protein MtrE. 
4.3.1.1 N-lemiinal truncated MtrC (MtrC"'""""-) 
After aligned MtrC with its homologue MexA, the G34 of MtrC conesponds to G25 of 
MexA, while M e x A A l - 2 5 was reported soluble(Higgins et cil., 2004). To obtain a high 
concentration of MtrC, but at the same time maintain the concentration of detergent with the 
membrane, an N-terminal transmembrane domain truncated MtrC was made by deleting 34 
amino acids from N-terminus of MtrC (using primers "MtrC truncate Ndel F" and "MtrC 
Xhol R" in table 2.7). Therefore, the MtrC was turned into a soluble protein with three main 
domains, the lipoyl domain, the p-barrel domain and the a-helical hairpin. 
Figure 4.9 the predicted secondary structure of MtrC (generated by on-line Secondary 
Structure Prediction Server: Jpred 3, which based at university of Dundee) 
M t r C 1 M A F A S K A M R A A A L A A A V A L A L S S C G K G G D A A Q G G Q P A G R 
l l l I I i H l l l l l i l l l i l l l l H U H M M U l I 
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M t r C 41 E A P A P V V G V V T V H P Q T V A L T V E L P G R L E S L R T A D V R A Q V G 
M t r C 81 G l I Q K R L F Q E G S Y V R A G Q P L Y Q I D S S T Y E A G L E S A R A Q L A 
— — H I l H I - m i l H H l l l l i l H H M l l 
M t r C 121 T A Q A T L A K A D A D L A R Y K P L V S A D A I S K Q E Y D A A V T A K R S A 
l I H l l l l H I l I l i l l l l l H M I I l l I i m i l l H U I I r r H U H I - l H I l l l l l l l l l l l l i H 
M t r C 161 E A G V K A A Q A A I K S A G I N L N R S R I T A P I S G F I G Q S K V S E G T 
i l l l M l l H H H H H H l l l l H M I I H l l 
M t r C 201 L L N A G D T T V L A T T R Q T N P M Y V N V T Q S A S E V M K L R R Q I A E G 
. . . . . . H H I - I H H H H 
M t r C 24! K L L L A A D G A l A V G I K f D D G T V Y P E K G R L L F A D P T V E E S T G Q 
M t r C 281 I T L R A A V S N D Q N I L M P G L Y V R V L M D Q V A A D N A F I V P Q Q A V 
M t r C 321 T R G A K D T V M I V N A Q G G M E P R E V T V A Q Q Q G T N W I V T S G L K D 
M t r C 361 G D K V V V E G I S I A G M T G A K K V T P K E W A P S E N Q A A A P Q A G V Q 
M t r C 401 T A S E A K P A S E A K 
The strain and construct used to overexpress MtrC""""" was B L 2 i (DE3) [pET21a-
MtrC A ( l -34) (Ndel+Xhol)]. To overexpress the protein, one colony was used to inoculate 
30ml of LB broth with IOO|ig/mi Carbenicillin (final concentration). 3ml of overnight culture 
was used to inoculate 1 litre of YT-broth with Carbenicillin. I m M of IPTG (final 
concentration) was added to induce the expression of the protein when the OD600 reached 
0.5-0.6. The ceils were harvested 3 hour after being induced. 
The cells were resuspended in lysis buffer, which was Tris 20mM NaCl 300mM 
Glycerol 10% DTT ImM pH 7.5. The resuspended cells were passed through French Press 2 
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times at a pressure of 2()KPSI. The hoinogeiiatc w as loaded onto a Ni-NT.'\ chchiting column 
aftei- the Imidazole concentratii>n had been adjusted to l5mM. The column was connected 
onto an AK l . \ piu ifier and washed w ith the same buffer abo\e but with 5()mM of Imidazole. 
Finally, the protein was eluled with above buffer containing .lOOmM of Imidazole. 
Figure 4.10 MtrC'"'""""' after purified by Nickel chelating chromatography 
2 3 4 5 6 7 8 9 10 11 
N-tcrminal 
truncated 
M t r C 
- I S S k D a 
- 4 S K D a 
-52ICDa 
-2 1 K D a 
- I ' J K D a 
f.ane 1-10: the fraction elutecl from the Nickel chelating columns 
Lane 11: See-Hlue marker (Invitrogen) 
Because the purity of the MtrC'"'""'" was poor, a further gel filtration purification step 
was performed as following. A IliLoad 16 60 Superdex 200 gel filtration column from 
Amersham was equilibrated with Tris 20mM NaCI 300mM Glycerol 10".. DTT I m M p l l 7.5; 
then 4ml of MtrC""""'"'' from abo\e was loaded onto the column using a superloop. The 
column was washed with the same butTer abo\e at a the fiow rate of 1ml;minute, ant! 
fractions were collected and analysized by SDS-PAGE. 
Figure 4.11 Purify the MtrC"'"""'' by gel filtration chromatogi-aphy 
I I 
i \ I \ 
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Figure 4.12 MtrC'™"'^'^ after being purified by GF and concentrated 












Lane 1, 10: See-Blue Marker (Invitrogen) 
Lane 2-9: M t r C * ^ " " after being purified by gel filtration (20fil/lane) 
Lane 11: purified MtrC'™"'^ '^^  after being concentrated (5fil/lane) 
A n analysis by SDS-PAGE revealed that the big peak in the graph is pure MtrC'™""'^ 
The fractions were collected and concentrated using a 30kDa ultrafiltration spin column. In 
order to keep the same detergent concentration as for the membrane protein in ITCexperiment, 
D D M was added to a concentration of 0.1%, the same as for the membrane protein samples. 
4.3.1.2 The construction and purification of the MtrC*^"^'" a-helical hairpin of MtrC 
( M t r C " ^ " ) 
Figure 4.13 Sequence alignment of the a-helical hairpin of AcrA, MexA and MtrC 
a-helix 1 a-helix 2 
AcrA 95 I P A H T Y O | < G | | A 1 A A A N I A Q L T V N B < L | G T Q Y I | E Y D Q A L A O A Q ( | N 
MexA 93 | p A | j o Y Q | Q A N | S | E Q A - Q B < L | / A D Q A V H - Q Y A D | N 
MtrC 1 0 2 | S S | E | G [ j ^ f m B T A | A T L A K A D A D L A B < P | V S A D A I H E Y D A A V T A K R S | E 
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a-helix 2 
AcrA 155 ]f< V T A A K | V E T H | A Y T K V 
MexA 140 | A Y L Q S K | V E C | R | I R Y T K V 
MtrC 162 | G V K A A C J 1 K S | G | | N R S R I 
The above figure is the alignment of the a-helical hairpin o f MtrC with MexA 
{Pseudomonas aeruginosa) and AcrA {Escherichia.coli){Y{\ggms et al., 2004; Mikolosko et 
al, 2006), for which the structures are known. The corresponding heptad position is shown 
above and the residues which are conserved are highlighted in grey and mauve. 
A construct for the expressing of the MtrC*"""^"" was made using the primers "MtrC 
hairpin Ndel F" and "MtrC hairpin Xhol R" from table 2.7. They were designed according to 
the alignment above f rom Isoleucine (103) to Isoleucine (183). The amplified gene firagment 
was ligated into pET2 la expression vector and was transferred to BL21 (DE3). 
The recombinant strain was used to inoculate an overnight culture, and 3ml of overnight 
culture was used to inoculate 1 litre of YT-broth with 100|ag/ml of Carbenicillin (final 
concentration). I m M of IPTG was added to induce the overexpression when the OD600 
reached 0.6-0.7. The cells were harvested 3 hours after being induced. 
As described in Chapter 4.3.1.1, the cells were resuspended in the same buffer as 
MtrC"™"'^ and then passed through a French Press twice. After ultracentrifugation, the 
supernatant was collected and loaded on a to Nickel-NTA chelating column after the 
Imidazole concentration had been adjusted to lOmM. 
The column was connected to an A K T A purifier and washed and eluted like MtrC°™"". 
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Figure 4.14 MtrC after purified by Nickel chelating column 
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Lane 1-5: Fractions of MtrC''''""''"' purified from a Nickel chelating column 
Lane 6: SeeBlue marker (Invitrogen) 
The MtrC'"'"'''"' wa.s also purified by gel filtration chromatography. An HiLoad 16/60 
Superdex 75 gel filtration column from Amersham was employed in this .study. The ecilumn 
was pre-equilibrated with Tris 20mM NaCl 3()()mM Glycerol 10% pH7.5, then the protein 
was loaded onto the column using a superloop. The same buffer was u.sed to elute the protein 
Figure 4.1 5 the (iel Filtration Chromatography of MtiC"'""''"' 
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The abo\e graph shows the elution peak lor MtrC'""'"" purified bv gel fillraiion 
chromatography. Fractions were collected and analysized by 18% SDS-PACil- electrophoresis, 
establishing that the peak is pure hairpin 
Figure 4.16 SDS-PAGE (18%) analysis of MtrC after being purified and concentrated 
1 2 3 4 5 6 7 8 9 
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Lane 1-7: MtrC''''"'"" fractions from gel filtration chromatography 
Lane 8: SeeBlue marker (Invitrogen) 
Lane 9: MtrC'""'"" after being concentrated using a lOkDa ultrafiltration spin column 
The pure MtrC'""'"" fraction was collected and concentrated using a lOkDa ultrallllration to a concentration of spin column. Like MtrC""""'", D D M was added to concentrate MtrC'""'"' 
0.1%. 
4.3.2 ITC analysis of the interaction of the MtrCDE proteins 
ITC measurements were candied out at 25°C using a VP-ITC MicroCalorimeter 
(MicroCal). MtrD and MtrH were in buffer Tris 20mM NaCI 300mM Glycerol 10% D D M 
0.1"/., pH 7.5. After adding D D M to MtrC"""""'' and MtrC""""'"" to 0.1%, they were dialysis in 
different dialysis cassettes at the same time with MtrD or MtrE respectively again.st the .same 
buffer as above. After dialysis, the concentration of each protein was determined using a 
Bradford Protein assay kit. 
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Fitiure 4.17 ITC between MtrC DH 
Time imin) 
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A: MtrC"""'"' titrated into MtrE 
B: MtrC'"'"""' titrated into MtrD 
C: MtrL titrated into MtrD 
ITC experiment were performed by stepwise titration of MtrC' (2()()|.iM) in to the 
MtrE (15pM). and the heat energy change accompanying the reaction was detected upon each 
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injection by comparison wi th a reference cell. The heat changes were integrated after 
subtracting values obtained when MtrC was titrated into buffer (top left) . The top right graph 
was for the titration o f M t r E (IS^iM) into M t r D (12 | iM). 
Figure 4.18 ITC between MtrC'''"P'" wi th M t r D and M t r E 
Time (min) 
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A : MtrC""'"^'" titrated into M t r E 
B : MtrC"^"'^'" titrated into M t r D 
Similar ITC assays were carried out to study interaction o f the MtrC**""'"" w i th the M t r E 
(top left) and M t r D proteins (top right).The concentration of MtrC*"**^'" was 500 pM and the 
M t r E and M t r D were 15 |u,M and 12 | j ,M, respectively. 
Table 4.4 Thermodynamic parameters o f interactions. 
Protein Phases N K ( M " ' ) AH(KCal- M ') AS(Cal 'M 'K" ' ) 
MtrC'"^""=/MtrE 1 0.258 1.0 (+ 0.50) X 10^ -6.836 -0.01 
MtrC^^'^'/MtrD 1 0.238 1.2 (+ 1.2) X 10' 1.4 32.5 
MtrC'^'^^/MtrE 2 0.0915 4.6 (+ 0.61) X 10^ -11.19 -11.4 
0.196 3.2 (+ 0.96) X 10' -61.49 -190 
MtrC'"^'7MtrD 2 0.0332 2.1 ( + 0 . 0 1 ) x l 0 ^ -152.4 -487 
0.663 3.1 (+ 1.22) X 10' 266.8 906 
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The titration o f M t r C " " " ' " ' into M t r E is signified as MtrC""" ' ' ' ' ' / Mt rE . The 
number of phases indicates how many different sequential binding reactions were obtained for 
each titration. 
When MtrC'™"''""'' was titrated into MtrE a weak exothemiic interaction, with a Kd of 
9.8M, was detected, which was characterized by a change in enthalpy (AH) of -6.836 
kcal.mol"' and entropy (AS) of-O.Olcal.mof' .K"' . In contrast, when MtrC'™"''""'' was titrated 
into MtrD, a strong endothermic reaction, with a of 0.84M, was detected, which was 
characterized by a AH of 1.4 kcaLmol ' and AS of 32.5 cal.mof'.K"'. We also attempted to f i t 
the data in each case to a two-site model: in the case of MtrE this simply indicated two sites 
that only had a 2-fold difference in their affinities; whilst in the case of MtrD this indicated 
sites with a 10-fold difference in affinity, the sum of squares of the variance of the data was 
greater than for a monophasic fit. In accord with our pull-down experiments that suggested 
that MtrD interacts weakly with MtrE, no appreciable interaction was detected by ITC. It is 
notable that MtrD binds MtrC an order of magnitude more strongly than MtrE binds MtrC 
and that this interaction is entropically driven. 
ITC was used to confimi that the hairpin domain of MtrC binds to MtrE; but, 
interestingly, we also found that it binds to MtrD. In contrast to the binding of MtrC''^ ^"'^ '^® to 
MtrD, which is an endothermic process, the binding of its MtrC^^''^'" (residues 103-183) to 
MtrD is an exothermic process. It is conceivable that the binding of MtrC''^""'^^'^ to MtrD is 
similar but only the latter endothermic process at higher molar ratios was detected; consistent 
with such a proposal, the baseline heat exchange for MtrD, titrated with buffer, was lower 
than the heat exchange at the start of the titration cune with MtrC''^^"'^^'^ (data not shown). 
Neither the curve for the binding of the hairpin to MtrE or to MtrD could be adequately fitted 
to a monophasic function but both data sets could be fitted to a biphasic function, suggesting 
that these proteins might have both high- and low-affinity sites for the hairpin. Such finding is 
not fu l ly unexpected considering the fact that both MtrE and Mt rD protomers have arisen 
from an internal gene duplication event, and hence their trimers present a pseudo six-fold 
symmetry. However, whilst binding of the hairpin to both sites on MtrE were exothermic 
processes, with respective values for K j , A H and AS o f 2.2M, -11.2 kcaLmol'' and -11.6 
cal.mol '.K"' for the high-affinity site, and 0.3 mM, -61.5 kcal.mof' and -190 cal.mol ' .K ' ' , 
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respectively, for the low-affinity site; binding to the high-affinity site of MtrD was an 
exothermic process but to the low-affinity site an endothermic process, with values of 4.9 M , 
-152 kcal.mol"' and -487 cal.mol '.K"' and 3.3 mM, 266.8 kcal.mol"' and 906 cal.mol '.K: ', for 
the respective sites. It is noteable that the MtrC''^"''"" is bound more fightly than MtrC''"' '""'^ 
by MtrE, whilst the MtrC"^''"'" is bound less tightly than MtrC"'""''^'^ by MtrD. This is 
consistent with the a-helical coiled-coil domain of MtrC predominantly interacting with MtrE, 
whilst the P-domain of MtrC predominantly, but not exclusively, interacts with MtrD . 
4.4 Circular Dichroism spectrum analysis of MtrC'""""" and MtrC''"'''''" 
CD spectrum analysis was perfomed to see i f the purified MtrC'™""" and MtrC'"''^'" 
were folded properly. 
The analysis was carried out after dialysing the MtrC""""'" and MtrC'"''^'" against the 
buffer Tris-H2S04 20mM NaF 300inM pH7.5, oveiTiight. The concentrations were caculated 
using a Bradford Protein Assay kit. 
Figure 4.19 The CD spectaim of MtrCtruncate and MtrChairpin 
l ia irpin M t r C 
imncalc 
190 200 220 240 
Wavelength [nm 
260 
Table 4.5 Analysis of the CD spectrum data 
result Helix 1 Helix2 Strand I Strand2 Turns Unordered Total 
MtrC""""'" 0.707 0.284 0.000 0.009 0.000 0.000 1 
0.144 0.155 0.111 0.058 0.181 0.351 1 
The secondary structure of MtrC^^"'"" was shown all a-helical stmcture, which 
resembles the secondary stmcture prediction and the alignment. A mixture of helix and 
strand was found in MtrC'™"*^ '^^ ; from the reported homologous stn.ictures(Higgins et ai, 
2004; Mikolosko et al., 2006), it was not out of our surprise that membrane fusion proteins 
are composed by both a-helices and |3-strands. 
The data above were produced by the On Line Circular Dichroism Analysis software 
"DICHROWEB", which is hosted by the School of Crystallography, Birkbeck college. 
University of London. 
4.5 Chemical cross-linking and Atomic-force-microscope ( A F M ) analyses of M t r C D E 
The cross-linkers, EOS (spacer ami 16.1 A) , DMA (spacer ann 8.6 A) Glutaraldehyde, 
were used to analyses the interaction between the MtrCDE proteins. D M A is a water soluble, 
membrane penneable, homobifunctional imidoester cross-linker. EOS is a water insoluble, 
homobifunctional N-hydroxysuccinimide ester (NHS ester). Among them, EGS was the one 
that could cross-link the MtrCDE; D M A , on the contrary, didn't work in this study, which 
probably due to the shorter spacer arm it has. 
Because fonnation of the ester between cross-linker and the amino group of the proteins 
renders proteins cross-linked, the free amino groups in reactions need to be eliminated. 
The buffer for the membrane proteins were changed to phosphate buffer by Ion Exchange 
chromatography, whilst the soluble N-terminal truncated MtrC and MtrC hairpin were 
changed into phosphate buffer at the step of gel filtration. 
The stocks of DMA and EGS solution were freshly prepared in DMSO and water, to 
concentrations of 50mM and lOOmM. The final concentrations used in this study were 20mM 
and 33mM. The protein samples and the cross-linker were mixed and left at room temperature 
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for 1 hour. The reactions were terminated by adding lOOmM Tris buffer (final concentration) 
and mixing with loading buffer. The reactions were then heated to 1()()°C ibr 5 minutes before 
performing 4%-12% SDS-PAGE. 
Figure 4.20 the cross-lini< of MtrDE with MtrC'""''''" by EGS 
1 2 3 4 5 6 7 „ • , ^, n 
y Potential MtrE and 
' ' r ^ J r " ^ MtrC hairpin complex 
Potential MtrD and 




MtrC hairpin hexamcr 
MtrC hairpin pcntanier 
MtrC hairpin tetraincr 
MtrC hairpin trimer 
MtrC hairpin dimer 
MtrC hairpin monomer 
Lane I : MtrE +EGS 
Lane 2: marker 
Lane 3: MtrD + EGS 
Lane 4: MtrC hairpin + EGS 
Lane 5: MtrC hairpin +MtrE+EGS 
Lane 6: MtrC hairpin +MtrD +EGS 
Lane 7; MtrD +MtrE + EGS 
From the photo above, the Mt rD and MtrE formed oligomers after being cross-linked by 
EGS. The MtrC a-helical hairpin forms up to 6 obvious bands, which represent the monomer, 
dimer, trimer, tetramer, pentamer and hexamer. After cross-linking the MtrC hairpin and the 
inner membrane protein MtrD, an extra band was shown, which may be a band for the 
MtrD-MtrC hairpin complex. However, the complex band of MtrE and MtrC hairpin is not 
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V C 1 7 clear. MtrD and MtrE didn't fonn a complex from the gel. which is reasonable because 
the inner membrane protein and outer membrane protein are not considered to torm a stable 
structure. 











Lane I : MtrC'™"""' 
Lane 2: MtrC"""""'+EGS 
Lane 3: MtrC"""""' +Gluteralderhyde 
Lane 4: MtrE+ MtrC"""""' +EGS 
Lane 5: MtrE+ MtrC"""""' +Gluteraldehyde 
Lane 6: MtrD+ MtrC'""^"'"' +EGS 
Lane 7; MtrD+ MtrC'™"""' +G]uteralderhyde 
Lane 8: Marker 
After cross-linking with EGS, the MtrC'"'"""'" can obviously forni oligomers like its 
a-helical hairpin domain. It could form at least 6 clear bands, which is also the same as its 
a-helical hairpin domain. When MtrC"^"""'"" was cross-linked with MtrD and MtrE, although 
no extra bands were found to be the potential complexes, it doesn't mean that MtrC"^""""" can 
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not iiitci acl \\ \lh Mt r l ) and MtrE. 
(iluiaialdchycic (.Hdii'l w oik w ell in this sludy as a cross linker, l l i c protcm pi'ccipilalcd 
seriously during the cross-lniking, which made the bands in die gel not clear at all. Another 
try with lower concentrations of ghitai-a!dehyde needs to be performed in the future. 
Figure 4.22 Cross-linking of MtrC '"''"" with M l r l ) and Mtrf. by DMA 







Lane I : Marker 
Lane 2: MtrE+DMA 
Lane 3: M t r D + D M A 
Lane 4; MtrC hairpin + D M A 
Lane 5: MtrL+ NhrC hairpin + DIVIA 
Lane 6: MtrD+ MtrC'"'""" + D M A 
Lane 7: MtrD+MtrE+DMA 
Using the D M A as a cross-linker, the MtrE and MtrC''''"''"" domain weren't clearly 
cross-linked. Moreover, there were no obvious e.\tra bands after mi.xing them, wliieli may 
represent the comple.x. Due to the shoil spacer arm of 8.6 A compared with 16.1 A for EGS, it 
might have attributed to the failure of D M A to cross-hnk MtrC hairpin. 
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Figure 4.23 Three dimensional imagines of MtrC hairpin domain by Atomic Force 
Electromicroscope (AFM) -was performed by Dr Nelson Barrera, department o f Chemistry, 
University of Cambridge 
Hairpins histogram 
approx 6 fold 41 +/-1 nm" 
244 +/- 4 nm-^  
100 150 200 250 300 
Molecular Volume (nm"^) 
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To fuilher investigate the oligomeric state of the MtrC a-helical domain, which formed 
hexamers, A F M was employed to have a "deeper look" at it. The MtrC haiipin was diluted to 
a final concentration of lj.ig/ml, and 4 5 |ul of the sample was allowed to adsorb to freshly 
cleaved mica. Imaging in air was performed with a Multimode atomic force microscope 
(Digital Instruments, Santa Barbara, CA) in tapping mode. The silicon cantilevers containing 
a diamond-like extratip had a drive frequency o f p^SOO kHz, a specified spring constant of 4 0 
N/m (MikroMasch, Portland, OR) and the applied imaging force was kept as low as possible 
(target amplitude r : : I . 6 - I . 8 V and amplitude set-point wl.S-l .S V ) . The molecular volumes 
of the protein particles were detemiined from particle dimensions based on A F M images 
using the SPIP software (Image Metrology). 
It was clear to see individual hairpins and cylindrical stRicti.ire oligomers in 
solution by atomic-force microscopy. Frequency distribution o f molecular volumes o f 
M t r C hairpin monomers (top left) and hexamers (top right). In each case the curve 
indicates a f i t ted Gaussian function.These particles had average molecular volumes o f 
41 ± 1 and 243 ± 5 nm3, which is also compatible w i t h the hexamer o f M t r C hairpins. 
4.6 Discussion 
In gram negative bacteria, some transporters utilize a tripartite protein complex rather 
than a single transporter protein. These transporter systems consist of an inner membrane 
protein (IMP), an outer membrane protein (OMP) and a membrane fusion protein (MFP). The 
importance of the MFP in assembling the tripartite transporter has been reported by many 
research works (Mokhonov et al., 2 0 0 4 ; Tikhonova and Zgurskaya, 2 0 0 4 ) . In order to 
investigate this phenomenon, we sought to detennine the role of MtrC, the MFP that couples 
the IMP MtrD, an RND transporter, with the OMP MtrE. Three different approaches, 
including pull-down assays, growth curve analyses and ITC measurement were used, 
resemble for the existence of the stable MtrCDE complex. In pull-down assays (f ig 4 . 8 ) and 
ITC ( f ig 4 . 1 7 ) experiments, because the previous reports of the stable interaction between 
MFP and lMP(Husain et al., 2 0 0 4 ; Zgurskaya and Nikaido, 2 0 0 0 ) or OMP(Gerken and Misra, 
2 0 0 4 ; Lobedanz et al., 2 0 0 7 ) , it is not siuprising that the MtrC could be co-purified with 
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MlrD and MtrE. However, the MtrE could be co-purified with MtrD without cross-linking 
was out of our expectation. This comple.x formed without the presence of substrate or energy 
supply, which indicates that the MtrD and MtrE can interact directly. This finding is in 
agieement with the hypothesis that the IMP directly interacts with the OMP first, then the 
complex is stabilized by the MFP(Tamura et al., 2005). This interacton wasn't determined by 
ITC, probably due to the difference in the sensitivity of two experimemtal methods. The 
growth curve results (f ig 4.2, fig 4.3) are consistent with the conclusion that MtrCDE form a 
functional effiux puinp. We also found that MtrC enhanced the resistance to Nafcill in 
conferred by MtrD alone suggesting that it modulated the activity of the MtrD transporter. 
By analysing the growth cun,'es for recombinant strains which overexpressed different 
components of the MtrCDE system, we raised a possible mechanism of the opening of the 
MtrE periplasmic tunnel entrance, which is considered to be a critical event in multidrug 
effiux. Augustus el al has reported that the TolC derivative R367H, in which the intennonoer 
hydrogen bond between H4 and adjacent H8 from another monomer was distruped, caused 
the TolC to open, leading to an increased sensitivity of TolC to the large hydrophilic 
antibiotic, Vancomycin(Andersen e! ciL, 2002; Augustus et al., 2004). Based on this principle, 
a series of growth curve were done to detemiine the opening mechanism of the MtrE. It is 
quite clear that due to the size of the vancomycin, it can't pass the closed periplasmic entrance 
of MtrE into the periplasm, which allowed the non-inhibitory growth of all the recombinant 
strains with the presence of vancomycin alone (f ig 4.6). The presence of MtrC and MtrD, 
even both MtrC and MtrD, were not sufficient to trigger the opening of MtrE. In order to find 
the essential factor in this mechanism, the substrate Nafcillin was added to the culture along 
with the vancomycin. Surprisingly, the growth of the strains that overexpress MtrD and MtrE 
and one that expressed MtrCDE were partially inhibited, when compared with the presence of 
Nafcillin alone and vancomycin alone (f ig 4.6). The growth inhibitory was due to the 
vancomycin passing through of the opened MtrE, which indicated the opening o f the MtrE 
needed the assistance of both MtrD and substrate. However, from this result, two questions 
arise, firstly, is MtrC necessary for opening of MtrE? As we described above, the mutants that 
increase the sensitivity of TolC to vancomycin, was recently proved by crystallography can 
lead to a partially opened TolC (Bavro et al., 2008). We propose that the interaction between 
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MtrD and MtrE in the presence of Nafcil l in could only open the MtrE imcompletely, but it 
was already big enough for vancomycin to pass through, while the additional assistance of 
MtrC could open the MtrE completely. This proposed mechanism is highly consistant with 
the conclusion we got before: that the IMP interacts first with the OMP directly, and then the 
complex is stabilized by the MFP(Tamura et ciL, 2005). The second question is, can MtrC 
alone open MtrE? Because the strain that overexpresses MtrC and MtrE didn't grow in both 
Nafcill in and Nafcill in with vancomycin, it is hard to decide i f the growth was inhibited by 
the Nafcil l in or Vancomycin, accordingly to make sure whether MtrE can be opened by MtrC 
with substrate or not. It may need to be proved by other experimental methods. 
The importance of the hairpin domain of the MFP has been shown previously 
(Stegmeier et ciL, 2006); apparently the function of MFP hairpin domain is to interact with the 
coiled-coil of the OMP and may be involve in opening the OMP channel (K-nshnamoorthy et 
ai. 2008; Lobedanz et a!., 2007); while the C-tenninal of the MFP is involved in the 
interaction with the lMP(Nehme et a!., 2004; Tilchonova et a/., 2002; Touze et ciL, 2004). 
However, in this study, the ITC experiments showed that the a-helical hairpin domain of 
MtrC could interact with both IMP MtrD and the OMP MtrE ( f ig 4.18). To further analyses 
the function of the hairpin domain of MtrC, the hairpin domain was constructed with an 
N-terminal g i l l signal sequence, to target it to the periplasm. This glll-MtrC''""'"" fusion 
protein was co-overexpressed with MtrD and the growth situation in presence of Nafcillin 
was compared with the strain which can overexpress MtrD and full-length MlrC. It turned out 
that the growth of the strain expressing M t r D / g l l l - MtrC'""'"" was inhibited by nafcillin, 
which means that the periplasmic MtrC hairpin domain can't execute the fu l l flmction like 
full-length MtrC does. It might be that although the haii-pin domain of the MFP can interact 
with the IMP, stablizing the IMP-OMP complex and even opening the channel of OMP, it is 
still not capable of performing the fu l l function of passing the substrate to IMP without the 
assistance of the (3-barrel domain, which has been reported to interact with the IMP (Gerken 
and Misra, 2004) and may take part in binding of sustrates (Borges-Walmsley et ai, 2003; 
Higgins et ai, 2004). After knowing the hairpin domain of MtrC can not fu l ly assist the MtrD 
in substrate transport, another question arise, wi l l the presence of the extra hairpin domain 
interfere in the transport function of the MtrCDE system? The periplasmic g l l l - MtrC''""^'" 
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was co-overexpressed with MtrCDE to find out the answer. Interestingly, with the extra MtrC 
hairpin domain, the growth of the strain that overexpresses MtrCDE seemed less inhibited 
than the one without it (f ig 4.7). This data clearly indicates that oveiproduction of the hairpin 
in the periplasm can elevated the pump function.The explanation could be, due to the finding 
that MFP has a flexible confoimation (Mikolosko et a/., 2006; Vaccaro et ai, 2006), The 
MFP may emply a hing-bend motion to accomplish the function. In details, with the presence 
of substrate, the MFP can bind the substrate and then interact with the both IMP and OMP 
through the conformational change; after passing the substrate to IMP, the interaction 
between them is released or partially released, which leads to the weakness the the transport. 
Because the MtrC hairpin could interact with both MtrE and MtrD, probably hold MtrE in the 
open state, with the presence of extra periplasmic MtrC hairpin domain, it may confer the 
ability to stabilize the tripartite complex and open MtrE while the full-length MtrC works on 
transfen-ing the substrates, at the same time, stabilizing the complex. The effect of the MtrC 
hairpin domain could be persistent because it lacks the hinge structure and can't achieve the 
conformational change, which makes the assembling of the pump stable and leads to the more 
efficient transport. 
Our understanding of the oligomeric state of the MFP is still ambiguous, although 
forming an oligomer has been shown as a precondition of transport activity(Zgurskaya and 
Nikaido, 2000). The compositional stoichiometry is still uncertain, with a trimeric form found 
in vivo but a monomer fonn in vitro (Akama et a/., 2004b; Higgins el ciL, 2004; Zgurskaya 
and Nikaido, 1999a,, 2000). In this study, in vitro cross-linking of MtrC was peiformed along 
with the Atomic Force Microscope (AFM) to find out the oliogmeric state of the MFP. Both 
MtrC'™'"''"" and MtrC showed six clear bands after being cross-linked, which indicate the 
presence of at least a hexamer. This result was observed better in AFM studies, showed a ring 
of MtrC''""'"" domains that composed of six monomers. These results suggest that the 
oligomeric state of MtrC is a hexamer, which may lead to a stoichiometry of 1:2:1 
(IMP:MFP:OMP) model that resembles the one proposed by Akama et al in 2004(Akama et 
«/., 2004b). 
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Chapter 5 The oligomeric state of the repressor MtrR and 
Characterization of MtrR when it interacts with Penicillin G 
and antimicrobial polypeptide L L - 3 7 
5.1 Construction and puriilcation of MtrR 
The MtrR constinction described in chapter 2, for which the pET2la expression vector, 
was adopted again for MtrR. The gene expressing mtrR was amplified by primers "MtrR Ndel 
F" and "MtrR Xhol R" from table 2.7 with Genomic DNA of Neisseria gonorrhoea FA 19 as 
template. The E.co/i strain B L 2 I - A I was used as the expression host this time because of its 
tighter regulation of expression for production of proteins using the T7 promoter. 
To overexpress MtrR, one colony was used to inoculate an ovemight culture and 3ml of 
overnight culture was used to inoculate 1 litre of YT-broth with Carbenicillin. When the OD 
reached 0.6-0.7, IPTG was added to a final concentration of 0.2mM and 0.04% (w/v) 
L-arabinose was added to induce the expression of MtrR. The temperature was then adjusted 
to 28°C and the cells were harvestd 3 hours after induction. 
The cells were resuspended in buffer Tris 20mM NaCl 300mM Glycerol 10% pHS.O. 
After adding an appropriate amount of DNAase I and Proteinase inhibitor tablets, the cells 
were passed through French Press twice at the pressure of 20KPS1. Ultracentrifugation was 
perfomied and then the supernatant was collected. 
After loading to the Nickel chelating columns, the columns were washed by Tris 20mM 
NaCI 300mM Glycerol \0% Imidazole 50mM pH 8.0 and the protein was eluted with the 
buffer above but with 300mM imidazole. 
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Figuie 5.1 the M t i R al'tei- benig pui ' i l ied using a Nicke l chelating column 
1 2 3 4 
6 4 K D ; i - " 
5 I K D , i - • * 
2 8 K D a - ^ ^ M t r R 
l ^ K D a - • I'-
I 2 K D J -
Lane 1: .SeeBliie marker ( Invi t rogen) 
Lane 2.4: Mt rR fractions f r o m Nickel chelating columns 
In order to get l i igh pur i t \ M t i R . a further gel filtration pur i f ica t ion step was performed 
afierwards. . \ n l l i l o a d U>,60 superdex 200 prep grade gel filtration column f r o m , '\mersliam 
was equilibrated first u i lh bu l fe r ' l ris 2 0 m M N a t l 3()()mM Glycerol 10"o D T T l i n M pH 8.0. 
5inl o l ' Mt rR protein solution was loaded onto the co lumn using a superloop. which is 
tlesigned to load a large annnint o f sample (up to 20ml) to chromatographic columns, then the 
protein was eluted wi th the buf fe r abo\e, the fractions o f two peaks were collected and 
analysi/etl by SDS-PAGE electrophoresis. 
Figure 5.2 the gel filtration chromatography o f M t r R 
V l t r R Hiload 1660 SirpcTdex200 170806 
MtrR lliLoad l<>60 StiperdexZOO 170806 
MirR HiLoacI 1660 -Siiperdex2(.>0 170806 
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Figure 5.3 The SDS-PAGE electrophoresis analyses effractions 
1 2 3 4 5 6 7 8 9 10 11 12 13 
19lkDa--
64KDa-





Lane 1: SeeBlue Marker (Invitrogen) 
Lane 2-3: fractions o f peak] 
Lane 4-13: fractions o f peak 
From the gel, the first peak of MtrR gel filtration chromatography doesn't contain 
reasonable MtrR protein according to the size of the peak. This phenomenon has been found 
for another regulating repressor that was purified in our lab. It might due to the fact that 
oligomeric MtrR is able to bind the DNA from host cells, which has an absorbance at 260nm. 
The second peak is the pure MtrR that was used to perfonn the following study. 
5.2 Mass spectrum analysis of MtrR 
This analysis was done by Matthew F Button in the Department of Chemistry, The mass 
spectrtun indicated a Mr for MtrR of 25.26 kDa, which is consistent with the size of MtrR 
with attached 6xHistidine tag. 
5.3 The oligomeric state of MtrR and cooperative bind to double-strand DNA 
5.3.1 Determination of the oligomeric state of MtrR by Size Exclusion Chromatography (SEC) 
A Superdex 200 PC 3.2/30 column from Amersham was adopted here for the analysis of 
the oligomeric state of native MtrR and when bound DNA. Initially, the column was 
equilibrated with filtered and degassed buffer Tris 20mM NaCl 300mM Glycerol 10% pH 
8.0. Then 50|.il o f sample which has been centrifuged at 13,000rpm for 10 minutes was loaded 
onto the column. The column was washed at a flow rate of O.OSml/minute and the times of 
emergence of the samples were recorded and analysized. 
Figure 5.4 Double-stranded 31-bp oligonucleotide encompassing the m/rT?-binding site on the 
mtrC coding strand and the complementary sequence, with pseudo direct repeats underlined . 
(Hagman et al., 1997) 
5--TTTTTATCCGTGCAATCGTGTATGTATAATG-3' 
3 '-AAAAATAGGCACGTTAGCACATACATATTAC-5' 
Table 5.1 the standard samples for SEC 
Name Calculated 
M W 
Log M r Elut ion volume Kav* 
Chymotrypsinogen 20.3kDa 4.31 1.94ml 0.6592 
Ovalbumin 46.7kDa 4.67 1.84iTil 0.5852 
Adolase I82kDa 5.26 1.62ml 0.4222 
Catalase 213kDa 5.33 1.58ml 0.3926 
Dextran blue - - l.OSral -
*: Kav= (Ve-Vo) / (Vt-Vo) 
Ve is the elution volume of each sample 
Vt is the column volume, 2.4ml in this case 
Vo is the void volume, which is the elution volume of Dextran blue in this case 
According to the logMr and the Kav of each standard samples, a standard curve was 
produced and an equation for calculating the molecular mass from the elution volume derived 
from it. 
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Figure 5.5 the standard cun'e of SEC 
S E C standard curve 
y = -3.7974X + 6.8474 
The equation for calculating the log Mr(Y axis) according to Kav (X axis) in this study is 
y=-3.7974x+6.8474. 
To estimate the molecular mass of native MtrR and MtrR with ssDNA and dsDNA, the 
runs were performed as follows. 
For native MtrR, SOpl of 50)iM MtrR protein was loaded onto the column, and the saine 
buffer used for the standard samples was used to elute the protein. The elution volume was 
recorded. 
As to MtrR with ssDNA, the final concentration of MtrR (50nM) was mixed with ssDNA 
(20 | 4 M ) and left on ice for 15minutes. 
Similarly, for dsDNA, the MtrR (50|iM) was mixed with dsDNA (15)iM) and left on ice 
for 15 minutes. 
Before applying to column, all these samples were centrifuged at I3,000rpm for 10 
minutes. 
Figure 5.6 the size exclusion chromatography of MtrR and with ssDNA and dsDNA 
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Table 5.2 SEC data of native MtrR and MtrR with ssDNA and dsDNA 
Name Elution 
volume 
Kav Loa M r M r 
M t r R 1.82 
Mt rR+ssDNA 1.89 
M t r R + d s D N A 1.66 
0.5704 bv ^ 4.6814 48kDa 
equation 
0.6222 above 4.4846 30.5kDa 
0.4518 5.1317 135kDa 
From the final Mr that we got, it is easy to see that MtrR froms a dimer in its native 
state; whilst a pair of dimers appear to bind to one dsDNA. Most interestingly, in the presence 
of ssDNA, the MtrR dimer split into a pair of monomers and forms monomer-ssDNA 
complex. 
5.3.2 MtrR binds to operator DNA by ITC 
The dsDNA that was used in SEC analysis was prepared for ITC according to the 
following procedure. The same 31-mer oligonucleotide and its complementary strand as the 
ones used in the SEC experiment above were used in this study. The two single strand 
oligonucleotides were annealed as described before. The dsDNA was dialysized in a different 
dialysis cassettes with MtrR against the buffer Tris 20mM NaCI 300mM Glycerol 10% DTT 
I m M pH 8.0, overnight. The concentration of dsDNA was detennined by testing the OD^fio; 
then adjusting the concentration of dsDNA lo 50mM with the buffer that the D N A and MtrR 
protein has been dialysized in. 
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Figure 5.7 the interaction of MtrR with 31-mer double strand oligonucleotide by ITC 
Time (min) 
10 20 30 <o 50 50 
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Table 5.3 Thennodynamic paraineters o f interaction 
Protein Phases N K(M" ' ) AH(K.Cal'M"') AS(Cal 'M-'K"') 
dsDNA/MtrR 2 () .03I3±0.00I0I 8.35x10' 2.1 152 
0.204±0.0I77 1.54x10" 2.28 -3.48 
5.4 Human antimicrobial polypeptide L L - 3 7 binds to MtrR 
5.4.1 MtrR can bind LL-37 
Before applying to calorimetry analysis, the MtrR from peak two of the gel filtration 
chromatography (Fig 5.4) was dialysized against the buffer Tris 20mM NaCI 300mM 
Glycerol 10% DTT I m M pH8.0, overnight. The buffer was collected as well as the protein 
for the purpose of dissolving the substrates. 
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Figure 5.8 the sequences of synthesized fragments of LL-37 (all the LL-37 peptide fragments 
were sythesized by Mr Matthew burton in the Department of Chemistry, Durham University) 
Sequence of L L - 3 7 : 
1 10 20 30 
L L G D F F R K S K E K I G K E F K R I V Q R I K D F L R N L V P R T E S 
L L - 3 7 full length 
Synthesized L L - 3 7 fragments: 
L L G D F F R K S K E 
L L - 3 7 N T (1-11) 
F K R I V Q R I K D F L R 
L L - 3 7 Core (17-29) 
D F L R N L V P R T E S 
L L - 3 7 C T (26-37) 
Figure 5.9 LL-37 NT (1-11) titrated into MtrR 
Time (min) 
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It was not surprising to Unci out that LL-37 NT (1-1 1) did not bind to MtrR from ITC. 
From the reported studies oi' LL-37, the N-temiinous in\ol\es in oligomer formation instead 
o f a n t i m i c r o b i a I a c t i \ • i I y. 
Fiuure 5.10 LL-37 Core (17-29) titrated into MtrR 
0 0 0 
•0 30 
•0 35 
Obviously, the core part of LL-37 (17-29) can bind to MtrR from ITC. Unfortunately, 
the experiment wasn't accomplished due to the failure of the equipment. This needs to be 
conducted again once the peptide is ready; and then the thermodynamic parameter can be 
calculated. 
figure 5.11 LL-37 CT (26-37) titrated into MtrR 
Time (min) 
-10 0 10 20 30 1 0 50 60 70 BO 
-05 0,0 0 5 1 0 1 5 20 25 30 35 4Q 4 5 
Molar Ratio 
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A endothermic interation was detected when ImM ofLL-B? C-terminal part (29-37) was 
titrated into 120|.ilVI of MtrR, with binding stoichiometry of 1.3, Kd of 0.33M , enthalpy of 
-16.7KCal-M ' and entropy of-26.5Cal'M"'K"'. 
5.4.2 LL-37 resistance is due to the overexpression of MtrCDE system 
To test i f the resistance to LL-37 resistance is due to MtrCDE system, a growth curve 
analysis was adapted to see i f the pump system can export this antimicrobial polypeptide. 
From the above ITC data, it is already clear that the C-terminal end of LL-37 can bind MtrR. 
Accordingly, LL-37 CT (26-37) was used as a substrate for various recombinant strains. 
Figure 5.14 growth curve of Mtr system with presence of LL-37 CT (26-37) 
control 
MtrCD 
MtrCDE n 0.6 
Time (h) 
It is obvious from the growth of the control cells (Kam3/pACYC) and the one 
overexpress MtrD alone couldn't export the LL-37 CT, so their growth was totally inhibited. 
However, the strain expressing MtrC and MtrD was partially inhibited in comparison with the 
one that overexpress MtrCDE, which grew the fastest. 
5.5 MtrR may work like a beta-lactamase 
Because it has been reported that the Penicillin G (PG) resistance in Neisseria 
gonorrhoea is due to the overexpression of the Mtr system, we had the initial idea of testing 
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whether MtrR would bind Penicillin G. However, our ITC analysis of MtrR with PG revealed 
a potentially different story. 
ITC was originally developed to measure binding energies and was recently introduced as 
a powerful tool for assaying enzyme kinetics in soluble systems and characterized by the 
mechanism, £• + 5 £ 5 — > E + P , Where enzyme (E) binds reversibly to the 
substrate (S) to fonn an enzyme-substrate complex (ES), which then undergoes an essentially 
irreversible reaction characterized by rate constant (kcat) to form product (P) and release the 
enzyme. As long as the enzyme is not saturated with substrate, subsequent titrations with 
substrate aliquots wi l l result in increased bound enzyme concentrations in the cell and thus 
the differential thermal power level at each steady state wi l l change accordingly. Once 
saturation is achieved, the thennal power does not change with increased substrate 
concentrations in the cell and instead remains constant as long as the enzymes maintain 
activity and the substrate to enzyme ratio remains high. 
Tris-HCI buffer (Tris 20mM NaCl 300mlVI Glycerol 10% pH 8.0) was used initially for 
FTC with PG, an apparent buffer effect was found under these conditions. 
Fisure 5.15 Penicillin G titrated into MtrR in Tris buffer 
UTRRP9nGRAW_Ep 
MTRRPenGBASE 
33.33 66.67 100.00 
Time (min) 
The baseline shift was caused by PG being hydrolyzed, while the buffer effect was 
introduced by some ingradient in the Tris-HCI buffer. A control was done to see i f this was 
the case. 
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The same buffer effect appeared when the PG was titrated into Tris-HCl buffer. However, 
the basehne shift that appeared when titrated PG into MirR didn't present, which suggests that 
PG was really hydrolyzed for some reason other than the bulTer. 
Phosphate buffer (Na:HPO_, 20mM NaGl 2()()mM (ilyccrol 10% pH7.8) was then used to 
repeat the same titration, which was undeilaken by titrating ImM PG into 12()|aM MtrR at 
25°C. 
Figure 5.17 Enzyme-substrate reaction test of MtrR with Penicillin G by ITC with Multi 
Injection Method ( M I M ) in phosphate buffer 
MtrRPG3RAW_cp 
' 1 ' 1 ' 1 ' 1 1 1 < 1 ' 1 I 1 < 1 1 I < 
-
-500 0 500 1000 1500 2000 2500 3000 3500 4000 4500 5000 
Timeisec) 
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Figure 5.18 Enzvme Kinetic Parameters 
0 QQ005 -
0.1 0 2 
IS] (mM) 
To further understand this hypothesis. His 105 of MtrR was substituted to Tyr (was done 
by Bing Zhang, Department of Biological and Biomedical Science), which was reported to be 
found in Penicillin G sensitive isolates(Pan and Spratt, 1994). After titrating Penicillin G into 
MtrRHlOSY, the Kcat, ICm and Kcat/Km were shown in table 5.5. 
Figure 5.19 PG titrated into MtrR H105Y 
H102YPGRAW_cp 
92 
' 1 • ! 
r 
'•A 
-500 0 500 1000 1500 2000 2500 3000 3500 4000 4500 
Time(sec) 
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Figure 5.20 Enzvme Kinetic Parameters of MtrR H105Y with PG 
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Table 5.5 Comparison of MtrR WT and MtrR H105Y 
Kcat (mM S"') KjTi{mM) Kcat/Klm 
MtrR WT 9.09±0.08xl0" ' 0.12±0.0028 7.575x10-^ 
MtrR HI05Y 3 . 0 7 ± 0 . 0 4 5 x l o ' 0.0911±0.0037 3.37x10'-' 
The reduced Kcat/Km of MtrR H105Y showed the less activatity of mutant MtrR than 
wild type one. 
The beta-lactamase inhibitor Clauvlanic acid was used to test i f it could block the activity 
of MtrR. First, I m M Clauvlanic acid was titrated into O.lmM MtrR (in phosphate buffer) to 
see i f they could bind to one other, then 2mM of PG was titrated directly into the mixture of 
MtrR with clauvlanic acid from the last titration. It showed that after binding with clauvlanic 
acid, MtrR is incapable of hydrolyzing Penicillin G anymore, which was reflected from the 
disappearance of the baseline shifting. 
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Figure 5.21 PG titrated into MtrR with Claviilanic acid 
Time (min) 
-10 0 -a 20 30 10 50 60 70 60 30 100 
0 0 0 5 1.0 15 
IVIolar Ratio 
5.6 Discussion 
DNA binding stoichiometry- To determine the oligomeric state of native MtrR and with 
its operator, Size Exclusive Chromatogrphy (SEC) was used to estimate the Mr of MtrR under 
non-denaturing conditions (Fig 5.6). After producing a standard curve for a series of protein 
with known Mr, we are able to calculate the Mr of unknown proteins according to their 
elution volumn. MtrR alone ran as a single protein peak, with a calculated M r of 48 kDa that 
is consistent with a homodimer (with a predicted M r of 50.5 kDa). However, upon the 
addition of a quartennolar concentration of dsDNA, the peak shifted forward, indicating that 
it fonns complex with DNA. This complex had a calculated Mr of 135 kDa, consistent with 
the formation of a tetramer (4 protomerx25.26kDa=101KDa, 31 bpx660Da/bp=25.5kDa, 
I26.5kDa in total), as would be expected i f a pair of MtrR dimers bound to the DNA. The 
difference can be explaned to the non-globular overall stmcture of the MtrR-dsDNA complex. 
This result is consistent with previous work on MtrR(Hoffmann et al., 2005), in which 
fluorescence polarization assay and Dynamic Light Scattering were used to detennine the 
stoichiometry that MtrR employs. This DNA binding stoichiometry is the same as that 
utilized by TetR family member QacR(Schumacher et al., 2002) but different to the other two 
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members, TetR which binds one dimer (Oilh el ciL, 2000) and EthR which putatively binds 
four dimers (Dover e! al.., 2004). Interestingly, we found that MirR could bind ssDNA (e.g. 
either strand of the promoter dsDNA) to fomi a complex that had a calculated Mr of 
30.5 kDa, suggesting that the dimer interface was destabilised by the presence of the ssDNA. 
The C-ierminal fragments ofLL-37 is the part that binds to MirR- Antimicrobial peptides 
and their precursor molecules form the central part of human and mammalian inate immunity 
against both Gram-positive and Gram-negative bacteria, fungi and virases. There are two 
groups of antimicrobial peptides, defensins and cathelincidins, which contribute to the peptide 
based defense in mammals. Defensins contain conserved cysteine residues in their sequences 
and exhibit characteristic p-sheet structures stabilized by intramolecular disulfide 
bonds(Shafer et al., 1998), whilst cathelicidins are characterized by highly conserved 
cathelin-like pro-sequences and variable carboxyl-terminal sequences(Gennaro and Zanetti, 
2000; Zanetti et «/., 1995). LL-37. the only cathelicidin-derived antimicrobial peptide found 
in humans, is a 37-residues, amphipathic helical peptide that has been shown to exhibit a 
broad spectrum of antimicrobial activity. The structure of LL-37 was reported as a 
helix-turn-helix conformation, with KL12 located at the break point between the N-terminal 
and C-tenninal helices (Hung et al., 1998; Porcelli et al., 2008). It has been reported that 
LL-37 resistance in Neisseria gonorrhoe is due to the mtr efflux system(Shafer et al., 1998). 
Moreover, the nitr system was also reported to be involved in the LL-37 resistance in 
Neisseria meningitic/es(Tzeng et al., 2005). Our results from growth curve studies also 
support this report. The growth of the strain that expressed MtrCDE wasn't inhibited by 
LL-37, which means that MtrCDE can fonn a precise efflux pump to export this oligo 
peptide. To understand which part of LL-37 that can bind MtrR, the transcriptional repressor 
of the mtr system, a series of LL-37 fragments were synthesized and titrated into MtrR in a 
calorimeter. Unfortunately, these ITC experiments haven't been accomplished due to the 
failure of synthesiser. From the data already got, we can tell that the C-terminal part of LL-37 
(17-37) can bind MtrR, whilst the N-tenninal fragment (1-1 J) can't. This result resembles 
previous research that reported the C-tenninal part of LL-37 has the antibacterial activity, 
while N-terminal has not (Buchaklian and Klug, 2006; Nagaoka et a I., 2002). Another 
important point is, that our results may bive rise to a new mechanism for amphipathic 
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a-helical antimicrobial peptides, which is different from the present hypothesis that LL-37 
interrupts the cell membrane by its integration via a "barrel-stave" model or a carpet 
model(Henzler Wildman el al., 2003; Porcelli ef a/., 2008). I f LL-37 can bind to MtrR, this 
possibly suggests another unknown mechanism of LL-37 antimicrobial activity other than 
disniption of cell membrane. 
MtrR may work as a 8-laclaniase- This is still an ongoing work and needs to be 
confomied. The p-lactamase family of enzymes degrade P-lactam antibiotics and are found 
widely disseminated amongst Gram-positive and Gram-negative bacteria. They are excreted 
into the periplasm in Gram-negative bacteria. The catalytic mechanisms by which these 
enzymes inactivate p-lactam antibiotics are through the hydrolysis of the amide bond of the 
p-lactam ring (Frere, 1995; Livermore, 1995). In this study, because the MtrR was shown to 
belong to Penicillin G resistance N.gonorrhoeae by Mass Spectrometry, which has a Histidine 
at 105, our initial aim was to test for the interaction of MtrR with penicillin G by ITC. 
Suiprisingly. the results looked like enzyme-hydrolysis reaction (fig 5.17), characterised by 
Kcat, Km and Kcat/Kin with values of 9.09±0.08x lO ' m M S"', 0.12±0.0028 mM and 
7.575x10" respectively. Moreover, this catalystical reaction could be inhibitated by the 
P-lactamase inhibitor cla\adanic acid (f ig 5.19, fig 5.20). The Penicillin G in the MtrR-PG 
mixture was analysized by mass spectrometry after eliminating the protein, and compared 
with pure Penicillin G, these studies revealed that the p-lactam ring was all hydrolyzed to the 
open fomi , while those of latter were only partially opened (was done by Matthew Burton, 
Department of Chemistry, data not shown). To further test this hypothesis, His]05 of MtrR 
was substituted to Tyr, which was reported to be found in Penicillin G sensitive isolates(Pan 
and Spratt, 1994). After titrating Penicillin G into MtrRH105Y, the Kcat, K m and Kcat/Km 
values were 3.07±0.045xl0' ' ' mM S"', 0.091 l±0.0037mM and 3.37x10-' respectively, 
indicating that MtrRHlOSY is less efficient than MtrRWT at hydrolyzing Penicillin G. 
For the reason that the hydrolyzing activity of MtrR can be inhibited by clauvlanic acid, it 
might classify in Class A/D beta-lactamase, which are penicillinases, cephalosporinases, 
inhibited by clavulanic acid and act by a serine-based mechanism. According to this, the 
future work should focus on the alignment of MtrR with know beta-lactamase in same group. 
After finding the conserved motifs of MtrR with other beta-lactamases, mutagenesis can be 
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used toidetermine the limpdrtaiice dftlhese cohsei vedi hiotifs.-
Although iall the datai so ilar showed the beta-lactamase activity' of MtrR; ilhere: is still 
adoubt about this fiiidijig,; for example, how is iit: necessary lo hydrolyze PeniciJilini G in 
eyiGplasm \vhile Penicijlini disiiipt' the cell wall sytliesis by Ibinding !to ipenicillin-'Binging 
--PrGtein in (periplasm? Does Renicijlm/G dissociate MtrR front' the /);/;• promoter, enabling 
ti^aiiscriptidh of the MtrC-DE system! like other repressor? Uhforlunatly, lowilig; to' tiine 
constraints, tin-ther'biocheniical studies,could notIbe conducted to elucidate this clearly, bul it 
w i l l be an Interesting directionj lor futher 'Work. 
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Chapter 6 Final discussion 
In Gram-negative bacteria, the tripartite-pumps that consist of an IMP and an OMP, as 
well as a periplasmic MFP, compose a pump that can span across the inner and the outer 
membranes, are considered to be involved in the extnision of cytotoxic compounds, such as 
antibiotics and other antimicrobial compounds. To further understand how these proteins are 
assembled we have characterized the Neisseria! MtrCDE pump, which is an important 
contributor in conferring resistance to penicillin and structural diverse hydrophobic agents 
(HAs), such as drugs, dyes, detergents and host-derived compounds (fatty acids and bile salts), 
as well as some cationic antimicrobial peptides, such as PC-8 and LL-37(Shafer et al., 1998; 
Tzenget al., 2005) 
Crystallization attempts of the Inner membrane protein MtrD and the Outer 
membrane protein MtrE-J\\tst two membrane protein were overexpressed and purified 
successfully using the non-ionic detergent DDM. A sparse matrix screen was used for 
establishing initial conditions and better quality crystals were produced by optimization 
screens, with the best crystals of MtrD and MtrE shown to diffract to 20A and 8 A 
respectively. Although we didn't elucidate the crystal structures for MtrD and MtrE yet, 
crystallisation trials have successfully yielded crystals that bring us a step closer to realising 
this potential. It is anticipated that successful structural detennination wil l elucidate the 
mechanism by which MtrE interacts with its cognate antiporter MtrD. The crystal structure 
wi l l also provide insights into how these three components assemble together and act as a 
functional efflux pump. 
MtrCDE form a functional tripartite efflux pump- Using pull-down assays and ITC 
experiments, the MFP MtrC was shown to bind both the IMP MtrD and the OMP MtrE. In 
growth curve studies, the resistance of MtrD transformant could be elevated by the presence 
of MtrC and it was further enhanced by MtrE, indicating MtrCDE could form an extaiding 
pump. Interestingly, the a-helical hairpin domain of MtrC binds to both MtrD and MtrE. The 
hairpin bound to a high-affinity site on MtrE, with a slightly greater affinity than MtrC, and 
with a similar affinity to MtrD, suggesting the hairpin domain is the primary domain 
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interacting with MtrE, while the (3 bairel domain and lipoyi domain is largely responsible for 
the high-affmity binding of MtrC to MtrD. In order to study the opening mechanism of the 
OMP MtrE, Vancomycin was introduced into giowth curve analyses. The results showed that 
the presence of both the IMP Mt rD and the substrates Nafcillin are required for opening of 
MtrE. 
The MtrC hairpin domain forms a hexameric structure- The fonnation of the MFP 
oligomers has been shown as a precondition of transport activity(Zginskaya and Nikaido, 
2000). To find out the stoichiometry of binding, we used EGS as a cross-linker to test for 
interactions between MtrC hairpins, establishing that a number of complexes could be trapped 
up to and including the hexamer. Similarly, cross-linking NT-MtrC indicated that it can fomi 
hexamers. A F M images revealed that the hairpins are assembled into a cylindrical structure, 
which could accommodate the MtrE trimer, assuming this has similar dimensions to TolC. 
These results indicate that the oligomeric the MFP is an hexamer, which may lead to a 
stoichiometry of 1:2:1 (1MP:MFP:0MP) for the pump assembly, which resembles the one 
proposed by Akama et al in 2004(Akama et al., 2004b). 
A possible tetrameric state for DNA-hound MtrR- Through analytical SEC, the Mr of 
both apo and DNA-bound forms of MtrR were calculated to be --48kDa and ~ l 35 kDa, which 
would be consistent with apo MtrR forming a dimer and a pair of dimers binding to ds DNA. 
Interestingly, when bound to single strand DNA, the MtrR dimer split into monomers. This 
result is consistent with the previous work on MtrR(Hoffmann et al., 2005). This DNA 
binding stoichiometry is the same as another TetR family member, QacR(Schumacher et al., 
2002). 
The C-terminal fragments of LL-37 can bind to MtrR- ITC was used to test for the 
interaction between MtrR and a vaiety o f LL-37 fragments. It has been reported that LL-37 
resistance in Neisseria gonorrhoe is due to the mtr efflux system(Shafer et a/., 1998). 
N-temiinal 1-11), core (17-29) and C-terminal (26-37) of LL-37 were sythesised in the 
Department of Chemistry and tested for binding to MtrR. We showed that the C-terminal part 
of LL-37 is the active part in binding MtrR, with an approximate binding stiochiometi7 of 1:1. 
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This work hasn't reached a final conclusion yet, but it is anticipated that we can work out the 
binding domain of MtrR with this a-helical antimicrobial peptide, as well as how LL-37 
regulates the expression of the mtr system. 
MtrR may work as a S-lactainase-This is still an ongoing work. Based on the result of 
catalytical reaction of Penicillin G with MtrR and that its enzymatic activity can be inhibited 
by P-lactamase inhibitor, we assume that MtrR works as a P-lactamase. Less activity was 
found for MtrRHiOSY, which was reported to belong to a Penicillin G sensitive strain. 
Previous works have shown decreased hypersusceptibility to Penicillin that is caused by the 
mutantions in MtrR, but after testing the MtrR-Penicillin G interaction by ITC, stopped flow, 
electrophoretic mobility shift assay and Size Exlusion Chromatography, we could neither get 
any evidence that Penicillin binds to MtrR, nor Penicillin G could dissociate the MtrR-DNA 
complex. We have tested the growth of cells expressing Mti-CDE, in presence of Penicillin G; 
these cells were unable to grow like those that don"t ovcrexpress drug pumps, indicating that 
theMtrCDE drug pump couldn't export Penicillin. Drawing us to further conclude, although 
more evidence are needed to prove our hypothesis, that MtrR acts as a P-lactamase, raised a 
possible mechanism of P-lactam resistance in bacteria. 
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